[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	918.9345	2	14	MEEEIAALVIDNGSGMCK	M(Met-loss+Acetyl)EEEIAALVIDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-11_FTMSms2hcd	60.527	1	18	57.0	2.9e-21	3.0e-24	1	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-11_FTMSms2hcd	22.825	313	326	56.5	4.2e-18	5.5e-21	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	849.6371	5	10	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHRK	Oxidation@355	37	V20130429-11_FTMSms2hcd	76.758	337	373	54.5	8.5e-17	1.8e-19	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	1116.0393	2	2.9	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-11_FTMSms2hcd	47.929	292	312	54.0	2.7e-16	2.6e-19	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	239	254	51.5	3.7e-15	4.3e-18	10	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	360	373	47.7	8.9e-14	1.1e-16	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	787.0576	3	-0.67	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-11_FTMSms2hcd	41.801	291	312	46.9	1.6e-13	1.7e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	977.5388	2	3.0	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.644	96	113	46.1	2.1e-13	5.8e-16	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-11_FTMSms2hcd	23.408	360	373	39.1	5.1e-13	6.0e-16	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	1067.2146	3	6.3	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-11_FTMSms2hcd	53.150	148	177	34.0	7.7e-13	1.1e-15	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	51	62	36.4	1.3e-12	1.7e-15	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	85	95	30.4	6.1e-12	8.0e-15	9	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-11_FTMSms2hcd	37.721	184	191	31.2	2.1e-11	4.0e-14	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-11_FTMSms2hcd	24.770	316	326	38.4	3.2e-11	4.9e-14	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	51	61	38.8	6.9e-11	1.4e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-11_FTMSms2hcd	17.559	40	62	26.1	1.7e-10	1.6e-13	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	327	336	36.8	2.6e-9	8.9e-11	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	29	39	42.0	1.7e-8	6.4e-11	9	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	329	335	27.1	7.4e-7	4.0e-9	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	316	326	25.9	8.6e-7	1.4e-9	6	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	566.7700	2	5.1	GYSFTTTAER	GYSFTTTAER		10	V20130429-11_FTMSms2hcd	24.715	197	206	36.7	3.3e-6	5.8e-9	2	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-11_FTMSms2hcd	47.388	178	191	22.8	7.7e-6	9.8e-9	7	41793.2	HUMAN	Actin, cytoplasmic 2
[1]		P63261	ACTG_HUMAN	ACTG1	23	64.0	11.81	2.9e-21	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	62	68	17.9	0.019	1.2e-4	10	41793.2	HUMAN	Actin, cytoplasmic 2
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	890.8930	2	3.3	MDDDIAALVVDNGSGMCK	M(Met-loss+Acetyl)DDDIAALVVDNGSGM(Oxidation)CK	Met-loss+Acetyl@1;Oxidation@16	18	V20130429-11_FTMSms2hcd	52.215	1	18	57.0	3.5e-21	4.5e-24	1	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@313;Oxidation@325	14	V20130429-11_FTMSms2hcd	22.825	313	326	56.5	4.2e-18	5.5e-21	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	849.6371	5	10	YSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK	YSVWIGGSILASLSTFQQM(Oxidation)WISKQEYDESGPSIVHRK	Oxidation@355	37	V20130429-11_FTMSms2hcd	76.758	337	373	54.5	8.5e-17	1.8e-19	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	1116.0393	2	2.9	DLYANTVLSGGTTMYPGIADR	DLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	21	V20130429-11_FTMSms2hcd	47.929	292	312	54.0	2.7e-16	2.6e-19	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	239	254	51.5	3.7e-15	4.3e-18	10	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	360	373	47.7	8.9e-14	1.1e-16	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	787.0576	3	-0.67	KDLYANTVLSGGTTMYPGIADR	KDLYANTVLSGGTTM(Oxidation)YPGIADR	Oxidation@305	22	V20130429-11_FTMSms2hcd	41.801	291	312	46.9	1.6e-13	1.7e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	977.5388	2	3.0	VAPEEHPVLLTEAPLNPK	VAPEEHPVLLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.644	96	113	46.1	2.1e-13	5.8e-16	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-11_FTMSms2hcd	23.408	360	373	39.1	5.1e-13	6.0e-16	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	1067.2146	3	6.3	TTGIVMDSGDGVTHTVPIYEGYALPHAILR	TTGIVM(Oxidation)DSGDGVTHTVPIYEGYALPHAILR	Oxidation@153	30	V20130429-11_FTMSms2hcd	53.150	148	177	34.0	7.7e-13	1.1e-15	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	51	62	36.4	1.3e-12	1.7e-15	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	85	95	30.4	6.1e-12	8.0e-15	9	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@190	8	V20130429-11_FTMSms2hcd	37.721	184	191	31.2	2.1e-11	4.0e-14	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@325	11	V20130429-11_FTMSms2hcd	24.770	316	326	38.4	3.2e-11	4.9e-14	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	51	61	38.8	6.9e-11	1.4e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@44;Oxidation@47	23	V20130429-11_FTMSms2hcd	17.559	40	62	26.1	1.7e-10	1.6e-13	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	327	336	36.8	2.6e-9	8.9e-11	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	29	39	42.0	1.7e-8	6.4e-11	9	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	329	335	27.1	7.4e-7	4.0e-9	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	316	326	25.9	8.6e-7	1.4e-9	6	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	566.7700	2	5.1	GYSFTTTAER	GYSFTTTAER		10	V20130429-11_FTMSms2hcd	24.715	197	206	36.7	3.3e-6	5.8e-9	2	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@190	14	V20130429-11_FTMSms2hcd	47.388	178	191	22.8	7.7e-6	9.8e-9	7	41737.1	HUMAN	Actin, cytoplasmic 1
[1-1]	1	P60709	ACTB_HUMAN	ACTB	23	64.0	11.77	3.5e-21	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	62	68	17.9	0.019	1.2e-4	10	41737.1	HUMAN	Actin, cytoplasmic 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-11_FTMSms2hcd	22.825	315	328	56.5	4.2e-18	5.5e-21	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	241	256	51.5	3.7e-15	4.3e-18	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	659.6408	3	1.0	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-11_FTMSms2hcd	38.439	71	86	34.9	5.0e-14	5.3e-17	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	869.1639	4	-0.98	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-11_FTMSms2hcd	53.321	71	97	45.3	4.5e-13	4.4e-16	2	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	53	64	36.4	1.3e-12	1.7e-15	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	87	97	30.4	6.1e-12	8.0e-15	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-11_FTMSms2hcd	37.721	186	193	31.2	2.1e-11	4.0e-14	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-11_FTMSms2hcd	24.770	318	328	38.4	3.2e-11	4.9e-14	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	53	63	38.8	6.9e-11	1.4e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-11_FTMSms2hcd	17.559	42	64	26.1	1.7e-10	1.6e-13	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	329	338	36.8	2.6e-9	8.9e-11	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	31	41	42.0	1.7e-8	6.4e-11	9	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	1049.8094	3	-11	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-11_FTMSms2hcd	59.049	259	286	19.7	2.6e-7	2.5e-10	4	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	331	337	27.1	7.4e-7	4.0e-9	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	318	328	25.9	8.6e-7	1.4e-9	6	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-11_FTMSms2hcd	47.388	180	193	22.8	7.7e-6	9.8e-9	7	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-2]	3	P68032	ACTC_HUMAN	ACTC1	17	39.5	10.10	4.2e-18	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	64	70	17.9	0.019	1.2e-4	10	42019.4	HUMAN	Actin, alpha cardiac muscle 1
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-11_FTMSms2hcd	22.825	315	328	56.5	4.2e-18	5.5e-21	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	241	256	51.5	3.7e-15	4.3e-18	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	659.6408	3	1.0	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-11_FTMSms2hcd	38.439	71	86	34.9	5.0e-14	5.3e-17	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	869.1639	4	-0.98	YPIEHGIITNWDDMEKIWHHTFYNELR	YPIEHGIITNWDDM(Oxidation)EKIWHHTFYNELR	Oxidation@84	27	V20130429-11_FTMSms2hcd	53.321	71	97	45.3	4.5e-13	4.4e-16	2	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	53	64	36.4	1.3e-12	1.7e-15	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	87	97	30.4	6.1e-12	8.0e-15	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-11_FTMSms2hcd	37.721	186	193	31.2	2.1e-11	4.0e-14	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-11_FTMSms2hcd	24.770	318	328	38.4	3.2e-11	4.9e-14	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	53	63	38.8	6.9e-11	1.4e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-11_FTMSms2hcd	17.559	42	64	26.1	1.7e-10	1.6e-13	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	329	338	36.8	2.6e-9	8.9e-11	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	31	41	42.0	1.7e-8	6.4e-11	9	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	1049.8094	3	-11	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-11_FTMSms2hcd	59.049	259	286	19.7	2.6e-7	2.5e-10	4	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	331	337	27.1	7.4e-7	4.0e-9	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	318	328	25.9	8.6e-7	1.4e-9	6	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-11_FTMSms2hcd	47.388	180	193	22.8	7.7e-6	9.8e-9	7	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-3]	3	P68133	ACTS_HUMAN	ACTA1	17	39.5	10.10	4.2e-18	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	64	70	17.9	0.019	1.2e-4	10	42051.4	HUMAN	Actin, alpha skeletal muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@315;Oxidation@327	14	V20130429-11_FTMSms2hcd	22.825	315	328	56.5	4.2e-18	5.5e-21	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	241	256	51.5	3.7e-15	4.3e-18	10	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	659.6408	3	1.0	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@84	16	V20130429-11_FTMSms2hcd	38.439	71	86	34.9	5.0e-14	5.3e-17	4	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	53	64	36.4	1.3e-12	1.7e-15	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@192	8	V20130429-11_FTMSms2hcd	37.721	186	193	31.2	2.1e-11	4.0e-14	7	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@327	11	V20130429-11_FTMSms2hcd	24.770	318	328	38.4	3.2e-11	4.9e-14	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	53	63	38.8	6.9e-11	1.4e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@46;Oxidation@49	23	V20130429-11_FTMSms2hcd	17.559	42	64	26.1	1.7e-10	1.6e-13	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	329	338	36.8	2.6e-9	8.9e-11	7	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	31	41	42.0	1.7e-8	6.4e-11	9	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	1049.8094	3	-11	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@271=38	28	V20130429-11_FTMSms2hcd	59.049	259	286	19.7	2.6e-7	2.5e-10	4	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	331	337	27.1	7.4e-7	4.0e-9	7	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	318	328	25.9	8.6e-7	1.4e-9	6	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@192	14	V20130429-11_FTMSms2hcd	47.388	180	193	22.8	7.7e-6	9.8e-9	7	42009.4	HUMAN	Actin, aortic smooth muscle
[1-4]	2	P62736	ACTA_HUMAN	ACTA2	15	36.6	10.10	4.2e-18	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	64	70	17.9	0.019	1.2e-4	10	42009.4	HUMAN	Actin, aortic smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	790.9054	2	0.81	MQKEITALAPSTMK	M(Oxidation)QKEITALAPSTM(Oxidation)K	Oxidation@314;Oxidation@326	14	V20130429-11_FTMSms2hcd	22.825	314	327	56.5	4.2e-18	5.5e-21	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	240	255	51.5	3.7e-15	4.3e-18	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	659.6408	3	1.0	YPIEHGIITNWDDMEK	YPIEHGIITNWDDM(Oxidation)EK	Oxidation@83	16	V20130429-11_FTMSms2hcd	38.439	70	85	34.9	5.0e-14	5.3e-17	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	677.8154	2	0.13	DSYVGDEAQSKR	DSYVGDEAQSKR		12	V20130429-11_FTMSms2hcd	11.431	52	63	36.4	1.3e-12	1.7e-15	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-11_FTMSms2hcd	37.721	185	192	31.2	2.1e-11	4.0e-14	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	589.3106	2	0.53	EITALAPSTMK	EITALAPSTM(Oxidation)K	Oxidation@326	11	V20130429-11_FTMSms2hcd	24.770	317	327	38.4	3.2e-11	4.9e-14	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	599.7643	2	-0.76	DSYVGDEAQSK	DSYVGDEAQSK		11	V20130429-11_FTMSms2hcd	12.961	52	62	38.8	6.9e-11	1.4e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	635.5474	4	0.54	HQGVMVGMGQKDSYVGDEAQSKR	HQGVM(Oxidation)VGM(Oxidation)GQKDSYVGDEAQSKR	Oxidation@45;Oxidation@48	23	V20130429-11_FTMSms2hcd	17.559	41	63	26.1	1.7e-10	1.6e-13	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	328	337	36.8	2.6e-9	8.9e-11	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	30	40	42.0	1.7e-8	6.4e-11	9	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	1049.8094	3	-11	CPETLFQPSFIGMESAGIHETTYNSIMK	CPETLFQPSFIGM(Oxidation)ESAGIHETTYNSIMK	Oxidation@270=38	28	V20130429-11_FTMSms2hcd	59.049	258	285	19.7	2.6e-7	2.5e-10	4	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	330	336	27.1	7.4e-7	4.0e-9	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	581.3100	2	-4.9	EITALAPSTMK	EITALAPSTMK		11	V20130429-11_FTMSms2hcd	31.689	317	327	25.9	8.6e-7	1.4e-9	6	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-11_FTMSms2hcd	47.388	179	192	22.8	7.7e-6	9.8e-9	7	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-5]	2	P63267	ACTH_HUMAN	ACTG2	15	36.7	10.10	4.2e-18	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	63	69	17.9	0.019	1.2e-4	10	41877.3	HUMAN	Actin, gamma-enteric smooth muscle
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	939	954	51.5	3.7e-15	4.3e-18	10	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	1060	1073	47.7	8.9e-14	1.1e-16	7	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-11_FTMSms2hcd	23.408	1060	1073	39.1	5.1e-13	6.0e-16	7	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	785	795	30.4	6.1e-12	8.0e-15	9	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	729	739	42.0	1.7e-8	6.4e-11	9	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	656.6871	3	-17	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.669	796	813	26.4	4.7e-8	9.4e-11	4	121364.6	HUMAN	POTE ankyrin domain family member E
[1-6]	1	Q6S8J3	POTEE_HUMAN	POTEE	7	7.2	8.51	3.7e-15	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	762	768	17.9	0.019	1.2e-4	10	121364.6	HUMAN	POTE ankyrin domain family member E
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	939	954	51.5	3.7e-15	4.3e-18	10	121445.7	HUMAN	POTE ankyrin domain family member F
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	1060	1073	47.7	8.9e-14	1.1e-16	7	121445.7	HUMAN	POTE ankyrin domain family member F
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-11_FTMSms2hcd	23.408	1060	1073	39.1	5.1e-13	6.0e-16	7	121445.7	HUMAN	POTE ankyrin domain family member F
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	785	795	30.4	6.1e-12	8.0e-15	9	121445.7	HUMAN	POTE ankyrin domain family member F
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	729	739	42.0	1.7e-8	6.4e-11	9	121445.7	HUMAN	POTE ankyrin domain family member F
[1-7]	0	A5A3E0	POTEF_HUMAN	POTEF	6	5.5	8.51	3.7e-15	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	762	768	17.9	0.019	1.2e-4	10	121445.7	HUMAN	POTE ankyrin domain family member F
[1-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	5	15.7	8.51	3.7e-15	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	239	254	51.5	3.7e-15	4.3e-18	10	42016.6	HUMAN	Putative beta-actin-like protein 3
[1-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	5	15.7	8.51	3.7e-15	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	360	373	47.7	8.9e-14	1.1e-16	7	42016.6	HUMAN	Putative beta-actin-like protein 3
[1-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	5	15.7	8.51	3.7e-15	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@360	14	V20130429-11_FTMSms2hcd	23.408	360	373	39.1	5.1e-13	6.0e-16	7	42016.6	HUMAN	Putative beta-actin-like protein 3
[1-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	5	15.7	8.51	3.7e-15	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	85	95	30.4	6.1e-12	8.0e-15	9	42016.6	HUMAN	Putative beta-actin-like protein 3
[1-8]	1	Q9BYX7	ACTBM_HUMAN	POTEKP	5	15.7	8.51	3.7e-15	656.6871	3	-17	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.669	96	113	26.4	4.7e-8	9.4e-11	4	42016.6	HUMAN	Putative beta-actin-like protein 3
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	1060	1073	47.7	8.9e-14	1.1e-16	7	121283.5	HUMAN	POTE ankyrin domain family member I
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1060	14	V20130429-11_FTMSms2hcd	23.408	1060	1073	39.1	5.1e-13	6.0e-16	7	121283.5	HUMAN	POTE ankyrin domain family member I
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	785	795	30.4	6.1e-12	8.0e-15	9	121283.5	HUMAN	POTE ankyrin domain family member I
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	400.2408	3	2.0	AVFPSIVGRPR	AVFPSIVGRPR		11	V20130429-11_FTMSms2hcd	35.029	729	739	42.0	1.7e-8	6.4e-11	9	121283.5	HUMAN	POTE ankyrin domain family member I
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	656.6871	3	-17	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.669	796	813	26.4	4.7e-8	9.4e-11	4	121283.5	HUMAN	POTE ankyrin domain family member I
[1-9]	1	P0CG38	POTEI_HUMAN	POTEI	6	5.7	7.77	8.9e-14	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	762	768	17.9	0.019	1.2e-4	10	121283.5	HUMAN	POTE ankyrin domain family member I
[1-10]	1	P0CG39	POTEJ_HUMAN	POTEJ	5	4.8	7.77	8.9e-14	822.9031	2	0.79	QEYDESGPSIVHRK	QEYDESGPSIVHRK		14	V20130429-11_FTMSms2hcd	18.297	1023	1036	47.7	8.9e-14	1.1e-16	7	117391.0	HUMAN	POTE ankyrin domain family member J
[1-10]	1	P0CG39	POTEJ_HUMAN	POTEJ	5	4.8	7.77	8.9e-14	543.2632	3	2.4	QEYDESGPSIVHRK	Q(Gln->pyro-Glu)EYDESGPSIVHRK	Gln->pyro-Glu@1023	14	V20130429-11_FTMSms2hcd	23.408	1023	1036	39.1	5.1e-13	6.0e-16	7	117391.0	HUMAN	POTE ankyrin domain family member J
[1-10]	1	P0CG39	POTEJ_HUMAN	POTEJ	5	4.8	7.77	8.9e-14	505.9215	3	0.52	IWHHTFYNELR	IWHHTFYNELR		11	V20130429-11_FTMSms2hcd	30.862	748	758	30.4	6.1e-12	8.0e-15	9	117391.0	HUMAN	POTE ankyrin domain family member J
[1-10]	1	P0CG39	POTEJ_HUMAN	POTEJ	5	4.8	7.77	8.9e-14	656.6871	3	-17	VAPEEHPILLTEAPLNPK	VAPEEHPILLTEAPLNPK		18	V20130429-11_FTMSms2hcd	40.669	759	776	26.4	4.7e-8	9.4e-11	4	117391.0	HUMAN	POTE ankyrin domain family member J
[1-10]	1	P0CG39	POTEJ_HUMAN	POTEJ	5	4.8	7.77	8.9e-14	400.7714	2	0.34	RGILTLK	RGILTLK		7	V20130429-11_FTMSms2hcd	25.261	725	731	17.9	0.019	1.2e-4	10	117391.0	HUMAN	POTE ankyrin domain family member J
[1-11]	0	Q562R1	ACTBL_HUMAN	ACTBL2	5	10.6	8.51	3.7e-15	895.9476	2	-2.2	SYELPDGQVITIGNER	SYELPDGQVITIGNER		16	V20130429-11_FTMSms2hcd	47.558	240	255	51.5	3.7e-15	4.3e-18	10	42003.6	HUMAN	Beta-actin-like protein 2
[1-11]	0	Q562R1	ACTBL_HUMAN	ACTBL2	5	10.6	8.51	3.7e-15	507.7440	2	-0.49	DLTDYLMK	DLTDYLM(Oxidation)K	Oxidation@191	8	V20130429-11_FTMSms2hcd	37.721	185	192	31.2	2.1e-11	4.0e-14	7	42003.6	HUMAN	Beta-actin-like protein 2
[1-11]	0	Q562R1	ACTBL_HUMAN	ACTBL2	5	10.6	8.51	3.7e-15	388.9201	3	-0.48	IKIIAPPERK	IKIIAPPERK		10	V20130429-11_FTMSms2hcd	21.657	328	337	36.8	2.6e-9	8.9e-11	7	42003.6	HUMAN	Beta-actin-like protein 2
[1-11]	0	Q562R1	ACTBL_HUMAN	ACTBL2	5	10.6	8.51	3.7e-15	398.2402	2	1.0	IIAPPER	IIAPPER		7	V20130429-11_FTMSms2hcd	18.791	330	336	27.1	7.4e-7	4.0e-9	7	42003.6	HUMAN	Beta-actin-like protein 2
[1-11]	0	Q562R1	ACTBL_HUMAN	ACTBL2	5	10.6	8.51	3.7e-15	547.2836	3	0.16	LDLAGRDLTDYLMK	LDLAGRDLTDYLM(Oxidation)K	Oxidation@191	14	V20130429-11_FTMSms2hcd	47.388	179	192	22.8	7.7e-6	9.8e-9	7	42003.6	HUMAN	Beta-actin-like protein 2
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	871.1329	3	11	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLM(Oxidation)TTVHAITATQK	Oxidation@175	24	V20130429-11_FTMSms2hcd	61.577	163	186	55.4	4.6e-18	1.0e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	865.7951	3	4.2	VIHDNFGIVEGLMTTVHAITATQK	VIHDNFGIVEGLMTTVHAITATQK		24	V20130429-11_FTMSms2hcd	70.890	163	186	55.0	4.2e-17	1.0e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	989.1530	3	0.35	VIISAPSADAPMFVMGVNHEKYDNSLK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	27	V20130429-11_FTMSms2hcd	42.479	119	145	45.7	8.5e-17	8.7e-20	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	847.4548	3	1.2	AENGKLVINGNPITIFQERDPSK	AENGKLVINGNPITIFQERDPSK		23	V20130429-11_FTMSms2hcd	48.230	62	84	60.0	1.0e-16	2.4e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	756.0612	3	0.36	LTGMAFRVPTANVSVVDLTCR	LTGM(Oxidation)AFRVPTANVSVVDLTCR	Oxidation@231	21	V20130429-11_FTMSms2hcd	52.373	228	248	51.1	2.7e-16	4.1e-19	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	765.0178	3	2.6	WGDAGAEYVVESTGVFTTMEK	WGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	21	V20130429-11_FTMSms2hcd	53.412	87	107	44.9	1.4e-15	1.4e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	845.4143	3	6.5	IKWGDAGAEYVVESTGVFTTMEK	IKWGDAGAEYVVESTGVFTTM(Oxidation)EK	Oxidation@105	23	V20130429-11_FTMSms2hcd	53.641	85	107	48.9	1.7e-15	1.7e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	617.3017	2	-0.39	VVDLMAHMASK	VVDLM(Oxidation)AHM(Oxidation)ASK	Oxidation@328;Oxidation@331	11	V20130429-11_FTMSms2hcd	14.862	324	334	42.6	4.5e-15	6.6e-18	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	781.1428	4	1.6	RVIISAPSADAPMFVMGVNHEKYDNSLK	RVIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEKYDNSLK	Oxidation@130;Oxidation@133	28	V20130429-11_FTMSms2hcd	40.256	118	145	32.5	1.1e-13	1.3e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	882.4058	2	1.1	LISWYDNEFGYSNR	LISWYDNEFGYSNR		14	V20130429-11_FTMSms2hcd	49.378	310	323	56.5	4.7e-13	5.3e-16	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	681.8229	2	-0.50	VVDLMAHMASKE	VVDLM(Oxidation)AHM(Oxidation)ASKE	Oxidation@328;Oxidation@331	12	V20130429-11_FTMSms2hcd	15.989	324	335	40.8	1.4e-12	1.9e-15	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	749.0392	3	1.7	VIISAPSADAPMFVMGVNHEK	VIISAPSADAPM(Oxidation)FVM(Oxidation)GVNHEK	Oxidation@130;Oxidation@133	21	V20130429-11_FTMSms2hcd	41.036	119	139	41.2	2.1e-11	2.3e-14	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	761.4308	3	-3.9	LVINGNPITIFQERDPSKIK	LVINGNPITIFQERDPSKIK		20	V20130429-11_FTMSms2hcd	50.503	67	86	41.0	4.3e-11	2.5e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	807.4581	2	4.9	LVINGNPITIFQER	LVINGNPITIFQER		14	V20130429-11_FTMSms2hcd	56.789	67	80	47.8	4.4e-11	1.3e-13	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	1021.0582	2	0.71	LVINGNPITIFQERDPSK	LVINGNPITIFQERDPSK		18	V20130429-11_FTMSms2hcd	52.094	67	84	49.0	9.0e-10	2.4e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	737.3903	2	0.23	VPTANVSVVDLTCR	VPTANVSVVDLTCR		14	V20130429-11_FTMSms2hcd	43.144	235	248	50.4	3.6e-9	5.7e-12	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	706.3997	2	1.3	GALQNIIPASTGAAK	GALQNIIPASTGAAK		15	V20130429-11_FTMSms2hcd	38.785	201	215	36.6	4.8e-9	1.3e-11	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	483.2757	3	-2.0	LEKPAKYDDIKK	LEKPAKYDDIKK		12	V20130429-11_FTMSms2hcd	13.934	249	260	37.4	5.3e-7	1.5e-9	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[2]		P04406	G3P_HUMAN	GAPDH	19	53.7	10.08	4.6e-18	403.2196	2	0.51	VGVNGFGR	VGVNGFGR		8	V20130429-11_FTMSms2hcd	22.006	6	13	36.7	7.9e-6	1.5e-8	1	36053.5	HUMAN	Glyceraldehyde-3-phosphate dehydrogenase
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	1006.5420	3	5.7	TATESFASDPILYRPVAVALDTKGPEIR	TATESFASDPILYRPVAVALDTKGPEIR		28	V20130429-11_FTMSms2hcd	56.255	93	120	58.4	6.9e-16	2.1e-18	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	1088.0717	2	8.4	LAPITSDPTEATAVGAVEASFK	LAPITSDPTEATAVGAVEASFK		22	V20130429-11_FTMSms2hcd	55.133	401	422	54.1	1.9e-14	3.0e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	826.4597	3	1.4	KGVNLPGAAVDLPAVSEKDIQDLK	KGVNLPGAAVDLPAVSEKDIQDLK		24	V20130429-11_FTMSms2hcd	51.165	207	230	45.5	2.3e-14	1.1e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	668.6727	3	7.0	FGVEQDVDMVFASFIRK	FGVEQDVDM(Oxidation)VFASFIRK	Oxidation@239	17	V20130429-11_FTMSms2hcd	67.733	231	247	38.2	6.1e-14	7.1e-17	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	803.0905	3	0.78	KGDVVIVLTGWRPGSGFTNTMR	KGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	22	V20130429-11_FTMSms2hcd	49.850	505	526	45.9	2.8e-13	5.2e-16	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	607.2915	2	-0.98	ITLDNAYMEK	ITLDNAYM(Oxidation)EK	Oxidation@149	10	V20130429-11_FTMSms2hcd	26.859	142	151	46.0	1.2e-12	1.8e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	890.4443	2	3.0	GADFLVTEVENGGSLGSK	GADFLVTEVENGGSLGSK		18	V20130429-11_FTMSms2hcd	49.031	189	206	51.9	2.3e-12	2.8e-15	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	783.7686	3	11	GVNLPGAAVDLPAVSEKDIQDLK	GVNLPGAAVDLPAVSEKDIQDLK		23	V20130429-11_FTMSms2hcd	55.172	208	230	31.1	2.9e-11	1.1e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	883.4124	4	0.79	MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCR	M(Met-loss+Acetyl)SKPHSEAGTAFIQTQQLHAAM(Oxidation)ADTFLEHM(Oxidation)CR	Met-loss+Acetyl@1;Oxidation@22;Oxidation@30	32	V20130429-11_FTMSms2hcd	45.006	1	32	44.6	8.0e-11	8.0e-14	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	679.3484	3	0.58	QKGADFLVTEVENGGSLGSK	QKGADFLVTEVENGGSLGSK		20	V20130429-11_FTMSms2hcd	44.343	187	206	36.5	7.8e-10	9.3e-13	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	610.0131	3	1.8	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-11_FTMSms2hcd	55.051	295	311	34.0	2.1e-9	6.8e-12	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	722.3915	4	12	GFFKKGDVVIVLTGWRPGSGFTNTMR	GFFKKGDVVIVLTGWRPGSGFTNTM(Oxidation)R	Oxidation@525	26	V20130429-11_FTMSms2hcd	54.576	501	526	33.6	2.3e-9	7.1e-12	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	613.3084	3	-0.34	RFDEILEASDGIMVAR	RFDEILEASDGIM(Oxidation)VAR	Oxidation@291	16	V20130429-11_FTMSms2hcd	45.302	279	294	26.9	1.8e-8	2.1e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	696.7047	3	5.9	EAEAAIYHLQLFEELRR	EAEAAIYHLQLFEELRR		17	V20130429-11_FTMSms2hcd	53.137	384	400	39.1	4.4e-8	7.6e-11	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	398.5533	3	0.62	SVETLKEMIK	SVETLKEM(Oxidation)IK	Oxidation@64	10	V20130429-11_FTMSms2hcd	22.998	57	66	25.5	1.6e-7	3.2e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	625.9749	3	8.3	FGVEQDVDMVFASFIR	FGVEQDVDM(Oxidation)VFASFIR	Oxidation@239	16	V20130429-11_FTMSms2hcd	73.763	231	246	21.8	8.0e-7	8.8e-10	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	599.3284	2	1.8	LDIDSPPITAR	LDIDSPPITAR		11	V20130429-11_FTMSms2hcd	35.609	33	43	37.5	9.2e-7	2.2e-9	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	420.7686	2	-0.29	APIIAVTR	APIIAVTR		8	V20130429-11_FTMSms2hcd	26.540	448	455	37.9	1.3e-6	1.2e-8	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	571.3090	2	0.69	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-11_FTMSms2hcd	38.582	295	305	25.2	5.6e-6	1.2e-8	2	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	697.8917	2	0.78	IISKIENHEGVR	IISKIENHEGVR		12	V20130429-11_FTMSms2hcd	16.626	267	278	50.6	5.5e-5	1.5e-7	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	471.7322	4	1.8	LNFSHGTHEYHAETIK	LNFSHGTHEYHAETIK		16	V20130429-11_FTMSms2hcd	22.317	74	89	11.8	0.019	2.1e-5	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3]		P14618	KPYM_HUMAN	PKM2	22	56.3	8.91	6.9e-16	651.8400	2	-8.2	NTGIICTIGPASR	NTGIICTIGPASR		13	V20130429-11_FTMSms2hcd	36.716	44	56	10.1	0.085	1.2e-4	1	57937.4	HUMAN	Pyruvate kinase isozymes M1/M2
[3-1]	0	P30613	KPYR_HUMAN	PKLR	2	3.0	4.81	2.1e-9	610.0131	3	1.8	GDLGIEIPAEKVFLAQK	GDLGIEIPAEKVFLAQK		17	V20130429-11_FTMSms2hcd	55.051	338	354	34.0	2.1e-9	6.8e-12	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[3-1]	0	P30613	KPYR_HUMAN	PKLR	2	3.0	4.81	2.1e-9	571.3090	2	0.69	GDLGIEIPAEK	GDLGIEIPAEK		11	V20130429-11_FTMSms2hcd	38.582	338	348	25.2	5.6e-6	1.2e-8	2	61830.7	HUMAN	Pyruvate kinase isozymes R/L
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	981.5100	4	0.94	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR	LHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALR		34	V20130429-11_FTMSms2hcd	57.401	237	270	51.9	1.8e-16	4.5e-19	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	635.7876	2	4.7	LGDLYEEEMR	LGDLYEEEM(Oxidation)R	Oxidation@154	10	V20130429-11_FTMSms2hcd	26.333	146	155	31.6	5.2e-13	8.3e-16	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	859.9149	4	-0.58	LQEEMLQREEAENTLQSFRQDVDNASLAR	LQEEM(Oxidation)LQREEAENTLQSFRQDVDNASLAR	Oxidation@193	29	V20130429-11_FTMSms2hcd	51.178	189	217	43.2	5.3e-13	5.6e-16	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	831.4808	2	4.3	KVESLQEEIAFLKK	KVESLQEEIAFLKK		14	V20130429-11_FTMSms2hcd	42.611	223	236	49.9	8.4e-12	4.3e-14	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	592.9600	3	1.7	FADLSEAANRNNDALR	FADLSEAANRNNDALR		16	V20130429-11_FTMSms2hcd	30.253	295	310	42.3	8.9e-12	9.8e-15	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	833.0918	3	1.6	LLQDSVDFSLADAINTEFKNTR	LLQDSVDFSLADAINTEFKNTR		22	V20130429-11_FTMSms2hcd	62.451	79	100	37.4	1.9e-11	2.6e-14	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	589.6071	3	1.1	LQDEIQNMKEEMAR	LQDEIQNM(Oxidation)KEEM(Oxidation)AR	Oxidation@372;Oxidation@376	14	V20130429-11_FTMSms2hcd	16.229	365	378	34.4	1.2e-10	1.3e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	504.2400	3	-0.83	MFGGPGTASRPSSSR	M(Oxidation)FGGPGTASRPSSSR	Oxidation@14	15	V20130429-11_FTMSms2hcd	14.361	14	28	35.8	1.8e-10	2.5e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	655.3069	2	0.47	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-11_FTMSms2hcd	35.274	283	292	36.0	2.6e-10	3.6e-13	2	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	748.3968	2	-0.0054	TYSLGSALRPSTSR	TYSLGSALRPSTSR		14	V20130429-11_FTMSms2hcd	30.417	37	50	41.4	2.9e-10	4.5e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	798.3839	3	1.8	EEAENTLQSFRQDVDNASLAR	EEAENTLQSFRQDVDNASLAR		21	V20130429-11_FTMSms2hcd	46.471	197	217	46.4	6.3e-10	6.4e-13	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	785.9520	2	1.00	ISLPLPNFSSLNLR	ISLPLPNFSSLNLR		14	V20130429-11_FTMSms2hcd	65.349	411	424	51.5	1.2e-9	4.2e-12	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	794.4023	2	0.021	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-11_FTMSms2hcd	26.553	101	113	47.9	2.8e-9	3.3e-12	2	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	547.2668	2	-0.86	FADLSEAANR	FADLSEAANR		10	V20130429-11_FTMSms2hcd	25.300	295	304	40.8	4.1e-8	7.6e-11	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	513.9755	3	0.96	ILLAELEQLKGQGK	ILLAELEQLKGQGK		14	V20130429-11_FTMSms2hcd	45.281	130	143	48.1	5.3e-8	4.1e-10	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	457.7327	2	0.37	SYVTTSTR	SYVTTSTR		8	V20130429-11_FTMSms2hcd	11.308	29	36	33.7	2.9e-7	5.8e-10	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	456.9925	4	1.7	ETNLDSLPLVDTHSKR	ETNLDSLPLVDTHSKR		16	V20130429-11_FTMSms2hcd	35.687	425	440	32.4	4.2e-7	6.1e-10	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	512.2589	2	-0.027	QQYESVAAK	QQYESVAAK		9	V20130429-11_FTMSms2hcd	11.231	274	282	25.5	6.9e-6	1.1e-8	1	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	480.5906	3	0.67	MALDIEIATYRK	M(Oxidation)ALDIEIATYRK	Oxidation@391	12	V20130429-11_FTMSms2hcd	36.976	391	402	13.7	1.4e-4	2.3e-7	2	53652.1	HUMAN	Vimentin
[4]		P08670	VIME_HUMAN	VIM	20	56.9	9.22	1.8e-16	556.2739	3	-0.40	RMFGGPGTASRPSSSR	RM(Oxidation)FGGPGTASRPSSSR	Oxidation@14	16	V20130429-11_FTMSms2hcd	12.293	13	28	14.4	2.2e-4	2.5e-7	1	53652.1	HUMAN	Vimentin
[4-1]	0	P41219	PERI_HUMAN	PRPH	2	4.7	5.50	2.6e-10	655.3069	2	0.47	NLQEAEEWYK	NLQEAEEWYK		10	V20130429-11_FTMSms2hcd	35.274	279	288	36.0	2.6e-10	3.6e-13	2	53651.3	HUMAN	Peripherin
[4-1]	0	P41219	PERI_HUMAN	PRPH	2	4.7	5.50	2.6e-10	480.5906	3	0.67	MALDIEIATYRK	M(Oxidation)ALDIEIATYRK	Oxidation@387	12	V20130429-11_FTMSms2hcd	36.976	387	398	13.7	1.4e-4	2.3e-7	2	53651.3	HUMAN	Peripherin
[4-2]	0	P17661	DESM_HUMAN	DES	1	2.8	5.34	2.8e-9	794.4023	2	0.021	TNEKVELQELNDR	TNEKVELQELNDR		13	V20130429-11_FTMSms2hcd	26.553	106	118	47.9	2.8e-9	3.3e-12	2	53536.2	HUMAN	Desmin
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	995.8015	3	-1.4	SFIKDYPVVSIEDPFDQDDWGAWQK	SFIKDYPVVSIEDPFDQDDWGAWQK		25	V20130429-11_FTMSms2hcd	65.324	282	306	46.5	1.9e-16	1.8e-19	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	730.3936	3	4.6	FTASAGIQVVGDDLTVTNPKR	FTASAGIQVVGDDLTVTNPKR		21	V20130429-11_FTMSms2hcd	45.584	307	327	46.4	2.4e-15	4.8e-18	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	634.3263	4	-0.45	AAVPSGASTGIYEALELRDNDKTR	AAVPSGASTGIYEALELRDNDKTR		24	V20130429-11_FTMSms2hcd	43.044	33	56	64.6	1.2e-14	1.6e-17	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	771.3861	2	0.50	LAQANGWGVMVSHR	LAQANGWGVM(Oxidation)VSHR	Oxidation@368	14	V20130429-11_FTMSms2hcd	28.122	359	372	44.7	4.3e-14	5.2e-17	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	970.4985	2	6.6	LAMQEFMILPVGAANFR	LAM(Oxidation)QEFM(Oxidation)ILPVGAANFR	Oxidation@165;Oxidation@169	17	V20130429-11_FTMSms2hcd	56.307	163	179	49.4	2.8e-13	3.6e-16	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	753.6627	4	20	HIADLAGNSEVILPVPAFNVINGGSHAGNK	HIADLAGNSEVILPVPAFNVINGGSHAGNK		30	V20130429-11_FTMSms2hcd	58.265	133	162	53.8	1.6e-12	5.2e-15	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	731.9163	2	11	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-11_FTMSms2hcd	60.003	106	120	38.2	1.7e-12	5.1e-15	3	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	1148.5820	2	8.3	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-11_FTMSms2hcd	77.812	373	394	35.4	2.1e-12	2.8e-15	3	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	703.8641	2	3.4	GNPTVEVDLFTSK	GNPTVEVDLFTSK		13	V20130429-11_FTMSms2hcd	44.032	16	28	36.0	3.5e-11	4.9e-14	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	915.1327	3	1.8	DATNVGDEGGFAPNILENKEGLELLK	DATNVGDEGGFAPNILENKEGLELLK		26	V20130429-11_FTMSms2hcd	58.174	203	228	40.1	1.6e-10	2.1e-13	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	731.3638	3	3.5	AGYTDKVVIGMDVAASEFFR	AGYTDKVVIGM(Oxidation)DVAASEFFR	Oxidation@244	20	V20130429-11_FTMSms2hcd	51.218	234	253	24.9	4.4e-9	4.8e-12	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	457.4692	4	-0.31	SGKYDLDFKSPDDPSR	SGKYDLDFKSPDDPSR		16	V20130429-11_FTMSms2hcd	28.881	254	269	25.9	2.5e-8	2.8e-11	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	713.3664	2	-0.35	YISPDQLADLYK	YISPDQLADLYK		12	V20130429-11_FTMSms2hcd	48.460	270	281	33.6	4.0e-8	5.3e-11	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	572.3117	2	0.38	IGAEVYHNLK	IGAEVYHNLK		10	V20130429-11_FTMSms2hcd	22.792	184	193	41.2	1.7e-5	2.8e-8	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	482.2720	3	0.60	KLNVTEQEKIDK	KLNVTEQEKIDK		12	V20130429-11_FTMSms2hcd	17.180	81	92	24.9	5.8e-5	1.3e-7	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	452.7346	2	-0.31	IEEELGSK	IEEELGSK		8	V20130429-11_FTMSms2hcd	14.133	413	420	32.9	5.0e-4	8.4e-7	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	480.2752	2	1.0	NFRNPLAK	NFRNPLAK		8	V20130429-11_FTMSms2hcd	24.589	427	434	21.1	0.0028	4.8e-6	1	47169.4	HUMAN	Alpha-enolase
[5]		P06733	ENOA_HUMAN	ENO1	18	68.9	9.22	1.9e-16	403.7299	2	0.76	YNQLLR	YNQLLR		6	V20130429-11_FTMSms2hcd	21.026	407	412	23.8	0.016	3.4e-5	1	47169.4	HUMAN	Alpha-enolase
[5-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	6.90	1.7e-12	731.9163	2	11	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-11_FTMSms2hcd	60.003	106	120	38.2	1.7e-12	5.1e-15	3	47269.0	HUMAN	Gamma-enolase
[5-1]	0	P09104	ENOG_HUMAN	ENO2	2	8.5	6.90	1.7e-12	1148.5820	2	8.3	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-11_FTMSms2hcd	77.812	373	394	35.4	2.1e-12	2.8e-15	3	47269.0	HUMAN	Gamma-enolase
[5-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	6.90	1.7e-12	731.9163	2	11	FGANAILGVSLAVCK	FGANAILGVSLAVCK		15	V20130429-11_FTMSms2hcd	60.003	106	120	38.2	1.7e-12	5.1e-15	3	46932.2	HUMAN	Beta-enolase
[5-2]	0	P13929	ENOB_HUMAN	ENO3	2	8.5	6.90	1.7e-12	1148.5820	2	8.3	SGETEDTFIADLVVGLCTGQIK	SGETEDTFIADLVVGLCTGQIK		22	V20130429-11_FTMSms2hcd	77.812	373	394	35.4	2.1e-12	2.8e-15	3	46932.2	HUMAN	Beta-enolase
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	649.2673	3	-1.9	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@255=48	17	V20130429-11_FTMSms2hcd	11.992	250	266	41.9	1.1e-14	1.8e-17	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	683.3687	2	0.53	TLTLVDTGIGMTK	TLTLVDTGIGM(Oxidation)TK	Oxidation@93	13	V20130429-11_FTMSms2hcd	39.191	83	95	47.7	3.9e-14	6.3e-17	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	594.9882	3	0.19	HLEINPDHPIVETLR	HLEINPDHPIVETLR		15	V20130429-11_FTMSms2hcd	37.988	625	639	52.9	4.7e-13	8.3e-16	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	478.5160	4	-1.3	KHLEINPDHPIVETLR	KHLEINPDHPIVETLR		16	V20130429-11_FTMSms2hcd	33.185	624	639	35.9	1.2e-12	3.6e-15	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	996.8438	3	-4.8	DLVVLLFETALLSSGFSLEDPQTHSNR	DLVVLLFETALLSSGFSLEDPQTHSNR		27	V20130429-11_FTMSms2hcd	77.917	653	679	31.8	1.9e-12	2.9e-15	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	757.3980	2	2.0	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-11_FTMSms2hcd	44.203	379	392	48.4	5.9e-11	9.2e-14	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	698.7062	3	1.0	HSQFIGYPITLYLEKER	HSQFIGYPITLYLEKER		17	V20130429-11_FTMSms2hcd	51.821	205	221	36.2	7.7e-11	1.3e-13	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	863.8180	3	8.8	TLTLVDTGIGMTKADLINNLGTIAK	TLTLVDTGIGM(Oxidation)TKADLINNLGTIAK	Oxidation@93	25	V20130429-11_FTMSms2hcd	59.873	83	107	43.9	7.8e-11	4.0e-13	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	731.6523	3	1.0	YHTSQSGDEMTSLSEYVSR	YHTSQSGDEM(Oxidation)TSLSEYVSR	Oxidation@466	19	V20130429-11_FTMSms2hcd	30.024	457	475	25.7	3.4e-9	3.9e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	571.2836	2	0.26	LGIHEDSTNR	LGIHEDSTNR		10	V20130429-11_FTMSms2hcd	12.772	439	448	52.0	3.9e-9	6.4e-12	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	580.7951	2	-0.39	SIYYITGESK	SIYYITGESK		10	V20130429-11_FTMSms2hcd	29.784	482	491	32.0	4.8e-9	7.1e-12	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	904.9783	2	-4.9	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-11_FTMSms2hcd	55.973	205	219	28.2	2.3e-7	3.3e-10	3	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	625.3126	2	0.63	EQVANSAFVER	EQVANSAFVER		11	V20130429-11_FTMSms2hcd	23.730	492	502	43.0	3.0e-7	4.1e-10	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	918.4080	2	0.14	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@617;Oxidation@620;Oxidation@621	16	V20130429-11_FTMSms2hcd	15.117	608	623	24.0	8.5e-7	1.0e-9	2	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-11_FTMSms2hcd	43.524	96	107	37.5	1.7e-6	3.7e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-11_FTMSms2hcd	20.552	276	284	25.1	2.2e-6	3.3e-9	4	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6]		P08238	HS90B_HUMAN	HSP90AB1	17	27.3	8.26	1.1e-14	415.2689	2	1.3	ALLFIPR	ALLFIPR		7	V20130429-11_FTMSms2hcd	45.811	331	337	24.7	6.8e-4	2.5e-6	1	83264.9	HUMAN	Heat shock protein HSP 90-beta
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	683.3687	2	0.53	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@98	13	V20130429-11_FTMSms2hcd	39.191	88	100	47.7	3.9e-14	6.3e-17	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	757.3980	2	2.0	GVVDSEDLPLNISR	GVVDSEDLPLNISR		14	V20130429-11_FTMSms2hcd	44.203	387	400	48.4	5.9e-11	9.2e-14	3	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	863.8180	3	8.8	TLTIVDTGIGMTKADLINNLGTIAK	TLTIVDTGIGM(Oxidation)TKADLINNLGTIAK	Oxidation@98	25	V20130429-11_FTMSms2hcd	59.873	88	112	43.9	7.8e-11	4.0e-13	2	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	596.3196	3	-0.21	HLEINPDHSIIETLR	HLEINPDHSIIETLR		15	V20130429-11_FTMSms2hcd	41.961	633	647	20.5	1.7e-7	2.9e-10	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-11_FTMSms2hcd	43.524	101	112	37.5	1.7e-6	3.7e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-11_FTMSms2hcd	20.552	284	292	25.1	2.2e-6	3.3e-9	4	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-1]	2	P07900	HS90A_HUMAN	HSP90AA1	7	8.7	7.96	3.9e-14	479.5159	4	1.1	KHLEINPDHSIIETLR	KHLEINPDHSIIETLR		16	V20130429-11_FTMSms2hcd	37.079	632	647	18.4	4.2e-6	1.1e-8	1	84660.4	HUMAN	Heat shock protein HSP 90-alpha
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	649.2673	3	-1.9	IEDVGSDEEDDSGKDKK	IEDVGS(Phospho)DEEDDSGKDKK	Phospho@177=48	17	V20130429-11_FTMSms2hcd	11.992	172	188	41.9	1.1e-14	1.8e-17	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	698.7062	3	1.0	HSQFLGYPITLYLEKER	HSQFLGYPITLYLEKER		17	V20130429-11_FTMSms2hcd	51.821	127	143	36.2	7.7e-11	1.3e-13	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	580.7951	2	-0.39	SIYYITGESK	SIYYITGESK		10	V20130429-11_FTMSms2hcd	29.784	258	267	32.0	4.8e-9	7.1e-12	2	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	904.9783	2	-4.9	HSQFLGYPITLYLEK	HSQFLGYPITLYLEK		15	V20130429-11_FTMSms2hcd	55.973	127	141	28.2	2.3e-7	3.3e-10	3	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-11_FTMSms2hcd	43.524	96	107	37.5	1.7e-6	3.7e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-2]	0	Q58FF8	H90B2_HUMAN	HSP90AB2P	6	17.1	8.26	1.1e-14	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-11_FTMSms2hcd	20.552	198	206	25.1	2.2e-6	3.3e-9	4	44349.3	HUMAN	Putative heat shock protein HSP 90-beta 2
[6-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	7.0	4.31	2.3e-7	904.9783	2	-4.9	HSQFIGYPITLYLEK	HSQFIGYPITLYLEK		15	V20130429-11_FTMSms2hcd	55.973	184	198	28.2	2.3e-7	3.3e-10	3	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[6-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	7.0	4.31	2.3e-7	625.3126	2	0.63	EQVANSAFVER	EQVANSAFVER		11	V20130429-11_FTMSms2hcd	23.730	365	375	43.0	3.0e-7	4.1e-10	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[6-3]	0	Q58FF7	H90B3_HUMAN	HSP90AB3P	3	7.0	4.31	2.3e-7	918.4080	2	0.14	AQALRDNSTMGYMMAK	AQALRDNSTM(Oxidation)GYM(Oxidation)M(Oxidation)AK	Oxidation@490;Oxidation@493;Oxidation@494	16	V20130429-11_FTMSms2hcd	15.117	481	496	24.0	8.5e-7	1.0e-9	2	68325.4	HUMAN	Putative heat shock protein HSP 90-beta-3
[6-4]	0	Q58FG1	HS904_HUMAN	HSP90AA4P	1	3.1	7.96	3.9e-14	683.3687	2	0.53	TLTIVDTGIGMTK	TLTIVDTGIGM(Oxidation)TK	Oxidation@38	13	V20130429-11_FTMSms2hcd	39.191	28	40	47.7	3.9e-14	6.3e-17	3	47712.3	HUMAN	Putative heat shock protein HSP 90-alpha A4
[6-5]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.58	1.7e-6	621.8547	2	-2.5	ADLINNLGTIAK	ADLINNLGTIAK		12	V20130429-11_FTMSms2hcd	43.524	101	112	37.5	1.7e-6	3.7e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[6-5]	0	Q14568	HS902_HUMAN	HSP90AA2	2	6.1	3.58	1.7e-6	576.2824	2	-0.32	YIDQEELNK	YIDQEELNK		9	V20130429-11_FTMSms2hcd	20.552	283	291	25.1	2.2e-6	3.3e-9	4	39365.1	HUMAN	Putative heat shock protein HSP 90-alpha A2
[6-6]	0	Q12931	TRAP1_HUMAN	TRAP1	1	2.0	6.24	5.9e-11	757.3980	2	2.0	GVVDSEDIPLNLSR	GVVDSEDIPLNLSR		14	V20130429-11_FTMSms2hcd	44.203	389	402	48.4	5.9e-11	9.2e-14	3	80110.7	HUMAN	Heat shock protein 75 kDa, mitochondrial
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	660.3000	2	-0.69	NSLESYAFNMK	NSLESYAFNM(Oxidation)K	Oxidation@549	11	V20130429-11_FTMSms2hcd	33.323	540	550	40.8	9.7e-16	1.4e-18	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	846.3669	2	0.56	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-11_FTMSms2hcd	22.684	221	236	58.6	1.8e-15	2.5e-18	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	661.3379	3	0.69	TVTNAVVTVPAYFNDSQR	TVTNAVVTVPAYFNDSQR		18	V20130429-11_FTMSms2hcd	45.892	138	155	42.5	9.9e-15	1.2e-17	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	616.3000	5	-0.37	RFDDAVVQSDMKHWPFMVVNDAGRPK	RFDDAVVQSDM(Oxidation)KHWPFM(Oxidation)VVNDAGRPK	Oxidation@87;Oxidation@93	26	V20130429-11_FTMSms2hcd	41.827	77	102	40.8	3.2e-14	3.1e-17	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	894.4987	2	-0.030	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-11_FTMSms2hcd	43.001	172	188	34.2	6.2e-12	1.8e-14	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	37	49	42.0	4.6e-11	5.7e-14	6	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	600.3418	2	1.7	DAGTIAGLNVLR	DAGTIAGLNVLR		12	V20130429-11_FTMSms2hcd	45.359	160	171	38.2	2.2e-10	4.5e-13	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	614.8175	2	-0.26	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	26	36	47.8	5.4e-9	8.4e-12	7	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	740.8821	2	1.8	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-11_FTMSms2hcd	44.765	300	311	53.6	6.7e-8	8.5e-11	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	627.3129	2	2.0	FEELNADLFR	FEELNADLFR		10	V20130429-11_FTMSms2hcd	48.269	302	311	44.1	2.2e-7	2.5e-10	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	816.8968	2	2.3	SFYPEEVSSMVLTK	SFYPEEVSSM(Oxidation)VLTK	Oxidation@122	14	V20130429-11_FTMSms2hcd	44.597	113	126	31.6	3.6e-7	4.1e-10	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	590.8137	2	-0.60	VQVEYKGETK	VQVEYKGETK		10	V20130429-11_FTMSms2hcd	13.077	103	112	30.8	3.7e-7	5.5e-10	2	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	522.6155	3	-0.17	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-11_FTMSms2hcd	45.123	349	361	31.5	4.6e-7	7.8e-10	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	541.2885	2	1.9	LLQDFFNGK	LLQDFFNGK		9	V20130429-11_FTMSms2hcd	44.885	349	357	30.6	9.1e-7	1.4e-9	3	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	417.8785	3	1.5	MVNHFIAEFK	M(Oxidation)VNHFIAEFK	Oxidation@237	10	V20130429-11_FTMSms2hcd	33.650	237	246	27.3	1.7e-5	2.2e-8	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7]		P11142	HSP7C_HUMAN	HSPA8	16	29.6	8.83	9.7e-16	495.2651	2	-3.3	LSKEDIER	LSKEDIER		8	V20130429-11_FTMSms2hcd	13.420	510	517	29.4	0.0012	2.0e-6	1	70898.7	HUMAN	Heat shock cognate 71 kDa protein
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	846.3669	2	0.56	STAGDTHLGGEDFDNR	STAGDTHLGGEDFDNR		16	V20130429-11_FTMSms2hcd	22.684	224	239	58.6	1.8e-15	2.5e-18	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	894.4987	2	-0.030	IINEPTAAAIAYGLDKK	IINEPTAAAIAYGLDKK		17	V20130429-11_FTMSms2hcd	43.001	173	189	34.2	6.2e-12	1.8e-14	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	38	50	42.0	4.6e-11	5.7e-14	6	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	614.8175	2	-0.26	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	27	37	47.8	5.4e-9	8.4e-12	7	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	740.8821	2	1.8	ARFEELNADLFR	ARFEELNADLFR		12	V20130429-11_FTMSms2hcd	44.765	303	314	53.6	6.7e-8	8.5e-11	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	627.3129	2	2.0	FEELNADLFR	FEELNADLFR		10	V20130429-11_FTMSms2hcd	48.269	305	314	44.1	2.2e-7	2.5e-10	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	590.8137	2	-0.60	VQVEYKGETK	VQVEYKGETK		10	V20130429-11_FTMSms2hcd	13.077	104	113	30.8	3.7e-7	5.5e-10	2	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	522.6155	3	-0.17	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-11_FTMSms2hcd	45.123	352	364	31.5	4.6e-7	7.8e-10	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-1]	0	P54652	HSP72_HUMAN	HSPA2	9	14.4	8.68	1.8e-15	541.2885	2	1.9	LLQDFFNGK	LLQDFFNGK		9	V20130429-11_FTMSms2hcd	44.885	352	360	30.6	9.1e-7	1.4e-9	3	70021.5	HUMAN	Heat shock-related 70 kDa protein 2
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	37	49	42.0	4.6e-11	5.7e-14	6	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	844.4619	2	9.0	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-11_FTMSms2hcd	48.114	172	187	41.7	1.5e-10	3.1e-13	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	614.8175	2	-0.26	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	26	36	47.8	5.4e-9	8.4e-12	7	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	555.2900	2	-0.99	LLQDFFNGR	LLQDFFNGR		9	V20130429-11_FTMSms2hcd	45.730	349	357	34.4	2.1e-6	3.6e-9	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	569.8086	2	-0.30	VQVSYKGETK	VQVSYKGETK		10	V20130429-11_FTMSms2hcd	13.047	103	112	26.2	2.4e-6	4.5e-9	1	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-2]	4	P08107	HSP71_HUMAN	HSPA1A	6	10.5	6.30	4.6e-11	502.2744	2	-0.33	LSKEEIER	LSKEEIER		8	V20130429-11_FTMSms2hcd	12.255	510	517	44.2	2.8e-4	4.6e-7	2	70052.8	HUMAN	Heat shock 70 kDa protein 1A/1B
[7-3]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.30	4.6e-11	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	39	51	42.0	4.6e-11	5.7e-14	6	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-3]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.30	4.6e-11	844.4619	2	9.0	IINEPTAAAIAYGLDR	IINEPTAAAIAYGLDR		16	V20130429-11_FTMSms2hcd	48.114	174	189	41.7	1.5e-10	3.1e-13	2	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-3]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.30	4.6e-11	614.8175	2	-0.26	VEILANDQGNR	VEILANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	28	38	47.8	5.4e-9	8.4e-12	7	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-3]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.30	4.6e-11	522.6155	3	-0.17	LLQDFFNGKELNK	LLQDFFNGKELNK		13	V20130429-11_FTMSms2hcd	45.123	351	363	31.5	4.6e-7	7.8e-10	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-3]	1	P17066	HSP76_HUMAN	HSPA6	5	8.2	6.30	4.6e-11	541.2885	2	1.9	LLQDFFNGK	LLQDFFNGK		9	V20130429-11_FTMSms2hcd	44.885	351	359	30.6	9.1e-7	1.4e-9	3	71028.7	HUMAN	Heat shock 70 kDa protein 6
[7-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.30	4.6e-11	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	39	51	42.0	4.6e-11	5.7e-14	6	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.30	4.6e-11	614.8175	2	-0.26	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	28	38	47.8	5.4e-9	8.4e-12	7	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-4]	1	P34931	HS71L_HUMAN	HSPA1L	3	5.0	6.30	4.6e-11	502.2744	2	-0.33	LSKEEIER	LSKEEIER		8	V20130429-11_FTMSms2hcd	12.255	512	519	44.2	2.8e-4	4.6e-7	2	70375.6	HUMAN	Heat shock 70 kDa protein 1-like
[7-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.30	4.6e-11	744.3556	2	1.8	TTPSYVAFTDTER	TTPSYVAFTDTER		13	V20130429-11_FTMSms2hcd	34.547	39	51	42.0	4.6e-11	5.7e-14	6	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[7-5]	0	P48741	HSP77_HUMAN	HSPA7	2	6.5	6.30	4.6e-11	614.8175	2	-0.26	VEILANDQGNR	VEILANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	28	38	47.8	5.4e-9	8.4e-12	7	40244.8	HUMAN	Putative heat shock 70 kDa protein 7
[7-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.19	5.4e-9	614.8175	2	-0.26	VEIIANDQGNR	VEIIANDQGNR		11	V20130429-11_FTMSms2hcd	20.515	50	60	47.8	5.4e-9	8.4e-12	7	72333.5	HUMAN	78 kDa glucose-regulated protein
[7-6]	1	P11021	GRP78_HUMAN	HSPA5	2	3.5	5.19	5.4e-9	617.3181	2	2.7	DAGTIAGLNVMR	DAGTIAGLNVM(Oxidation)R	Oxidation@196	12	V20130429-11_FTMSms2hcd	32.432	186	197	11.1	5.1e-4	7.5e-7	1	72333.5	HUMAN	78 kDa glucose-regulated protein
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	776.3562	4	-1.5	FWEVISDEHGIDPTGTYHGDSDLQLDR	FWEVISDEHGIDPTGTYHGDSDLQLDR		27	V20130429-11_FTMSms2hcd	50.633	20	46	48.4	2.4e-16	2.3e-19	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	1044.0498	2	7.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-11_FTMSms2hcd	57.978	104	122	38.4	4.5e-14	7.0e-17	5	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	933.4603	3	8.2	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-11_FTMSms2hcd	61.065	78	103	50.2	5.5e-14	5.8e-17	5	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	681.3714	3	13	MAVTFIGNSTAIQELFKR	M(Oxidation)AVTFIGNSTAIQELFKR	Oxidation@363	18	V20130429-11_FTMSms2hcd	58.649	363	380	58.0	9.4e-12	2.1e-14	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	553.9719	3	3.6	ALTVPELTQQVFDAK	ALTVPELTQQVFDAK		15	V20130429-11_FTMSms2hcd	56.776	283	297	40.0	5.3e-11	1.1e-13	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	668.3533	2	1.2	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-11_FTMSms2hcd	35.886	163	174	40.1	6.6e-11	1.1e-13	4	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	606.3151	3	4.4	ISVYYNEATGGKYVPR	ISVYYNEATGGKYVPR		16	V20130429-11_FTMSms2hcd	33.456	47	62	32.0	1.1e-8	1.5e-11	1	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	520.3012	2	1.6	YLTVAAVFR	YLTVAAVFR		9	V20130429-11_FTMSms2hcd	47.983	310	318	42.4	1.8e-7	7.0e-10	3	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	731.8523	2	8.9	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-11_FTMSms2hcd	20.832	325	336	22.2	3.7e-7	4.6e-10	4	49671.3	HUMAN	Tubulin beta chain
[8]		P07437	TBB5_HUMAN	TUBB	13	45.0	9.15	2.4e-16	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49671.3	HUMAN	Tubulin beta chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	854.4366	2	2.2	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-11_FTMSms2hcd	45.691	283	297	42.0	2.5e-14	3.2e-17	3	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	1044.0498	2	7.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-11_FTMSms2hcd	57.978	104	122	38.4	4.5e-14	7.0e-17	5	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	933.4603	3	8.2	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-11_FTMSms2hcd	61.065	78	103	50.2	5.5e-14	5.8e-17	5	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	809.4139	2	3.3	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-11_FTMSms2hcd	40.656	63	77	40.7	2.4e-12	3.0e-15	3	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	668.3533	2	1.2	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-11_FTMSms2hcd	35.886	163	174	40.1	6.6e-11	1.1e-13	4	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	520.3012	2	1.6	YLTVAAVFR	YLTVAAVFR		9	V20130429-11_FTMSms2hcd	47.983	310	318	42.4	1.8e-7	7.0e-10	3	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	731.8523	2	8.9	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-11_FTMSms2hcd	20.832	325	336	22.2	3.7e-7	4.6e-10	4	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49831.5	HUMAN	Tubulin beta-4B chain
[8-1]	3	P68371	TBB4B_HUMAN	TUBB4B	12	34.6	8.06	2.5e-14	846.4382	2	1.1	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-11_FTMSms2hcd	57.630	283	297	17.4	2.4e-5	3.2e-8	3	49831.5	HUMAN	Tubulin beta-4B chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	854.4366	2	2.2	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-11_FTMSms2hcd	45.691	283	297	42.0	2.5e-14	3.2e-17	3	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	933.4603	3	8.2	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-11_FTMSms2hcd	61.065	78	103	50.2	5.5e-14	5.8e-17	5	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	809.4139	2	3.3	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-11_FTMSms2hcd	40.656	63	77	40.7	2.4e-12	3.0e-15	3	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	668.3533	2	1.2	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-11_FTMSms2hcd	35.886	163	174	40.1	6.6e-11	1.1e-13	4	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	520.3012	2	1.6	YLTVAAVFR	YLTVAAVFR		9	V20130429-11_FTMSms2hcd	47.983	310	318	42.4	1.8e-7	7.0e-10	3	49586.2	HUMAN	Tubulin beta-4A chain
[8-2]	3	P04350	TBB4A_HUMAN	TUBB4A	9	25.9	8.06	2.5e-14	846.4382	2	1.1	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-11_FTMSms2hcd	57.630	283	297	17.4	2.4e-5	3.2e-8	3	49586.2	HUMAN	Tubulin beta-4A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	1044.0498	2	7.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-11_FTMSms2hcd	57.978	104	122	38.4	4.5e-14	7.0e-17	5	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	933.4603	3	8.2	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-11_FTMSms2hcd	61.065	78	103	50.2	5.5e-14	5.8e-17	5	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	731.8523	2	8.9	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-11_FTMSms2hcd	20.832	325	336	22.2	3.7e-7	4.6e-10	4	49907.4	HUMAN	Tubulin beta-2A chain
[8-3]	0	Q13885	TBB2A_HUMAN	TUBB2A	7	23.1	7.95	4.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49907.4	HUMAN	Tubulin beta-2A chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	1044.0498	2	7.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-11_FTMSms2hcd	57.978	104	122	38.4	4.5e-14	7.0e-17	5	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	933.4603	3	8.2	SGPFGQIFRPDNFVFGQSGAGNNWAK	SGPFGQIFRPDNFVFGQSGAGNNWAK		26	V20130429-11_FTMSms2hcd	61.065	78	103	50.2	5.5e-14	5.8e-17	5	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	731.8523	2	8.9	EVDEQMLNVQNK	EVDEQM(Oxidation)LNVQNK	Oxidation@330	12	V20130429-11_FTMSms2hcd	20.832	325	336	22.2	3.7e-7	4.6e-10	4	49953.5	HUMAN	Tubulin beta-2B chain
[8-4]	0	Q9BVA1	TBB2B_HUMAN	TUBB2B	7	23.1	7.95	4.1e-14	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49953.5	HUMAN	Tubulin beta-2B chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	854.4366	2	2.2	ALTVPELTQQMFDAK	ALTVPELTQQM(Oxidation)FDAK	Oxidation@293	15	V20130429-11_FTMSms2hcd	45.691	283	297	42.0	2.5e-14	3.2e-17	3	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	1044.0498	2	7.5	GHYTEGAELVDSVLDVVRK	GHYTEGAELVDSVLDVVRK		19	V20130429-11_FTMSms2hcd	57.978	104	122	38.4	4.5e-14	7.0e-17	5	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	668.3533	2	1.2	IMNTFSVVPSPK	IM(Oxidation)NTFSVVPSPK	Oxidation@164	12	V20130429-11_FTMSms2hcd	35.886	163	174	40.1	6.6e-11	1.1e-13	4	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	50433.2	HUMAN	Tubulin beta-3 chain
[8-5]	2	Q13509	TBB3_HUMAN	TUBB3	6	15.6	8.06	2.5e-14	846.4382	2	1.1	ALTVPELTQQMFDAK	ALTVPELTQQMFDAK		15	V20130429-11_FTMSms2hcd	57.630	283	297	17.4	2.4e-5	3.2e-8	3	50433.2	HUMAN	Tubulin beta-3 chain
[8-6]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	4	10.6	7.10	1.5e-12	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49776.5	HUMAN	Tubulin beta-8 chain
[8-6]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	4	10.6	7.10	1.5e-12	809.4139	2	3.3	AVLVDLEPGTMDSVR	AVLVDLEPGTM(Oxidation)DSVR	Oxidation@73	15	V20130429-11_FTMSms2hcd	40.656	63	77	40.7	2.4e-12	3.0e-15	3	49776.5	HUMAN	Tubulin beta-8 chain
[8-6]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	4	10.6	7.10	1.5e-12	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49776.5	HUMAN	Tubulin beta-8 chain
[8-6]	1	Q3ZCM7	TBB8_HUMAN	TUBB8	4	10.6	7.10	1.5e-12	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49776.5	HUMAN	Tubulin beta-8 chain
[8-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	7.95	4.1e-14	848.9229	2	3.3	NSSYFVEWIPNNVK	NSSYFVEWIPNNVK		14	V20130429-11_FTMSms2hcd	53.740	337	350	36.1	4.1e-14	4.6e-17	7	49857.6	HUMAN	Tubulin beta-6 chain
[8-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	7.95	4.1e-14	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49857.6	HUMAN	Tubulin beta-6 chain
[8-7]	0	Q9BUF5	TBB6_HUMAN	TUBB6	3	8.5	7.95	4.1e-14	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49857.6	HUMAN	Tubulin beta-6 chain
[8-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	7.10	1.5e-12	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@195	14	V20130429-11_FTMSms2hcd	51.434	191	204	43.6	1.5e-12	1.9e-15	9	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	7.10	1.5e-12	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@185	10	V20130429-11_FTMSms2hcd	40.682	181	190	41.7	8.2e-10	1.4e-12	11	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-8]	0	A6NKZ8	YI016_HUMAN		3	8.6	7.10	1.5e-12	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	83	90	38.5	1.8e-6	2.9e-9	8	41775.5	HUMAN	Putative tubulin beta chain-like protein ENSP00000290377
[8-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	7.10	1.5e-12	818.9193	2	0.54	LHFFMPGFAPLTSR	LHFFM(Oxidation)PGFAPLTSR	Oxidation@267	14	V20130429-11_FTMSms2hcd	51.434	263	276	43.6	1.5e-12	1.9e-15	9	49573.1	HUMAN	Tubulin beta-8 chain B
[8-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	7.10	1.5e-12	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	49573.1	HUMAN	Tubulin beta-8 chain B
[8-9]	0	A6NNZ2	TBB8B_HUMAN		3	7.2	7.10	1.5e-12	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	49573.1	HUMAN	Tubulin beta-8 chain B
[8-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	5.63	8.2e-10	580.3193	2	1.8	LAVNMVPFPR	LAVNM(Oxidation)VPFPR	Oxidation@257	10	V20130429-11_FTMSms2hcd	40.682	253	262	41.7	8.2e-10	1.4e-12	11	50327.4	HUMAN	Tubulin beta-1 chain
[8-10]	0	Q9H4B7	TBB1_HUMAN	TUBB1	2	4.0	5.63	8.2e-10	539.2700	2	0.35	IREEYPDR	IREEYPDR		8	V20130429-11_FTMSms2hcd	12.022	155	162	38.5	1.8e-6	2.9e-9	8	50327.4	HUMAN	Tubulin beta-1 chain
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	813.9064	2	0.72	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-11_FTMSms2hcd	21.401	38	51	55.4	6.0e-18	7.1e-21	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-11_FTMSms2hcd	37.629	6	30	50.1	1.0e-16	4.3e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	794.9455	2	2.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-11_FTMSms2hcd	34.094	6	20	50.6	1.7e-16	4.2e-19	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	1307.7173	3	15	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-11_FTMSms2hcd	74.124	220	255	41.4	1.4e-15	9.8e-18	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	956.8201	3	12	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-11_FTMSms2hcd	77.212	101	129	45.5	9.2e-13	1.3e-15	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	844.4655	3	1.2	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-11_FTMSms2hcd	51.034	267	290	43.5	3.2e-11	1.2e-13	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	1200.5720	3	11	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-11_FTMSms2hcd	67.948	181	212	22.2	2.2e-9	2.4e-12	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	560.8038	2	0.56	STTTGHLIYK	STTTGHLIYK		10	V20130429-11_FTMSms2hcd	17.718	21	30	38.2	3.0e-9	5.0e-12	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	513.3087	2	-0.080	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-11_FTMSms2hcd	30.977	256	266	46.2	1.9e-8	1.4e-10	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	432.9905	4	-0.96	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-11_FTMSms2hcd	41.934	167	180	27.9	2.9e-7	6.6e-10	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	675.7031	6	2.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-11_FTMSms2hcd	70.003	219	255	20.5	4.9e-6	2.9e-8	2	50141.3	HUMAN	Elongation factor 1-alpha 1
[9]		P68104	EF1A1_HUMAN	EEF1A1	12	42.2	10.02	6.0e-18	457.7860	2	-2.4	QTVAVGVIK	QTVAVGVIK		9	V20130429-11_FTMSms2hcd	26.294	431	439	31.9	1.2e-5	3.5e-8	3	50141.3	HUMAN	Elongation factor 1-alpha 1
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	813.9064	2	0.72	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-11_FTMSms2hcd	21.401	38	51	55.4	6.0e-18	7.1e-21	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-11_FTMSms2hcd	37.629	6	30	50.1	1.0e-16	4.3e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	794.9455	2	2.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-11_FTMSms2hcd	34.094	6	20	50.6	1.7e-16	4.2e-19	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	1307.7173	3	15	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	DGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		36	V20130429-11_FTMSms2hcd	74.124	220	255	41.4	1.4e-15	9.8e-18	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	956.8201	3	12	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-11_FTMSms2hcd	77.212	101	129	45.5	9.2e-13	1.3e-15	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	844.4655	3	1.2	VETGVLKPGMVVTFAPVNVTTEVK	VETGVLKPGM(Oxidation)VVTFAPVNVTTEVK	Oxidation@276	24	V20130429-11_FTMSms2hcd	51.034	267	290	43.5	3.2e-11	1.2e-13	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	1200.5720	3	11	IGYNPDTVAFVPISGWNGDNMLEPSANMPWFK	IGYNPDTVAFVPISGWNGDNM(Oxidation)LEPSANM(Oxidation)PWFK	Oxidation@201;Oxidation@208	32	V20130429-11_FTMSms2hcd	67.948	181	212	22.2	2.2e-9	2.4e-12	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	560.8038	2	0.56	STTTGHLIYK	STTTGHLIYK		10	V20130429-11_FTMSms2hcd	17.718	21	30	38.2	3.0e-9	5.0e-12	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	513.3087	2	-0.080	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-11_FTMSms2hcd	30.977	256	266	46.2	1.9e-8	1.4e-10	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	432.9905	4	-0.96	YEEIVKEVSTYIKK	YEEIVKEVSTYIKK		14	V20130429-11_FTMSms2hcd	41.934	167	180	27.9	2.9e-7	6.6e-10	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	675.7031	6	2.0	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK	KDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYK		37	V20130429-11_FTMSms2hcd	70.003	219	255	20.5	4.9e-6	2.9e-8	2	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-1]	0	Q5VTE0	EF1A3_HUMAN	EEF1A1P5	12	42.2	10.02	6.0e-18	457.7860	2	-2.4	QTVAVGVIK	QTVAVGVIK		9	V20130429-11_FTMSms2hcd	26.294	431	439	31.9	1.2e-5	3.5e-8	3	50185.5	HUMAN	Putative elongation factor 1-alpha-like 3
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	813.9064	2	0.72	TIEKFEKEAAEMGK	TIEKFEKEAAEM(Oxidation)GK	Oxidation@49	14	V20130429-11_FTMSms2hcd	21.401	38	51	55.4	6.0e-18	7.1e-21	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	897.4940	3	1.9	THINIVVIGHVDSGKSTTTGHLIYK	THINIVVIGHVDSGKSTTTGHLIYK		25	V20130429-11_FTMSms2hcd	37.629	6	30	50.1	1.0e-16	4.3e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	794.9455	2	2.0	THINIVVIGHVDSGK	THINIVVIGHVDSGK		15	V20130429-11_FTMSms2hcd	34.094	6	20	50.6	1.7e-16	4.2e-19	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	956.8201	3	12	NMITGTSQADCAVLIVAAGVGEFEAGISK	NM(Oxidation)ITGTSQADCAVLIVAAGVGEFEAGISK	Oxidation@102	29	V20130429-11_FTMSms2hcd	77.212	101	129	45.5	9.2e-13	1.3e-15	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	560.8038	2	0.56	STTTGHLIYK	STTTGHLIYK		10	V20130429-11_FTMSms2hcd	17.718	21	30	38.2	3.0e-9	5.0e-12	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	513.3087	2	-0.080	IGGIGTVPVGR	IGGIGTVPVGR		11	V20130429-11_FTMSms2hcd	30.977	256	266	46.2	1.9e-8	1.4e-10	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	784.2342	5	0.93	EGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	EGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK		36	V20130429-11_FTMSms2hcd	73.388	220	255	24.6	2.1e-7	1.4e-9	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	1000.0300	4	-1.6	EGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	EGNASGVS(Phospho)LLEALDTILPPTRPTDKPLRLPLQDVYK	Phospho@224|227|234	36	V20130429-11_FTMSms2hcd	76.373	220	255	21.2	2.3e-7	6.9e-10	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	1032.0515	4	-3.7	KEGNASGVSLLEALDTILPPTRPTDKPLRLPLQDVYK	KEGNAS(Phospho)GVSLLEALDTILPPTRPTDKPLRLPLQDVYK	Phospho@224|227|234	37	V20130429-11_FTMSms2hcd	72.670	219	255	23.7	1.0e-6	4.7e-9	1	50470.6	HUMAN	Elongation factor 1-alpha 2
[9-2]	3	Q05639	EF1A2_HUMAN	EEF1A2	10	27.0	10.02	6.0e-18	457.7860	2	-2.4	QTVAVGVIK	QTVAVGVIK		9	V20130429-11_FTMSms2hcd	26.294	431	439	31.9	1.2e-5	3.5e-8	3	50470.6	HUMAN	Elongation factor 1-alpha 2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	714.3948	4	0.46	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-11_FTMSms2hcd	71.235	89	115	48.6	2.2e-15	9.6e-18	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	954.9467	2	2.1	AEDGSVIDYELIDQDAR	AEDGSVIDYELIDQDAR		17	V20130429-11_FTMSms2hcd	45.678	180	196	43.4	5.7e-13	6.1e-16	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-11_FTMSms2hcd	69.494	89	104	42.4	4.7e-12	6.8e-14	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	485.7459	4	0.54	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-11_FTMSms2hcd	40.440	153	169	37.1	6.0e-12	7.1e-15	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	922.9579	2	3.3	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-11_FTMSms2hcd	30.125	11	28	39.5	7.6e-12	8.6e-15	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	771.9283	2	0.47	GVDEVTIVNILTNR	GVDEVTIVNILTNR		14	V20130429-11_FTMSms2hcd	59.339	50	63	50.3	2.1e-10	5.1e-13	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	536.2790	2	0.39	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-11_FTMSms2hcd	33.980	1	10	37.3	2.0e-9	3.7e-12	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	719.0300	3	4.1	AYTNFDAERDALNIETAIK	AYTNFDAERDALNIETAIK		19	V20130429-11_FTMSms2hcd	49.798	29	47	31.8	7.1e-8	8.0e-11	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	556.2806	2	0.76	QDIAFAYQR	QDIAFAYQR		9	V20130429-11_FTMSms2hcd	30.430	69	77	34.6	5.1e-7	7.2e-10	1	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	828.4003	2	-0.72	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-11_FTMSms2hcd	21.267	105	119	23.0	4.4e-6	4.9e-9	2	38604.4	HUMAN	Annexin A2
[10]		P07355	ANXA2_HUMAN	ANXA2	11	41.9	8.63	2.2e-15	381.2331	2	-0.065	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-11_FTMSms2hcd	25.274	170	176	26.1	1.4e-5	4.9e-8	2	38604.4	HUMAN	Annexin A2
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	714.3948	4	0.46	SALSGHLETVILGLLKTPAQYDASELK	SALSGHLETVILGLLKTPAQYDASELK		27	V20130429-11_FTMSms2hcd	71.235	89	115	48.6	2.2e-15	9.6e-18	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	550.9978	3	-0.022	SALSGHLETVILGLLK	SALSGHLETVILGLLK		16	V20130429-11_FTMSms2hcd	69.494	89	104	42.4	4.7e-12	6.8e-14	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	485.7459	4	0.54	TDLEKDIISDTSGDFRK	TDLEKDIISDTSGDFRK		17	V20130429-11_FTMSms2hcd	40.440	153	169	37.1	6.0e-12	7.1e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	922.9579	2	3.3	LSLEGDHSTPPSAYGSVK	LSLEGDHSTPPSAYGSVK		18	V20130429-11_FTMSms2hcd	30.125	11	28	39.5	7.6e-12	8.6e-15	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	536.2790	2	0.39	MSTVHEILCK	M(Met-loss+Acetyl)STVHEILCK	Met-loss+Acetyl@1	10	V20130429-11_FTMSms2hcd	33.980	1	10	37.3	2.0e-9	3.7e-12	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	719.0300	3	4.1	AYTNFDAERDALNIETAIK	AYTNFDAERDALNIETAIK		19	V20130429-11_FTMSms2hcd	49.798	29	47	31.8	7.1e-8	8.0e-11	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	828.4003	2	-0.72	TPAQYDASELKASMK	TPAQYDASELKASM(Oxidation)K	Oxidation@118	15	V20130429-11_FTMSms2hcd	21.267	105	119	23.0	4.4e-6	4.9e-9	2	38659.3	HUMAN	Putative annexin A2-like protein
[10-1]	0	A6NMY6	AXA2L_HUMAN	ANXA2P2	8	30.1	8.63	2.2e-15	381.2331	2	-0.065	LMVALAK	LM(Oxidation)VALAK	Oxidation@171	7	V20130429-11_FTMSms2hcd	25.274	170	176	26.1	1.4e-5	4.9e-8	2	38659.3	HUMAN	Putative annexin A2-like protein
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	1004.4492	2	-0.96	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-11_FTMSms2hcd	50.992	41	60	47.1	2.7e-12	3.0e-15	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	851.4655	2	11	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-11_FTMSms2hcd	57.071	65	79	49.6	7.9e-12	1.7e-14	3	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	744.4496	2	8.6	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-11_FTMSms2hcd	67.372	230	243	47.2	2.2e-9	1.8e-11	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	508.2920	2	-1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-11_FTMSms2hcd	32.481	327	336	33.7	2.0e-7	3.6e-10	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11]		P68363	TBA1B_HUMAN	TUBA1B	10	30.2	8.85	8.7e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-11_FTMSms2hcd	15.039	157	164	29.9	4.8e-6	1.1e-8	5	50152.1	HUMAN	Tubulin alpha-1B chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	1004.4492	2	-0.96	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-11_FTMSms2hcd	50.992	41	60	47.1	2.7e-12	3.0e-15	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	851.4655	2	11	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-11_FTMSms2hcd	57.071	65	79	49.6	7.9e-12	1.7e-14	3	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	744.4496	2	8.6	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-11_FTMSms2hcd	67.372	230	243	47.2	2.2e-9	1.8e-11	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	508.2920	2	-1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-11_FTMSms2hcd	32.481	327	336	33.7	2.0e-7	3.6e-10	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-1]	0	Q9BQE3	TBA1C_HUMAN	TUBA1C	10	30.3	8.85	8.7e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-11_FTMSms2hcd	15.039	157	164	29.9	4.8e-6	1.1e-8	5	49895.8	HUMAN	Tubulin alpha-1C chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	1004.4492	2	-0.96	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-11_FTMSms2hcd	50.992	41	60	47.1	2.7e-12	3.0e-15	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	851.4655	2	11	AVFVDLEPTVIDEVR	AVFVDLEPTVIDEVR		15	V20130429-11_FTMSms2hcd	57.071	65	79	49.6	7.9e-12	1.7e-14	3	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	508.2920	2	-1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-11_FTMSms2hcd	32.481	327	336	33.7	2.0e-7	3.6e-10	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-2]	0	Q71U36	TBA1A_HUMAN	TUBA1A	9	27.1	8.85	8.7e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-11_FTMSms2hcd	15.039	157	164	29.9	4.8e-6	1.1e-8	5	50136.1	HUMAN	Tubulin alpha-1A chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	1004.4492	2	-0.96	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-11_FTMSms2hcd	50.992	41	60	47.1	2.7e-12	3.0e-15	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	508.2920	2	-1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-11_FTMSms2hcd	32.481	327	336	33.7	2.0e-7	3.6e-10	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-3]	0	Q13748	TBA3C_HUMAN	TUBA3C	8	23.8	8.85	8.7e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-11_FTMSms2hcd	15.039	157	164	29.9	4.8e-6	1.1e-8	5	49960.0	HUMAN	Tubulin alpha-3C/D chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	744.4496	2	8.6	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-11_FTMSms2hcd	67.372	230	243	47.2	2.2e-9	1.8e-11	5	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	49924.9	HUMAN	Tubulin alpha-4A chain
[11-4]	0	P68366	TBA4A_HUMAN	TUBA4A	7	20.3	8.85	8.7e-16	455.2551	2	-1.2	LSVDYGKK	LSVDYGKK		8	V20130429-11_FTMSms2hcd	15.039	157	164	29.9	4.8e-6	1.1e-8	5	49924.9	HUMAN	Tubulin alpha-4A chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.85	8.7e-16	800.0607	3	-4.6	QLFHPEQLITGKEDAANNYAR	Q(Gln->pyro-Glu)LFHPEQLITGKEDAANNYAR	Gln->pyro-Glu@85	21	V20130429-11_FTMSms2hcd	48.690	85	105	47.8	8.7e-16	9.0e-19	6	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.85	8.7e-16	604.5571	4	0.59	QLFHPEQLITGKEDAANNYAR	QLFHPEQLITGKEDAANNYAR		21	V20130429-11_FTMSms2hcd	40.538	85	105	48.8	2.1e-13	2.3e-16	6	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.85	8.7e-16	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.85	8.7e-16	744.4496	2	8.6	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-11_FTMSms2hcd	67.372	230	243	47.2	2.2e-9	1.8e-11	5	50094.0	HUMAN	Tubulin alpha-8 chain
[11-5]	0	Q9NY65	TBA8_HUMAN	TUBA8	5	14.9	8.85	8.7e-16	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	50094.0	HUMAN	Tubulin alpha-8 chain
[11-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.35	5.2e-13	878.9845	2	-0.86	IHFPLATYAPVISAEK	IHFPLATYAPVISAEK		16	V20130429-11_FTMSms2hcd	52.173	265	280	42.6	5.2e-13	1.3e-15	6	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.35	5.2e-13	1004.4492	2	-0.96	TIGGGDDSFNTFFSETGAGK	TIGGGDDSFNTFFSETGAGK		20	V20130429-11_FTMSms2hcd	50.992	41	60	47.1	2.7e-12	3.0e-15	5	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.35	5.2e-13	912.9967	2	0.38	VGINYQPPTVVPGGDLAK	VGINYQPPTVVPGGDLAK		18	V20130429-11_FTMSms2hcd	44.304	353	370	28.7	1.2e-9	2.5e-12	7	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.35	5.2e-13	573.6328	3	1.1	NLDIERPTYTNLNR	NLDIERPTYTNLNR		14	V20130429-11_FTMSms2hcd	33.863	216	229	45.6	4.2e-8	5.4e-11	7	49859.0	HUMAN	Tubulin alpha-3E chain
[11-6]	0	Q6PEY2	TBA3E_HUMAN	TUBA3E	5	17.3	7.35	5.2e-13	508.2920	2	-1.5	DVNAAIATIK	DVNAAIATIK		10	V20130429-11_FTMSms2hcd	32.481	327	336	33.7	2.0e-7	3.6e-10	5	49859.0	HUMAN	Tubulin alpha-3E chain
[11-7]	0	Q9H853	TBA4B_HUMAN	TUBA4B	1	5.8	5.40	2.2e-9	744.4496	2	8.6	LISQIVSSITASLR	LISQIVSSITASLR		14	V20130429-11_FTMSms2hcd	67.372	169	182	47.2	2.2e-9	1.8e-11	5	27551.5	HUMAN	Putative tubulin-like protein alpha-4B
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	779.3681	2	6.5	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-11_FTMSms2hcd	42.851	56	69	42.5	3.0e-15	3.6e-18	2	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	916.4597	2	0.47	SIYGEKFEDENFILK	SIYGEKFEDENFILK		15	V20130429-11_FTMSms2hcd	46.244	77	91	33.5	3.7e-13	4.3e-16	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	769.3723	2	1.6	VKEGMNIVEAMER	VKEGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	13	V20130429-11_FTMSms2hcd	17.753	132	144	43.4	4.0e-12	4.9e-15	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	973.5070	2	2.5	MVNPTVFFDIAVDGEPLGR	M(Met-loss)VNPTVFFDIAVDGEPLGR	Met-loss@1	19	V20130429-11_FTMSms2hcd	66.850	1	19	38.2	7.1e-12	1.0e-14	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	758.4022	2	1.1	TEWLDGKHVVFGK	TEWLDGKHVVFGK		13	V20130429-11_FTMSms2hcd	36.528	119	131	36.1	1.3e-10	2.1e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	655.7894	2	0.0082	EGMNIVEAMER	EGM(Oxidation)NIVEAM(Oxidation)ER	Oxidation@136;Oxidation@142	11	V20130429-11_FTMSms2hcd	18.725	134	144	26.0	1.6e-10	2.6e-13	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	577.7885	2	-2.7	FEDENFILK	FEDENFILK		9	V20130429-11_FTMSms2hcd	41.413	83	91	29.1	7.1e-7	9.8e-10	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12]		P62937	PPIA_HUMAN	PPIA	8	52.1	8.56	3.0e-15	690.3834	2	1.9	VSFELFADKVPK	VSFELFADKVPK		12	V20130429-11_FTMSms2hcd	47.161	20	31	27.3	8.7e-6	2.0e-8	1	18012.7	HUMAN	Peptidyl-prolyl cis-trans isomerase A
[12-1]	0	Q9Y536	PAL4A_HUMAN	PPIAL4A	1	8.5	8.56	3.0e-15	779.3681	2	6.5	IIPGFMCQGGDFTR	IIPGFM(Oxidation)CQGGDFTR	Oxidation@61	14	V20130429-11_FTMSms2hcd	42.851	56	69	42.5	3.0e-15	3.6e-18	2	18182.0	HUMAN	Peptidyl-prolyl cis-trans isomerase A-like 4A/B/C
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	741.9041	2	1.7	TVTAMDVVYALKR	TVTAM(Oxidation)DVVYALKR	Oxidation@85	13	V20130429-11_FTMSms2hcd	40.492	81	93	38.5	2.2e-13	5.0e-16	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	663.8535	2	1.8	TVTAMDVVYALK	TVTAM(Oxidation)DVVYALK	Oxidation@85	12	V20130429-11_FTMSms2hcd	43.977	81	92	33.6	4.2e-10	8.3e-13	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	702.3794	3	10	VFLENVIRDAVTYTEHAK	VFLENVIRDAVTYTEHAK		18	V20130429-11_FTMSms2hcd	62.654	61	78	39.4	8.1e-10	1.6e-12	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	567.7750	2	0.13	DAVTYTEHAK	DAVTYTEHAK		10	V20130429-11_FTMSms2hcd	12.173	69	78	33.7	3.9e-9	6.3e-12	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	663.3802	2	-0.34	DNIQGITKPAIR	DNIQGITKPAIR		12	V20130429-11_FTMSms2hcd	27.131	25	36	46.7	1.5e-8	5.1e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	590.8147	2	1.1	ISGLIYEETR	ISGLIYEETR		10	V20130429-11_FTMSms2hcd	33.019	47	56	40.3	2.0e-8	3.1e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	495.2924	2	-0.32	VFLENVIR	VFLENVIR		8	V20130429-11_FTMSms2hcd	43.379	61	68	36.0	2.6e-8	8.2e-11	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	741.4310	2	0.025	DNIQGITKPAIRR	DNIQGITKPAIRR		13	V20130429-11_FTMSms2hcd	23.514	25	37	43.1	3.7e-8	1.9e-10	1	11367.4	HUMAN	Histone H4
[13]		P62805	H4_HUMAN	HIST1H4A	9	52.4	7.56	2.2e-13	489.6061	3	0.13	TVTAMDVVYALKR	TVTAMDVVYALKR		13	V20130429-11_FTMSms2hcd	48.742	81	93	20.9	5.9e-8	1.4e-10	1	11367.4	HUMAN	Histone H4
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	847.8539	2	0.25	NQGGYGGSSSSSSYGSGR	NQGGYGGSSSSSSYGSGR		18	V20130429-11_FTMSms2hcd	11.793	353	370	54.2	3.3e-19	4.8e-22	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	892.9649	2	9.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-11_FTMSms2hcd	57.952	16	31	44.9	2.2e-13	3.2e-16	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	814.8961	2	2.1	SSGPYGGGGQYFAKPR	SSGPYGGGGQYFAKPR		16	V20130429-11_FTMSms2hcd	25.287	337	352	53.5	2.8e-13	3.1e-16	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	591.4920	5	1.6	GFGFVTYATVEEVDAAMNARPHKVDGR	GFGFVTYATVEEVDAAM(Oxidation)NARPHKVDGR	Oxidation@72	27	V20130429-11_FTMSms2hcd	48.837	56	82	26.9	1.3e-8	1.3e-11	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	714.3785	2	0.59	SESPKEPEQLRK	SESPKEPEQLRK		12	V20130429-11_FTMSms2hcd	12.186	4	15	39.1	2.6e-8	3.8e-11	1	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	638.3326	3	-9.5	KLFIGGLSFETTDESLR	KLFIGGLSFETTDESLR		17	V20130429-11_FTMSms2hcd	52.516	15	31	26.2	3.0e-8	4.3e-11	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	761.0551	3	0.36	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-11_FTMSms2hcd	52.386	147	166	25.9	1.3e-7	1.7e-10	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14]		P09651	ROA1_HUMAN	HNRNPA1	8	32.8	10.70	3.3e-19	479.9190	3	-1.4	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-11_FTMSms2hcd	14.228	93	105	21.9	1.5e-4	2.0e-7	2	38746.9	HUMAN	Heterogeneous nuclear ribonucleoprotein A1
[14-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	4	15.6	7.55	2.2e-13	892.9649	2	9.0	LFIGGLSFETTDESLR	LFIGGLSFETTDESLR		16	V20130429-11_FTMSms2hcd	57.952	16	31	44.9	2.2e-13	3.2e-16	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[14-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	4	15.6	7.55	2.2e-13	638.3326	3	-9.5	KLFIGGLSFETTDESLR	KLFIGGLSFETTDESLR		17	V20130429-11_FTMSms2hcd	52.516	15	31	26.2	3.0e-8	4.3e-11	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[14-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	4	15.6	7.55	2.2e-13	761.0551	3	0.36	GFAFVTFDDHDSVDKIVIQK	GFAFVTFDDHDSVDKIVIQK		20	V20130429-11_FTMSms2hcd	52.386	147	166	25.9	1.3e-7	1.7e-10	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[14-1]	0	Q32P51	RA1L2_HUMAN	HNRNPA1L2	4	15.6	7.55	2.2e-13	479.9190	3	-1.4	EDSQRPGAHLTVK	EDSQRPGAHLTVK		13	V20130429-11_FTMSms2hcd	14.228	93	105	21.9	1.5e-4	2.0e-7	2	34225.6	HUMAN	Heterogeneous nuclear ribonucleoprotein A1-like 2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	847.9126	2	0.75	QMEQISQFLQAAER	QM(Oxidation)EQISQFLQAAER	Oxidation@90	14	V20130429-11_FTMSms2hcd	47.059	89	102	42.1	3.8e-11	4.0e-14	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	1050.5142	2	-3.5	YGINTTDIFQTVDLWEGK	YGINTTDIFQTVDLWEGK		18	V20130429-11_FTMSms2hcd	69.089	103	120	44.5	3.4e-10	3.4e-13	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	616.3450	2	0.0044	TLMNLGGLAVAR	TLM(Oxidation)NLGGLAVAR	Oxidation@130	12	V20130429-11_FTMSms2hcd	38.353	128	139	35.5	5.5e-10	1.2e-12	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	640.2993	2	0.0026	NFSDNQLQEGK	NFSDNQLQEGK		11	V20130429-11_FTMSms2hcd	20.526	161	171	39.0	1.1e-9	1.8e-12	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	708.3062	2	0.65	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-11_FTMSms2hcd	11.966	183	196	37.0	1.3e-9	2.3e-12	2	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	609.8167	2	0.16	NVIGLQMGTNR	NVIGLQM(Oxidation)GTNR	Oxidation@178	11	V20130429-11_FTMSms2hcd	24.238	172	182	32.6	6.2e-9	9.0e-12	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	506.7595	2	-1.5	IQASTMAFK	IQASTM(Oxidation)AFK	Oxidation@85	9	V20130429-11_FTMSms2hcd	20.205	80	88	35.0	6.7e-8	1.2e-10	1	22391.7	HUMAN	Transgelin-2
[15]		P37802	TAGL2_HUMAN	TAGLN2	8	50.8	6.35	3.8e-11	602.3151	2	0.024	MANRGPAYGLSR	M(Met-loss+Acetyl)ANRGPAYGLSR	Met-loss+Acetyl@1	12	V20130429-11_FTMSms2hcd	22.590	1	12	50.6	2.9e-7	4.3e-10	1	22391.7	HUMAN	Transgelin-2
[15-1]	0	Q9UI15	TAGL3_HUMAN	TAGLN3	1	7.0	5.21	1.3e-9	708.3062	2	0.65	GASQAGMTGYGMPR	GASQAGM(Oxidation)TGYGM(Oxidation)PR	Oxidation@189;Oxidation@194	14	V20130429-11_FTMSms2hcd	11.966	183	196	37.0	1.3e-9	2.3e-12	2	22472.9	HUMAN	Transgelin-3
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	1073.0798	2	11	ALMLQGVDLLADAVAVTMGPK	ALM(Oxidation)LQGVDLLADAVAVTM(Oxidation)GPK	Oxidation@40;Oxidation@55	21	V20130429-11_FTMSms2hcd	70.363	38	58	56.5	1.4e-17	3.2e-20	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	524.9764	3	7.4	GVMLAVDAVIAELKK	GVM(Oxidation)LAVDAVIAELKK	Oxidation@145	15	V20130429-11_FTMSms2hcd	58.984	143	157	40.7	2.7e-12	1.4e-14	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	549.6399	3	1.1	VGEVIVTKDDAMLLK	VGEVIVTKDDAM(Oxidation)LLK	Oxidation@356	15	V20130429-11_FTMSms2hcd	37.144	345	359	42.3	9.6e-11	2.2e-13	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	577.3859	2	-1.9	LKVGLQVVAVK	LKVGLQVVAVK		11	V20130429-11_FTMSms2hcd	37.106	291	301	35.2	2.4e-8	8.6e-10	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	672.8629	2	2.0	TVIIEQSWGSPK	TVIIEQSWGSPK		12	V20130429-11_FTMSms2hcd	36.582	61	72	32.6	1.6e-7	2.5e-10	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	408.9603	4	0.38	VGGTSDVEVNEKKDR	VGGTSDVEVNEKKDR		15	V20130429-11_FTMSms2hcd	11.209	406	420	30.2	1.9e-7	2.3e-10	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	506.2882	2	-0.28	GANPVEIRR	GANPVEIRR		9	V20130429-11_FTMSms2hcd	15.351	134	142	27.1	7.5e-5	2.5e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[16]		P10809	CH60_HUMAN	HSPD1	8	25.3	9.82	1.4e-17	1151.7955	4	2.2	TALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	TALLDAAGVAS(Phospho)LLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF	Phospho@537|540|547	47	V20130429-11_FTMSms2hcd	77.448	527	573	14.3	9.8e-5	1.4e-7	1	61055.2	HUMAN	60 kDa heat shock protein, mitochondrial
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	675.0189	3	1.9	ITLPVDFVTADKFDENAK	ITLPVDFVTADKFDENAK		18	V20130429-11_FTMSms2hcd	54.108	280	297	46.6	1.3e-16	1.8e-19	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	1124.5934	3	7.3	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEM(Oxidation)IIGGGM(Oxidation)AFTFLK	Oxidation@227;Oxidation@234;Oxidation@240	30	V20130429-11_FTMSms2hcd	63.930	217	246	49.9	1.9e-14	4.7e-17	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	835.6932	4	-0.11	VADKIQLINNMLDKVNEMIIGGGMAFTFLK	VADKIQLINNM(Oxidation)LDKVNEMIIGGGMAFTFLK	Oxidation@227=13	30	V20130429-11_FTMSms2hcd	75.944	217	246	46.0	5.6e-14	1.3e-16	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	545.6025	3	0.49	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-11_FTMSms2hcd	36.950	157	171	43.2	4.2e-13	4.9e-16	2	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	590.3364	3	-0.54	ALESPERPFLAILGGAK	ALESPERPFLAILGGAK		17	V20130429-11_FTMSms2hcd	55.811	200	216	41.4	1.9e-8	7.1e-11	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17]		P00558	PGK1_HUMAN	PGK1	6	21.8	9.30	1.3e-16	549.3137	2	0.020	VLPGVDALSNI	VLPGVDALSNI		11	V20130429-11_FTMSms2hcd	55.464	407	417	14.2	3.4e-4	1.1e-6	1	44615.1	HUMAN	Phosphoglycerate kinase 1
[17-1]	0	P07205	PGK2_HUMAN	PGK2	1	3.6	7.40	4.2e-13	545.6025	3	0.49	LGDVYVNDAFGTAHR	LGDVYVNDAFGTAHR		15	V20130429-11_FTMSms2hcd	36.950	157	171	43.2	4.2e-13	4.9e-16	2	44796.5	HUMAN	Phosphoglycerate kinase 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	835.4783	3	3.2	GAVILVSSIAAYNPVVALGVYNVSK	GAVILVSSIAAYNPVVALGVYNVSK		25	V20130429-11_FTMSms2hcd	73.940	143	167	43.3	6.9e-17	6.4e-19	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	887.5099	3	0.66	RGAVILVSSIAAYNPVVALGVYNVSK	RGAVILVSSIAAYNPVVALGVYNVSK		26	V20130429-11_FTMSms2hcd	68.303	142	167	49.8	1.2e-14	1.5e-16	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	803.4523	2	0.90	VAVVTGSTSGIGFAIAR	VAVVTGSTSGIGFAIAR		17	V20130429-11_FTMSms2hcd	46.383	16	32	27.7	1.8e-8	5.4e-11	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	478.2950	2	0.49	TLALELAPK	TLALELAPK		9	V20130429-11_FTMSms2hcd	38.230	176	184	25.8	1.9e-7	1.1e-9	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	520.7780	2	0.38	DGAHVVISSR	DGAHVVISSR		10	V20130429-11_FTMSms2hcd	14.716	37	46	33.5	7.6e-7	1.6e-9	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	422.7666	2	1.0	TALLGLTR	TALLGLTR		8	V20130429-11_FTMSms2hcd	34.693	168	175	27.1	2.0e-4	5.4e-7	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[18]		Q13268	DHRS2_HUMAN	DHRS2	7	33.7	9.45	6.9e-17	833.9663	2	18	LQGEGLSVAGIVCHVGK	LQGEGLSVAGIVCHVGK		17	V20130429-11_FTMSms2hcd	34.213	58	74	14.4	0.037	1.0e-4	1	27438.9	HUMAN	Dehydrogenase/reductase SDR family member 2
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	958.0370	2	1.0	TFVNITPAEVGVLVGKDR	TFVNITPAEVGVLVGKDR		18	V20130429-11_FTMSms2hcd	54.360	39	56	47.8	5.6e-16	2.3e-18	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	822.4790	2	8.5	TFVNITPAEVGVLVGK	TFVNITPAEVGVLVGK		16	V20130429-11_FTMSms2hcd	58.555	39	54	40.2	8.4e-12	4.1e-14	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	735.8853	2	3.1	SSFYVNGLTLGGQK	SSFYVNGLTLGGQK		14	V20130429-11_FTMSms2hcd	43.800	57	70	41.4	1.6e-8	2.4e-11	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	445.7727	2	0.19	TLVLLMGK	TLVLLM(Oxidation)GK	Oxidation@114	8	V20130429-11_FTMSms2hcd	34.732	109	116	23.1	5.3e-8	2.6e-10	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	563.2430	2	-2.5	CYEMASHLR	CYEM(Oxidation)ASHLR	Oxidation@131	9	V20130429-11_FTMSms2hcd	12.466	128	136	18.1	4.7e-7	9.5e-10	1	15054.4	HUMAN	Profilin-1
[19]		P07737	PROF1_HUMAN	PFN1	6	45.0	8.96	5.6e-16	690.3621	2	0.29	STGGAPTFNVTVTK	STGGAPTFNVTVTK		14	V20130429-11_FTMSms2hcd	32.820	92	105	30.1	1.6e-6	2.2e-9	1	15054.4	HUMAN	Profilin-1
[20]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.41	4.0e-13	1016.5317	2	3.1	AFLASPEYVNLPINGNGKQ	AFLASPEYVNLPINGNGKQ		19	V20130429-11_FTMSms2hcd	51.325	192	210	41.5	4.0e-13	6.0e-16	1	23356.0	HUMAN	Glutathione S-transferase P
[20]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.41	4.0e-13	669.3674	2	1.7	MPPYTVVYFPVR	M(Met-loss)PPYTVVYFPVR	Met-loss@1	12	V20130429-11_FTMSms2hcd	49.152	1	12	44.9	3.4e-12	7.2e-15	1	23356.0	HUMAN	Glutathione S-transferase P
[20]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.41	4.0e-13	1003.1651	3	3.0	MLLADQGQSWKEEVVTVETWQEGSLK	M(Oxidation)LLADQGQSWKEEVVTVETWQEGSLK	Oxidation@20	26	V20130429-11_FTMSms2hcd	57.469	20	45	37.1	5.7e-11	6.3e-14	1	23356.0	HUMAN	Glutathione S-transferase P
[20]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.41	4.0e-13	709.3903	3	-1.9	ALPGQLKPFETLLSQNQGGK	ALPGQLKPFETLLSQNQGGK		20	V20130429-11_FTMSms2hcd	53.269	122	141	44.0	9.4e-11	2.8e-13	1	23356.0	HUMAN	Glutathione S-transferase P
[20]		P09211	GSTP1_HUMAN	GSTP1	5	44.3	7.41	4.0e-13	942.4805	2	2.1	FQDGDLTLYQSNTILR	FQDGDLTLYQSNTILR		16	V20130429-11_FTMSms2hcd	49.191	56	71	35.3	4.2e-10	5.5e-13	1	23356.0	HUMAN	Glutathione S-transferase P
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	1122.1219	2	12	MSVQPTVSLGGFEITPPVVLR	M(Oxidation)SVQPTVSLGGFEITPPVVLR	Oxidation@81	21	V20130429-11_FTMSms2hcd	65.027	81	101	57.1	3.0e-18	1.1e-20	1	32575.3	HUMAN	Nucleophosmin
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	735.1904	5	0.77	TVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLK	TVSLGAGAKDELHIVEAEAM(Oxidation)NYEGSPIKVTLATLK	Oxidation@65	35	V20130429-11_FTMSms2hcd	62.464	46	80	39.8	1.7e-12	4.9e-15	1	32575.3	HUMAN	Nucleophosmin
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	565.8064	2	0.30	GPSSVEDIKAK	GPSSVEDIKAK		11	V20130429-11_FTMSms2hcd	14.798	240	250	35.0	6.8e-9	1.1e-11	1	32575.3	HUMAN	Nucleophosmin
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	466.2404	2	0.45	GPSSVEDIK	GPSSVEDIK		9	V20130429-11_FTMSms2hcd	16.792	240	248	25.2	2.0e-6	3.6e-9	1	32575.3	HUMAN	Nucleophosmin
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	515.4465	5	0.73	ADKDYHFKVDNDENEHQLSLR	ADKDYHFKVDNDENEHQLSLR		21	V20130429-11_FTMSms2hcd	28.948	25	45	22.8	7.8e-6	7.6e-9	1	32575.3	HUMAN	Nucleophosmin
[21]		P06748	NPM_HUMAN	NPM1	6	32.0	10.19	3.0e-18	392.2237	2	0.22	FINYVK	FINYVK		6	V20130429-11_FTMSms2hcd	24.702	268	273	17.4	1.8e-4	7.7e-7	1	32575.3	HUMAN	Nucleophosmin
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	901.4609	2	1.8	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-11_FTMSms2hcd	26.064	89	105	57.6	1.1e-13	1.3e-16	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	672.8846	2	-1.1	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-11_FTMSms2hcd	32.013	7	18	45.4	8.3e-11	2.0e-13	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	588.3315	2	-1.2	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-11_FTMSms2hcd	42.360	57	66	31.8	2.8e-7	6.2e-10	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	497.7432	2	1.7	GDFCIQVGR	GDFCIQVGR		9	V20130429-11_FTMSms2hcd	34.986	106	114	20.5	2.9e-7	5.5e-10	3	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	578.5546	4	4.7	SAEKEISLWFKPEELVDYK	SAEKEISLWFKPEELVDYK		19	V20130429-11_FTMSms2hcd	56.802	125	143	21.0	8.6e-7	1.4e-9	1	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	492.8128	2	-1.7	GLVGEIIKR	GLVGEIIKR		9	V20130429-11_FTMSms2hcd	32.026	19	27	34.1	7.7e-5	4.5e-7	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22]		P22392	NDKB_HUMAN	NME2	7	50.0	7.72	1.1e-13	414.7629	2	-0.49	GLVGEIIK	GLVGEIIK		8	V20130429-11_FTMSms2hcd	37.773	19	26	17.8	0.0014	3.7e-6	2	17298.2	HUMAN	Nucleoside diphosphate kinase B
[22-1]	0	P15531	NDKA_HUMAN	NME1	5	30.9	7.72	1.1e-13	901.4609	2	1.8	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@90	17	V20130429-11_FTMSms2hcd	26.064	89	105	57.6	1.1e-13	1.3e-16	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[22-1]	0	P15531	NDKA_HUMAN	NME1	5	30.9	7.72	1.1e-13	672.8846	2	-1.1	TFIAIKPDGVQR	TFIAIKPDGVQR		12	V20130429-11_FTMSms2hcd	32.013	7	18	45.4	8.3e-11	2.0e-13	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[22-1]	0	P15531	NDKA_HUMAN	NME1	5	30.9	7.72	1.1e-13	497.7432	2	1.7	GDFCIQVGR	GDFCIQVGR		9	V20130429-11_FTMSms2hcd	34.986	106	114	20.5	2.9e-7	5.5e-10	3	17148.9	HUMAN	Nucleoside diphosphate kinase A
[22-1]	0	P15531	NDKA_HUMAN	NME1	5	30.9	7.72	1.1e-13	492.8128	2	-1.7	GLVGEIIKR	GLVGEIIKR		9	V20130429-11_FTMSms2hcd	32.026	19	27	34.1	7.7e-5	4.5e-7	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[22-1]	0	P15531	NDKA_HUMAN	NME1	5	30.9	7.72	1.1e-13	414.7629	2	-0.49	GLVGEIIK	GLVGEIIK		8	V20130429-11_FTMSms2hcd	37.773	19	26	17.8	0.0014	3.7e-6	2	17148.9	HUMAN	Nucleoside diphosphate kinase A
[22-2]	1	O60361	NDK8_HUMAN	NME2P1	4	33.6	7.72	1.1e-13	901.4609	2	1.8	VMLGETNPADSKPGTIR	VM(Oxidation)LGETNPADSKPGTIR	Oxidation@75	17	V20130429-11_FTMSms2hcd	26.064	74	90	57.6	1.1e-13	1.3e-16	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[22-2]	1	O60361	NDK8_HUMAN	NME2P1	4	33.6	7.72	1.1e-13	634.3331	2	1.6	FKPEELVDYK	FKPEELVDYK		10	V20130429-11_FTMSms2hcd	35.507	119	128	38.3	1.3e-7	1.8e-10	1	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[22-2]	1	O60361	NDK8_HUMAN	NME2P1	4	33.6	7.72	1.1e-13	588.3315	2	-1.2	DRPFFPGLVK	DRPFFPGLVK		10	V20130429-11_FTMSms2hcd	42.360	42	51	31.8	2.8e-7	6.2e-10	2	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[22-2]	1	O60361	NDK8_HUMAN	NME2P1	4	33.6	7.72	1.1e-13	497.7432	2	1.7	GDFCIQVGR	GDFCIQVGR		9	V20130429-11_FTMSms2hcd	34.986	91	99	20.5	2.9e-7	5.5e-10	3	15529.2	HUMAN	Putative nucleoside diphosphate kinase
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	506.9844	3	1.3	LLIHQSLAGGIIGVK	LLIHQSLAGGIIGVK		15	V20130429-11_FTMSms2hcd	45.386	149	163	44.0	1.2e-11	3.9e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	615.0303	3	-1.3	ILSISADIETIGEILKK	ILSISADIETIGEILKK		17	V20130429-11_FTMSms2hcd	71.050	87	103	39.2	1.6e-11	1.7e-13	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	518.6476	3	1.4	IILDLISESPIKGR	IILDLISESPIKGR		14	V20130429-11_FTMSms2hcd	51.542	208	221	43.3	7.8e-9	6.6e-11	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	670.9146	2	14	IILDLISESPIK	IILDLISESPIK		12	V20130429-11_FTMSms2hcd	58.450	208	219	43.7	1.6e-8	1.2e-10	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	959.0211	2	1.1	GSYGDLGGPIITTQVTIPK	GSYGDLGGPIITTQVTIPK		19	V20130429-11_FTMSms2hcd	50.844	378	396	25.1	2.4e-7	5.5e-10	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[23]		P61978	HNRPK_HUMAN	HNRNPK	6	15.8	6.61	1.2e-11	507.6953	2	0.022	DYDDMSPR	DYDDM(Oxidation)SPR	Oxidation@283	8	V20130429-11_FTMSms2hcd	8.368	279	286	10.1	3.3e-6	1.5e-8	1	50976.7	HUMAN	Heterogeneous nuclear ribonucleoprotein K
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	548.6130	3	0.57	AQLGGPEAAKSDETAAK	AQLGGPEAAKSDETAAK		17	V20130429-11_FTMSms2hcd	15.299	189	205	48.5	3.4e-13	4.2e-16	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	953.5001	2	0.68	LATQSNEITIPVTFESR	LATQSNEITIPVTFESR		17	V20130429-11_FTMSms2hcd	48.485	172	188	53.1	1.2e-11	1.8e-14	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	892.4659	2	1.1	VSLDVNHFAPDELTVK	VSLDVNHFAPDELTVK		16	V20130429-11_FTMSms2hcd	46.710	97	112	39.0	3.7e-11	5.4e-14	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	569.7620	2	2.4	QLSSGVSEIR	Q(Gln->pyro-Glu)LS(Phospho)SGVSEIR	Gln->pyro-Glu@80;Phospho@82=9	10	V20130429-11_FTMSms2hcd	40.019	80	89	25.4	5.2e-7	7.4e-10	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	578.2739	2	-0.018	QLSSGVSEIR	QLS(Phospho)SGVSEIR	Phospho@82=12	10	V20130429-11_FTMSms2hcd	27.655	80	89	22.0	2.0e-6	2.9e-9	1	22782.7	HUMAN	Heat shock protein beta-1
[24]		P04792	HSPB1_HUMAN	HSPB1	6	33.2	7.45	3.4e-13	494.3092	2	1.3	RVPFSLLR	RVPFSLLR		8	V20130429-11_FTMSms2hcd	38.794	5	12	31.9	1.5e-4	9.1e-7	1	22782.7	HUMAN	Heat shock protein beta-1
[25]		P62158	CALM_HUMAN	CALM1	4	31.5	10.09	4.4e-18	1130.5472	3	-0.017	MADQLTEEQIAEFKEAFSLFDKDGDGTITTK	M(Met-loss+Acetyl)ADQLTEEQIAEFKEAFSLFDKDGDGTITTK	Met-loss+Acetyl@1	31	V20130429-11_FTMSms2hcd	72.861	1	31	58.6	4.4e-18	4.7e-21	1	16837.7	HUMAN	Calmodulin
[25]		P62158	CALM_HUMAN	CALM1	4	31.5	10.09	4.4e-18	877.9402	2	1.3	VFDKDGNGYISAAELR	VFDKDGNGYISAAELR		16	V20130429-11_FTMSms2hcd	36.515	92	107	50.0	1.7e-15	1.9e-18	1	16837.7	HUMAN	Calmodulin
[25]		P62158	CALM_HUMAN	CALM1	4	31.5	10.09	4.4e-18	782.3813	2	1.0	MADQLTEEQIAEFK	M(Met-loss+Acetyl)ADQLTEEQIAEFK	Met-loss+Acetyl@1	14	V20130429-11_FTMSms2hcd	48.282	1	14	38.2	1.1e-11	1.3e-14	1	16837.7	HUMAN	Calmodulin
[25]		P62158	CALM_HUMAN	CALM1	4	31.5	10.09	4.4e-18	615.6361	3	1.4	EAFSLFDKDGDGTITTK	EAFSLFDKDGDGTITTK		17	V20130429-11_FTMSms2hcd	42.505	15	31	29.6	4.1e-9	4.5e-12	1	16837.7	HUMAN	Calmodulin
[26]		P31947	1433S_HUMAN	SFN	5	36.3	9.77	1.8e-17	844.9053	4	2.1	TTFDEAMADLHTLSEDSYKDSTLIMQLLR	TTFDEAM(Oxidation)ADLHTLSEDSYKDSTLIM(Oxidation)QLLR	Oxidation@202;Oxidation@220	29	V20130429-11_FTMSms2hcd	72.993	196	224	46.9	1.8e-17	1.8e-20	1	27774.3	HUMAN	14-3-3 protein sigma
[26]		P31947	1433S_HUMAN	SFN	5	36.3	9.77	1.8e-17	945.1643	3	0.45	LGLALNFSVFHYEIANSPEEAISLAK	LGLALNFSVFHYEIANSPEEAISLAK		26	V20130429-11_FTMSms2hcd	70.109	170	195	44.1	5.4e-12	1.0e-14	1	27774.3	HUMAN	14-3-3 protein sigma
[26]		P31947	1433S_HUMAN	SFN	5	36.3	9.77	1.8e-17	773.8514	2	-1.6	SNEEGSEEKGPEVR	SNEEGSEEKGPEVR		14	V20130429-11_FTMSms2hcd	9.903	69	82	34.2	3.3e-10	4.2e-13	1	27774.3	HUMAN	14-3-3 protein sigma
[26]		P31947	1433S_HUMAN	SFN	5	36.3	9.77	1.8e-17	733.3870	2	1.5	YLAEVATGDDKKR	YLAEVATGDDKKR		13	V20130429-11_FTMSms2hcd	16.424	130	142	37.4	1.2e-9	1.6e-12	1	27774.3	HUMAN	14-3-3 protein sigma
[26]		P31947	1433S_HUMAN	SFN	5	36.3	9.77	1.8e-17	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	42	49	28.2	2.2e-4	7.4e-7	7	27774.3	HUMAN	14-3-3 protein sigma
[26-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	17.6	7.34	5.5e-13	774.8613	2	1.1	SVTEQGAELSNEER	SVTEQGAELSNEER		14	V20130429-11_FTMSms2hcd	20.633	28	41	53.3	5.5e-13	6.7e-16	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[26-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	17.6	7.34	5.5e-13	581.7912	2	-1.8	MDKNELVQK	Acetyl-M(Oxidation)DKNELVQK	Oxidation@1=7	9	V20130429-11_FTMSms2hcd	14.490	1	9	32.0	3.6e-7	5.2e-10	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[26-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	17.6	7.34	5.5e-13	652.8465	2	0.94	FLIPNASQAESK	FLIPNASQAESK		12	V20130429-11_FTMSms2hcd	34.625	104	115	27.6	1.4e-6	2.1e-9	1	27745.3	HUMAN	14-3-3 protein zeta/delta
[26-1]	3	P63104	1433Z_HUMAN	YWHAZ	4	17.6	7.34	5.5e-13	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	42	49	28.2	2.2e-4	7.4e-7	7	27745.3	HUMAN	14-3-3 protein zeta/delta
[26-2]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	10.07	4.8e-18	799.8737	2	-0.24	AVTEQGHELSNEER	AVTEQGHELSNEER		14	V20130429-11_FTMSms2hcd	14.503	30	43	59.6	4.8e-18	5.6e-21	1	28082.6	HUMAN	14-3-3 protein beta/alpha
[26-2]	1	P31946	1433B_HUMAN	YWHAB	2	8.9	10.07	4.8e-18	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	44	51	28.2	2.2e-4	7.4e-7	7	28082.6	HUMAN	14-3-3 protein beta/alpha
[26-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.65	1.1e-11	766.8640	2	1.3	AVTEQGAELSNEER	AVTEQGAELSNEER		14	V20130429-11_FTMSms2hcd	19.865	28	41	48.9	1.1e-11	1.3e-14	1	27764.5	HUMAN	14-3-3 protein theta
[26-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.65	1.1e-11	589.3101	2	-0.32	MEKTELIQK	Acetyl-M(Oxidation)EKTELIQK		9	V20130429-11_FTMSms2hcd	20.218	1	9	20.4	2.1e-4	3.1e-7	1	27764.5	HUMAN	14-3-3 protein theta
[26-3]	2	P27348	1433T_HUMAN	YWHAQ	3	12.7	6.65	1.1e-11	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	42	49	28.2	2.2e-4	7.4e-7	7	27764.5	HUMAN	14-3-3 protein theta
[26-4]	0	P61981	1433G_HUMAN	YWHAG	1	3.2	1.52	2.2e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	43	50	28.2	2.2e-4	7.4e-7	7	28302.8	HUMAN	14-3-3 protein gamma
[26-5]	0	P62258	1433E_HUMAN	YWHAE	1	3.1	1.52	2.2e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	43	50	28.2	2.2e-4	7.4e-7	7	29174.2	HUMAN	14-3-3 protein epsilon
[26-6]	0	Q04917	1433F_HUMAN	YWHAH	1	3.3	1.52	2.2e-4	454.2667	2	1.5	NLLSVAYK	NLLSVAYK		8	V20130429-11_FTMSms2hcd	35.495	43	50	28.2	2.2e-4	7.4e-7	7	28219.0	HUMAN	14-3-3 protein eta
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	801.9490	2	1.1	VVLAYEPVWAIGTGK	VVLAYEPVWAIGTGK		15	V20130429-11_FTMSms2hcd	55.452	198	212	40.2	5.5e-12	1.4e-14	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	733.8647	2	-0.87	TATPQQAQEVHEK	TATPQQAQEVHEK		13	V20130429-11_FTMSms2hcd	10.569	213	225	36.1	7.2e-12	8.8e-15	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	617.8052	2	0.73	SNVSDAVAQSTR	SNVSDAVAQSTR		12	V20130429-11_FTMSms2hcd	18.405	232	243	45.7	2.0e-9	2.7e-12	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	477.7458	2	1.2	FFVGGNWK	FFVGGNWK		8	V20130429-11_FTMSms2hcd	39.554	44	51	30.1	1.3e-7	1.8e-10	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	729.8653	2	0.68	HVFGESDELIGQK	HVFGESDELIGQK		13	V20130429-11_FTMSms2hcd	31.060	138	150	19.1	3.9e-5	4.8e-8	1	30791.3	HUMAN	Triosephosphate isomerase
[27]		P60174	TPIS_HUMAN	TPI1	6	21.7	6.80	5.5e-12	807.9167	2	1.7	RHVFGESDELIGQK	RHVFGESDELIGQK		14	V20130429-11_FTMSms2hcd	27.341	137	150	25.8	1.1e-4	1.5e-7	1	30791.3	HUMAN	Triosephosphate isomerase
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	872.8128	3	0.78	WLPAGDALLQMITIHLPSPVTAQK	WLPAGDALLQM(Oxidation)ITIHLPSPVTAQK	Oxidation@353	24	V20130429-11_FTMSms2hcd	71.425	343	366	34.8	1.1e-11	3.9e-14	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	785.0776	3	-0.18	GVQYLNEIKDSVVAGFQWATK	GVQYLNEIKDSVVAGFQWATK		21	V20130429-11_FTMSms2hcd	68.235	668	688	40.5	7.1e-11	1.1e-13	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	722.8877	2	-0.068	EGIPALDNFLDKL	EGIPALDNFLDKL		13	V20130429-11_FTMSms2hcd	71.718	846	858	28.1	1.5e-7	2.5e-10	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	485.2777	2	0.53	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-11_FTMSms2hcd	22.697	717	726	29.2	4.3e-7	1.4e-9	2	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	546.2953	2	-0.97	MVNFTVDQIR	M(Met-loss)VNFTVDQIR	Met-loss@1	10	V20130429-11_FTMSms2hcd	35.441	1	10	31.6	6.4e-7	1.1e-9	1	95339.0	HUMAN	Elongation factor 2
[28]		P13639	EF2_HUMAN	EEF2	6	10.4	6.63	1.1e-11	554.3244	2	0.62	VFSGLVSTGLK	VFSGLVSTGLK		11	V20130429-11_FTMSms2hcd	39.808	416	426	25.4	1.2e-4	4.9e-7	1	95339.0	HUMAN	Elongation factor 2
[28-1]	0	Q15029	U5S1_HUMAN	EFTUD2	1	1.0	3.08	4.3e-7	485.2777	2	0.53	GGGQIIPTAR	GGGQIIPTAR		10	V20130429-11_FTMSms2hcd	22.697	804	813	29.2	4.3e-7	1.4e-9	2	109436.7	HUMAN	116 kDa U5 small nuclear ribonucleoprotein component
[29]		P22626	ROA2_HUMAN	HNRNPA2B1	5	22.9	6.47	1.8e-11	689.3197	2	2.0	GGGGNFGPGPGSNFR	GGGGNFGPGPGSNFR		15	V20130429-11_FTMSms2hcd	27.036	214	228	39.5	1.8e-11	2.4e-14	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[29]		P22626	ROA2_HUMAN	HNRNPA2B1	5	22.9	6.47	1.8e-11	705.8474	2	0.17	YHTINGHNAEVR	YHTINGHNAEVR		12	V20130429-11_FTMSms2hcd	12.160	174	185	39.5	8.9e-11	1.1e-13	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[29]		P22626	ROA2_HUMAN	HNRNPA2B1	5	22.9	6.47	1.8e-11	956.4689	3	1.2	LFIGGLSFETTEESLRNYYEQWGK	LFIGGLSFETTEESLRNYYEQWGK		24	V20130429-11_FTMSms2hcd	69.572	23	46	36.7	1.1e-9	1.2e-12	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[29]		P22626	ROA2_HUMAN	HNRNPA2B1	5	22.9	6.47	1.8e-11	507.2251	2	-0.60	GGNFGFGDSR	GGNFGFGDSR		10	V20130429-11_FTMSms2hcd	25.527	204	213	22.6	3.7e-8	8.5e-11	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[29]		P22626	ROA2_HUMAN	HNRNPA2B1	5	22.9	6.47	1.8e-11	759.7247	3	2.0	GFGFVTFDDHDPVDKIVLQK	GFGFVTFDDHDPVDKIVLQK		20	V20130429-11_FTMSms2hcd	55.424	154	173	31.3	8.7e-8	1.2e-10	1	37430.0	HUMAN	Heterogeneous nuclear ribonucleoproteins A2/B1
[30]		P12814	ACTN1_HUMAN	ACTN1	5	6.2	7.74	1.0e-13	1012.4869	2	4.1	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@239	18	V20130429-11_FTMSms2hcd	53.425	237	254	43.0	1.0e-13	1.1e-16	2	103058.4	HUMAN	Alpha-actinin-1
[30]		P12814	ACTN1_HUMAN	ACTN1	5	6.2	7.74	1.0e-13	669.9944	3	2.7	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-11_FTMSms2hcd	60.963	237	254	28.1	4.4e-11	4.7e-14	2	103058.4	HUMAN	Alpha-actinin-1
[30]		P12814	ACTN1_HUMAN	ACTN1	5	6.2	7.74	1.0e-13	693.8908	2	0.25	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-11_FTMSms2hcd	65.457	715	726	42.6	2.1e-10	4.4e-13	2	103058.4	HUMAN	Alpha-actinin-1
[30]		P12814	ACTN1_HUMAN	ACTN1	5	6.2	7.74	1.0e-13	558.2900	2	3.2	ATLPDADKER	ATLPDADKER		10	V20130429-11_FTMSms2hcd	13.390	556	565	36.2	2.9e-7	5.3e-10	1	103058.4	HUMAN	Alpha-actinin-1
[30]		P12814	ACTN1_HUMAN	ACTN1	5	6.2	7.74	1.0e-13	623.3441	3	0.73	LLETIDQLYLEYAKR	LLETIDQLYLEYAKR		15	V20130429-11_FTMSms2hcd	58.097	503	517	16.8	8.3e-5	2.1e-7	1	103058.4	HUMAN	Alpha-actinin-1
[30-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	3.3	7.74	1.0e-13	1012.4869	2	4.1	AIMTYVSSFYHAFSGAQK	AIM(Oxidation)TYVSSFYHAFSGAQK	Oxidation@258	18	V20130429-11_FTMSms2hcd	53.425	256	273	43.0	1.0e-13	1.1e-16	2	104854.9	HUMAN	Alpha-actinin-4
[30-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	3.3	7.74	1.0e-13	669.9944	3	2.7	AIMTYVSSFYHAFSGAQK	AIMTYVSSFYHAFSGAQK		18	V20130429-11_FTMSms2hcd	60.963	256	273	28.1	4.4e-11	4.7e-14	2	104854.9	HUMAN	Alpha-actinin-4
[30-1]	0	O43707	ACTN4_HUMAN	ACTN4	3	3.3	7.74	1.0e-13	693.8908	2	0.25	VGWEQLLTTIAR	VGWEQLLTTIAR		12	V20130429-11_FTMSms2hcd	65.457	734	745	42.6	2.1e-10	4.4e-13	2	104854.9	HUMAN	Alpha-actinin-4
[31]		P23528	COF1_HUMAN	CFL1	5	51.8	7.46	3.3e-13	1021.5383	3	2.3	NIILEEGKEILVGDVGQTVDDPYATFVK	NIILEEGKEILVGDVGQTVDDPYATFVK		28	V20130429-11_FTMSms2hcd	64.326	46	73	44.1	3.3e-13	7.2e-16	1	18502.7	HUMAN	Cofilin-1
[31]		P23528	COF1_HUMAN	CFL1	5	51.8	7.46	3.3e-13	669.3257	2	14	YALYDATYETK	YALYDATYETK		11	V20130429-11_FTMSms2hcd	32.195	82	92	38.1	9.9e-12	1.4e-14	2	18502.7	HUMAN	Cofilin-1
[31]		P23528	COF1_HUMAN	CFL1	5	51.8	7.46	3.3e-13	670.8922	2	-0.95	LGGSAVISLEGKPL	LGGSAVISLEGKPL		14	V20130429-11_FTMSms2hcd	46.178	153	166	29.6	2.4e-8	9.1e-11	1	18502.7	HUMAN	Cofilin-1
[31]		P23528	COF1_HUMAN	CFL1	5	51.8	7.46	3.3e-13	572.8143	2	0.43	MASGVAVSDGVIK	M(Met-loss+Acetyl)ASGVAVSDGVIK	Met-loss+Acetyl@1	13	V20130429-11_FTMSms2hcd	35.389	1	13	37.9	3.6e-7	6.2e-10	1	18502.7	HUMAN	Cofilin-1
[31]		P23528	COF1_HUMAN	CFL1	5	51.8	7.46	3.3e-13	584.3239	4	15	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-11_FTMSms2hcd	61.361	93	112	23.1	1.0e-6	3.3e-9	2	18502.7	HUMAN	Cofilin-1
[31-1]	0	Q9Y281	COF2_HUMAN	CFL2	2	18.7	6.47	9.9e-12	669.3257	2	14	YALYDATYETK	YALYDATYETK		11	V20130429-11_FTMSms2hcd	32.195	82	92	38.1	9.9e-12	1.4e-14	2	18736.8	HUMAN	Cofilin-2
[31-1]	0	Q9Y281	COF2_HUMAN	CFL2	2	18.7	6.47	9.9e-12	584.3239	4	15	ESKKEDLVFIFWAPESAPLK	ESKKEDLVFIFWAPESAPLK		20	V20130429-11_FTMSms2hcd	61.361	93	112	23.1	1.0e-6	3.3e-9	2	18736.8	HUMAN	Cofilin-2
[32]		O60814	H2B1K_HUMAN	HIST1H2BK	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13890.3	HUMAN	Histone H2B type 1-K
[32]		O60814	H2B1K_HUMAN	HIST1H2BK	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13890.3	HUMAN	Histone H2B type 1-K
[32]		O60814	H2B1K_HUMAN	HIST1H2BK	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13890.3	HUMAN	Histone H2B type 1-K
[32]		O60814	H2B1K_HUMAN	HIST1H2BK	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13890.3	HUMAN	Histone H2B type 1-K
[32]		O60814	H2B1K_HUMAN	HIST1H2BK	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13890.3	HUMAN	Histone H2B type 1-K
[32-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13944.3	HUMAN	Histone H2B type F-S
[32-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13944.3	HUMAN	Histone H2B type F-S
[32-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13944.3	HUMAN	Histone H2B type F-S
[32-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13944.3	HUMAN	Histone H2B type F-S
[32-1]	0	P57053	H2BFS_HUMAN	H2BFS	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13944.3	HUMAN	Histone H2B type F-S
[32-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13936.3	HUMAN	Histone H2B type 1-D
[32-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13936.3	HUMAN	Histone H2B type 1-D
[32-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13936.3	HUMAN	Histone H2B type 1-D
[32-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13936.3	HUMAN	Histone H2B type 1-D
[32-2]	0	P58876	H2B1D_HUMAN	HIST1H2BD	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13936.3	HUMAN	Histone H2B type 1-D
[32-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[32-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[32-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[32-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[32-3]	0	P62807	H2B1C_HUMAN	HIST1H2BC	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13906.3	HUMAN	Histone H2B type 1-C/E/F/G/I
[32-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13920.3	HUMAN	Histone H2B type 2-F
[32-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13920.3	HUMAN	Histone H2B type 2-F
[32-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13920.3	HUMAN	Histone H2B type 2-F
[32-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13920.3	HUMAN	Histone H2B type 2-F
[32-4]	0	Q5QNW6	H2B2F_HUMAN	HIST2H2BF	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13920.3	HUMAN	Histone H2B type 2-F
[32-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13892.2	HUMAN	Histone H2B type 1-H
[32-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13892.2	HUMAN	Histone H2B type 1-H
[32-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13892.2	HUMAN	Histone H2B type 1-H
[32-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13892.2	HUMAN	Histone H2B type 1-H
[32-5]	0	Q93079	H2B1H_HUMAN	HIST1H2BH	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13892.2	HUMAN	Histone H2B type 1-H
[32-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13922.3	HUMAN	Histone H2B type 1-N
[32-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13922.3	HUMAN	Histone H2B type 1-N
[32-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13922.3	HUMAN	Histone H2B type 1-N
[32-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13922.3	HUMAN	Histone H2B type 1-N
[32-6]	0	Q99877	H2B1N_HUMAN	HIST1H2BN	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13922.3	HUMAN	Histone H2B type 1-N
[32-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13989.4	HUMAN	Histone H2B type 1-M
[32-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13989.4	HUMAN	Histone H2B type 1-M
[32-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13989.4	HUMAN	Histone H2B type 1-M
[32-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13989.4	HUMAN	Histone H2B type 1-M
[32-7]	0	Q99879	H2B1M_HUMAN	HIST1H2BM	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13989.4	HUMAN	Histone H2B type 1-M
[32-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	31.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13952.3	HUMAN	Histone H2B type 1-L
[32-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	31.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13952.3	HUMAN	Histone H2B type 1-L
[32-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	31.0	6.85	4.5e-12	633.3250	2	1.2	KESYSVYVYK	KESYSVYVYK		10	V20130429-11_FTMSms2hcd	25.488	35	44	35.2	7.3e-8	8.7e-11	9	13952.3	HUMAN	Histone H2B type 1-L
[32-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	31.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13952.3	HUMAN	Histone H2B type 1-L
[32-8]	0	Q99880	H2B1L_HUMAN	HIST1H2BL	5	31.0	6.85	4.5e-12	569.2778	2	1.8	ESYSVYVYK	ESYSVYVYK		9	V20130429-11_FTMSms2hcd	30.406	36	44	19.0	1.9e-6	2.9e-9	9	13952.3	HUMAN	Histone H2B type 1-L
[32-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	23.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13904.3	HUMAN	Histone H2B type 1-J
[32-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	23.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13904.3	HUMAN	Histone H2B type 1-J
[32-9]	0	P06899	H2B1J_HUMAN	HIST1H2BJ	3	23.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13904.3	HUMAN	Histone H2B type 1-J
[32-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	23.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13906.3	HUMAN	Histone H2B type 1-O
[32-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	23.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13906.3	HUMAN	Histone H2B type 1-O
[32-10]	0	P23527	H2B1O_HUMAN	HIST1H2BO	3	23.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13906.3	HUMAN	Histone H2B type 1-O
[32-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	23.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13950.3	HUMAN	Histone H2B type 1-B
[32-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	23.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13950.3	HUMAN	Histone H2B type 1-B
[32-11]	0	P33778	H2B1B_HUMAN	HIST1H2BB	3	23.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13950.3	HUMAN	Histone H2B type 1-B
[32-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	23.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13920.3	HUMAN	Histone H2B type 2-E
[32-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	23.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13920.3	HUMAN	Histone H2B type 2-E
[32-12]	0	Q16778	H2B2E_HUMAN	HIST2H2BE	3	23.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13920.3	HUMAN	Histone H2B type 2-E
[32-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	23.0	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	45	58	47.2	4.5e-12	1.4e-14	15	13908.2	HUMAN	Histone H2B type 3-B
[32-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	23.0	6.85	4.5e-12	888.4185	2	12	AMGIMNSFVNDIFER	AM(Oxidation)GIM(Oxidation)NSFVNDIFER	Oxidation@60;Oxidation@63	15	V20130429-11_FTMSms2hcd	54.870	59	73	51.4	4.6e-12	4.6e-15	14	13908.2	HUMAN	Histone H2B type 3-B
[32-13]	0	Q8N257	H2B3B_HUMAN	HIST3H2BB	3	23.0	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@48	11	V20130429-11_FTMSms2hcd	18.636	48	58	37.2	1.1e-7	1.6e-10	15	13908.2	HUMAN	Histone H2B type 3-B
[32-14]	1	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	22.8	6.85	4.5e-12	754.9260	2	1.1	VLKQVHPDTGISSK	VLKQVHPDTGISSK		14	V20130429-11_FTMSms2hcd	17.430	46	59	47.2	4.5e-12	1.4e-14	15	14167.6	HUMAN	Histone H2B type 1-A
[32-14]	1	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	22.8	6.85	4.5e-12	576.2878	2	-0.70	QVHPDTGISSK	Q(Gln->pyro-Glu)VHPDTGISSK	Gln->pyro-Glu@49	11	V20130429-11_FTMSms2hcd	18.636	49	59	37.2	1.1e-7	1.6e-10	15	14167.6	HUMAN	Histone H2B type 1-A
[32-14]	1	Q96A08	H2B1A_HUMAN	HIST1H2BA	3	22.8	6.85	4.5e-12	920.9031	2	-1.1	AMSIMNSFVTDIFER	AMSIMNSFVT(Phospho)DIFER	Phospho@69=8	15	V20130429-11_FTMSms2hcd	63.433	60	74	17.5	0.017	2.1e-5	1	14167.6	HUMAN	Histone H2B type 1-A
[33]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.99	4.8e-16	934.9924	2	1.2	YVASYLLAALGGNSSPSAK	YVASYLLAALGGNSSPSAK		19	V20130429-11_FTMSms2hcd	58.160	3	21	51.4	4.8e-16	7.9e-19	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[33]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.99	4.8e-16	591.6403	3	2.2	ILDSVGIEADDDRLNK	ILDSVGIEADDDRLNK		16	V20130429-11_FTMSms2hcd	34.973	26	41	34.2	1.1e-9	1.4e-12	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[33]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.99	4.8e-16	654.1025	4	5.8	ILDSVGIEADDDRLNKVISELNGK	ILDSVGIEADDDRLNKVISELNGK		24	V20130429-11_FTMSms2hcd	56.737	26	49	32.8	2.7e-9	7.0e-12	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[33]		P05387	RLA2_HUMAN	RPLP2	4	47.8	8.99	4.8e-16	628.8457	2	-0.29	NIEDVIAQGIGK	NIEDVIAQGIGK		12	V20130429-11_FTMSms2hcd	47.427	50	61	39.1	5.2e-8	9.8e-11	1	11665.0	HUMAN	60S acidic ribosomal protein P2
[34]		P06732	KCRM_HUMAN	CKM	4	13.1	7.04	1.9e-12	659.8195	2	0.74	GQSIDDMIPAQK	GQSIDDM(Oxidation)IPAQK	Oxidation@376	12	V20130429-11_FTMSms2hcd	23.118	370	381	39.0	1.9e-12	2.7e-15	1	43101.5	HUMAN	Creatine kinase M-type
[34]		P06732	KCRM_HUMAN	CKM	4	13.1	7.04	1.9e-12	754.4086	2	6.4	LSVEALNSLTGEFK	LSVEALNSLTGEFK		14	V20130429-11_FTMSms2hcd	55.107	157	170	49.9	5.1e-12	8.8e-15	1	43101.5	HUMAN	Creatine kinase M-type
[34]		P06732	KCRM_HUMAN	CKM	4	13.1	7.04	1.9e-12	893.4872	2	4.4	LGSSEVEQVQLVVDGVK	LGSSEVEQVQLVVDGVK		17	V20130429-11_FTMSms2hcd	49.698	342	358	38.1	1.8e-11	3.7e-14	1	43101.5	HUMAN	Creatine kinase M-type
[34]		P06732	KCRM_HUMAN	CKM	4	13.1	7.04	1.9e-12	454.2483	2	1.1	FEEILTR	FEEILTR		7	V20130429-11_FTMSms2hcd	29.959	308	314	29.4	2.4e-4	4.7e-7	1	43101.5	HUMAN	Creatine kinase M-type
[35]		P78371	TCPB_HUMAN	CCT2	4	9.5	7.01	2.3e-12	759.4511	2	0.77	LTSFIGAIAIGDLVK	LTSFIGAIAIGDLVK		15	V20130429-11_FTMSms2hcd	67.479	26	40	40.2	2.3e-12	1.7e-14	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[35]		P78371	TCPB_HUMAN	CCT2	4	9.5	7.01	2.3e-12	651.3846	2	12	MASLSLAPVNIFK	M(Met-loss+Acetyl)ASLSLAPVNIFK	Met-loss+Acetyl@1	13	V20130429-11_FTMSms2hcd	65.617	1	13	30.9	9.3e-9	3.8e-11	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[35]		P78371	TCPB_HUMAN	CCT2	4	9.5	7.01	2.3e-12	516.2354	3	0.13	AAHSEGNTTAGLDMR	AAHSEGNTTAGLDM(Oxidation)R	Oxidation@480	15	V20130429-11_FTMSms2hcd	11.750	467	481	17.8	1.4e-8	1.8e-11	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[35]		P78371	TCPB_HUMAN	CCT2	4	9.5	7.01	2.3e-12	435.7744	2	0.91	LAVEAVLR	LAVEAVLR		8	V20130429-11_FTMSms2hcd	36.298	182	189	26.2	4.3e-4	2.3e-6	1	57488.7	HUMAN	T-complex protein 1 subunit beta
[36]		P04075	ALDOA_HUMAN	ALDOA	4	13.2	7.26	7.8e-13	872.1196	3	4.7	VDKGVVPLAGTNGETTTQGLDGLSER	VDKGVVPLAGTNGETTTQGLDGLSER		26	V20130429-11_FTMSms2hcd	41.063	109	134	43.1	7.8e-13	1.3e-15	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[36]		P04075	ALDOA_HUMAN	ALDOA	4	13.2	7.26	7.8e-13	601.6416	3	-0.064	RLQSIGTENTEENRR	RLQSIGTENTEENRR		15	V20130429-11_FTMSms2hcd	14.400	43	57	21.5	1.5e-7	1.9e-10	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[36]		P04075	ALDOA_HUMAN	ALDOA	4	13.2	7.26	7.8e-13	823.9116	2	4.1	LQSIGTENTEENRR	LQSIGTENTEENRR		14	V20130429-11_FTMSms2hcd	16.122	44	57	47.0	6.4e-7	7.8e-10	1	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[36]		P04075	ALDOA_HUMAN	ALDOA	4	13.2	7.26	7.8e-13	382.2387	2	-1.5	VLAAVYK	VLAAVYK		7	V20130429-11_FTMSms2hcd	21.856	209	215	20.6	1.5e-4	7.4e-7	3	39420.4	HUMAN	Fructose-bisphosphate aldolase A
[36-1]	0	P05062	ALDOB_HUMAN	ALDOB	1	1.9	0.84	1.5e-4	382.2387	2	-1.5	VLAAVYK	VLAAVYK		7	V20130429-11_FTMSms2hcd	21.856	209	215	20.6	1.5e-4	7.4e-7	3	39473.4	HUMAN	Fructose-bisphosphate aldolase B
[36-2]	0	P09972	ALDOC_HUMAN	ALDOC	1	1.9	0.84	1.5e-4	382.2387	2	-1.5	VLAAVYK	VLAAVYK		7	V20130429-11_FTMSms2hcd	21.856	209	215	20.6	1.5e-4	7.4e-7	3	39456.2	HUMAN	Fructose-bisphosphate aldolase C
[37]		P07195	LDHB_HUMAN	LDHB	4	12.9	6.31	4.5e-11	755.8902	2	-1.1	IVADKDYSVTANSK	IVADKDYSVTANSK		14	V20130429-11_FTMSms2hcd	18.898	78	91	55.6	4.5e-11	6.1e-14	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[37]		P07195	LDHB_HUMAN	LDHB	4	12.9	6.31	4.5e-11	643.8702	2	1.3	LKDDEVAQLKK	LKDDEVAQLKK		11	V20130429-11_FTMSms2hcd	17.378	309	319	40.7	9.9e-7	2.5e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[37]		P07195	LDHB_HUMAN	LDHB	4	12.9	6.31	4.5e-11	480.2806	2	2.0	GLTSVINQK	GLTSVINQK		9	V20130429-11_FTMSms2hcd	26.269	300	308	31.2	1.2e-6	2.5e-9	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[37]		P07195	LDHB_HUMAN	LDHB	4	12.9	6.31	4.5e-11	457.2951	2	-0.0046	IVVVTAGVR	IVVVTAGVR		9	V20130429-11_FTMSms2hcd	27.508	92	100	32.0	4.3e-6	2.3e-8	1	36638.8	HUMAN	L-lactate dehydrogenase B chain
[38]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	8.3e-11	704.8041	2	0.018	CDSSPDSAEDVRK	CDSSPDSAEDVRK		13	V20130429-11_FTMSms2hcd	9.759	132	144	39.0	8.3e-11	1.4e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[38]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	8.3e-11	640.7563	2	-0.48	CDSSPDSAEDVR	CDSSPDSAEDVR		12	V20130429-11_FTMSms2hcd	13.222	132	143	34.4	1.3e-10	3.2e-13	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[38]		P02765	FETUA_HUMAN	AHSG	3	3.5	6.06	8.3e-11	744.7886	2	1.8	CDSSPDSAEDVRK	CDSSPDS(Phospho)AEDVRK	Phospho@138=7	13	V20130429-11_FTMSms2hcd	10.725	132	144	26.5	1.3e-9	3.2e-12	1	39325.0	HUMAN	Alpha-2-HS-glycoprotein
[39]		P35579	MYH9_HUMAN	MYH9	4	2.9	5.43	2.8e-10	975.5000	2	0.014	LQQELDDLLVDLDHQR	LQQELDDLLVDLDHQR		16	V20130429-11_FTMSms2hcd	57.871	1418	1433	30.4	2.8e-10	3.6e-13	1	226534.2	HUMAN	Myosin-9
[39]		P35579	MYH9_HUMAN	MYH9	4	2.9	5.43	2.8e-10	539.0087	3	11	VISGVLQLGNIVFKK	VISGVLQLGNIVFKK		15	V20130429-11_FTMSms2hcd	57.660	342	356	35.5	1.4e-9	1.0e-10	1	226534.2	HUMAN	Myosin-9
[39]		P35579	MYH9_HUMAN	MYH9	4	2.9	5.43	2.8e-10	493.6054	3	0.98	VIQYLAYVASSHK	VIQYLAYVASSHK		13	V20130429-11_FTMSms2hcd	39.567	187	199	33.5	6.4e-9	1.3e-11	1	226534.2	HUMAN	Myosin-9
[39]		P35579	MYH9_HUMAN	MYH9	4	2.9	5.43	2.8e-10	839.8893	2	0.74	EMEAELEDERKQR	EM(Oxidation)EAELEDERKQR	Oxidation@1594	13	V20130429-11_FTMSms2hcd	11.470	1593	1605	13.5	4.1e-4	4.6e-7	1	226534.2	HUMAN	Myosin-9
[40]		P07910	HNRPC_HUMAN	HNRNPC	4	11.4	5.50	9.1e-10	482.3016	3	1.1	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-11_FTMSms2hcd	44.898	18	30	33.1	9.1e-10	1.7e-11	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[40]		P07910	HNRPC_HUMAN	HNRNPC	4	11.4	5.50	9.1e-10	658.9040	2	5.4	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-11_FTMSms2hcd	51.623	18	29	31.4	5.4e-9	5.6e-11	2	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[40]		P07910	HNRPC_HUMAN	HNRNPC	4	11.4	5.50	9.1e-10	665.3330	2	0.084	GFAFVQYVNER	GFAFVQYVNER		11	V20130429-11_FTMSms2hcd	46.396	51	61	39.0	2.6e-8	3.8e-11	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[40]		P07910	HNRPC_HUMAN	HNRNPC	4	11.4	5.50	9.1e-10	614.8600	2	-11	LKGDDLQAIKK	LKGDDLQAIKK		11	V20130429-11_FTMSms2hcd	18.007	188	198	10.0	0.011	3.1e-5	1	33670.3	HUMAN	Heterogeneous nuclear ribonucleoproteins C1/C2
[40-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	2	4.4	4.91	9.1e-10	482.3016	3	1.1	VFIGNLNTLVVKK	VFIGNLNTLVVKK		13	V20130429-11_FTMSms2hcd	44.898	18	30	33.1	9.1e-10	1.7e-11	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[40-1]	0	O60812	HNRCL_HUMAN	HNRNPCL1	2	4.4	4.91	9.1e-10	658.9040	2	5.4	VFIGNLNTLVVK	VFIGNLNTLVVK		12	V20130429-11_FTMSms2hcd	51.623	18	29	31.4	5.4e-9	5.6e-11	2	32142.6	HUMAN	Heterogeneous nuclear ribonucleoprotein C-like 1
[41]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.33	2.9e-9	599.8428	2	-0.58	GKGGEIQPVSVK	GKGGEIQPVSVK		12	V20130429-11_FTMSms2hcd	17.994	55	66	33.1	2.9e-9	7.6e-12	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[41]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.33	2.9e-9	658.3827	2	0.10	VLQATVVAVGSGSK	VLQATVVAVGSGSK		14	V20130429-11_FTMSms2hcd	29.851	41	54	51.1	4.6e-9	1.3e-11	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[41]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.33	2.9e-9	538.8020	2	-1.8	VLLPEYGGTK	VLLPEYGGTK		10	V20130429-11_FTMSms2hcd	32.380	71	80	29.0	7.9e-7	1.6e-9	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[41]		P61604	CH10_HUMAN	HSPE1	4	42.2	5.33	2.9e-9	454.2552	2	-0.54	FLPLFDR	FLPLFDR		7	V20130429-11_FTMSms2hcd	48.925	9	15	30.4	7.4e-4	1.7e-6	1	10931.8	HUMAN	10 kDa heat shock protein, mitochondrial
[42]		P00338	LDHA_HUMAN	LDHA	4	12.3	4.88	2.0e-8	567.7845	2	-1.7	VTLTSEEEAR	VTLTSEEEAR		10	V20130429-11_FTMSms2hcd	18.911	306	315	40.4	2.0e-8	3.0e-11	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[42]		P00338	LDHA_HUMAN	LDHA	4	12.3	4.88	2.0e-8	465.2951	2	1.1	FIIPNVVK	FIIPNVVK		8	V20130429-11_FTMSms2hcd	44.950	119	126	30.0	1.4e-7	7.3e-10	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[42]		P00338	LDHA_HUMAN	LDHA	4	12.3	4.88	2.0e-8	748.3900	2	-1.6	IVSGKDYNVTANSK	IVSGKDYNVTANSK		14	V20130429-11_FTMSms2hcd	17.167	77	90	31.2	1.4e-6	2.0e-9	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[42]		P00338	LDHA_HUMAN	LDHA	4	12.3	4.88	2.0e-8	457.3000	2	11	LVIITAGAR	LVIITAGAR		9	V20130429-11_FTMSms2hcd	31.154	91	99	34.6	3.9e-6	2.8e-8	1	36689.1	HUMAN	L-lactate dehydrogenase A chain
[43]		P62081	RS7_HUMAN	RPS7	3	18.0	6.67	9.6e-12	631.6082	4	12	TLTAVHDAILEDLVFPSEIVGKR	TLTAVHDAILEDLVFPSEIVGKR		23	V20130429-11_FTMSms2hcd	64.857	121	143	42.5	9.6e-12	5.8e-14	1	22127.0	HUMAN	40S ribosomal protein S7
[43]		P62081	RS7_HUMAN	RPS7	3	18.0	6.67	9.6e-12	669.4329	2	2.2	AIIIFVPVPQLK	AIIIFVPVPQLK		12	V20130429-11_FTMSms2hcd	64.375	59	70	28.0	2.1e-9	8.6e-11	1	22127.0	HUMAN	40S ribosomal protein S7
[43]		P62081	RS7_HUMAN	RPS7	3	18.0	6.67	9.6e-12	789.7658	3	0.95	TLTAVHDAILEDLVFPSEIVGK	TLTAVHDAILEDLVFPSEIVGK		22	V20130429-11_FTMSms2hcd	68.502	121	142	18.8	1.8e-6	4.7e-9	1	22127.0	HUMAN	40S ribosomal protein S7
[44]		Q06830	PRDX1_HUMAN	PRDX1	4	26.6	4.83	1.0e-8	554.3051	2	-1.4	TIAQDYGVLK	TIAQDYGVLK		10	V20130429-11_FTMSms2hcd	32.516	111	120	29.9	1.0e-8	2.1e-11	1	22110.5	HUMAN	Peroxiredoxin-1
[44]		Q06830	PRDX1_HUMAN	PRDX1	4	26.6	4.83	1.0e-8	598.8203	2	1.9	LVQAFQFTDK	LVQAFQFTDK		10	V20130429-11_FTMSms2hcd	39.007	159	168	38.0	5.8e-8	1.1e-10	1	22110.5	HUMAN	Peroxiredoxin-1
[44]		Q06830	PRDX1_HUMAN	PRDX1	4	26.6	4.83	1.0e-8	453.9376	3	-0.89	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-11_FTMSms2hcd	52.347	129	140	34.4	8.5e-7	4.3e-9	2	22110.5	HUMAN	Peroxiredoxin-1
[44]		Q06830	PRDX1_HUMAN	PRDX1	4	26.6	4.83	1.0e-8	572.5380	4	1.2	ATAVMPDGQFKDISLSDYKGK	ATAVM(Oxidation)PDGQFKDISLSDYKGK	Oxidation@21	21	V20130429-11_FTMSms2hcd	36.635	17	37	14.2	0.0015	1.6e-6	1	22110.5	HUMAN	Peroxiredoxin-1
[44-1]	0	Q13162	PRDX4_HUMAN	PRDX4	1	4.4	3.44	8.5e-7	453.9376	3	-0.89	GLFIIDDKGILR	GLFIIDDKGILR		12	V20130429-11_FTMSms2hcd	52.347	201	212	34.4	8.5e-7	4.3e-9	2	30540.2	HUMAN	Peroxiredoxin-4
[45]		P50990	TCPQ_HUMAN	CCT8	5	14.1	5.25	7.3e-10	677.8845	2	3.0	LVPGGGATEIELAK	LVPGGGATEIELAK		14	V20130429-11_FTMSms2hcd	35.912	408	421	36.0	7.3e-10	2.3e-12	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[45]		P50990	TCPQ_HUMAN	CCT8	5	14.1	5.25	7.3e-10	689.8386	2	0.21	ETEGDVTSVKDAK	ETEGDVTSVKDAK		13	V20130429-11_FTMSms2hcd	13.364	226	238	29.6	1.6e-7	2.3e-10	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[45]		P50990	TCPQ_HUMAN	CCT8	5	14.1	5.25	7.3e-10	575.7971	2	-1.9	FAEAFEAIPR	FAEAFEAIPR		10	V20130429-11_FTMSms2hcd	41.262	441	450	30.6	1.7e-6	3.0e-9	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[45]		P50990	TCPQ_HUMAN	CCT8	5	14.1	5.25	7.3e-10	353.7157	2	-0.73	MALHVPK	M(Met-loss+Acetyl)ALHVPK	Met-loss+Acetyl@1	7	V20130429-11_FTMSms2hcd	23.540	1	7	15.6	0.011	5.1e-5	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[45]		P50990	TCPQ_HUMAN	CCT8	5	14.1	5.25	7.3e-10	929.4898	4	17	NVGLDIEAEVPAVKDMLEAGILDTYLGKYWAIK	NVGLDIEAEVPAVKDMLEAGILDT(Phospho)YLGKYWAIK	Phospho@500=10	33	V20130429-11_FTMSms2hcd	66.595	477	509	12.2	0.049	1.2e-4	1	59621.1	HUMAN	T-complex protein 1 subunit theta
[46]		P06753	TPM3_HUMAN	TPM3	3	14.8	5.82	3.7e-10	492.8980	3	-1.2	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-11_FTMSms2hcd	13.312	113	125	45.5	3.7e-10	4.3e-13	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[46]		P06753	TPM3_HUMAN	TPM3	3	14.8	5.82	3.7e-10	454.7294	4	-1.4	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-11_FTMSms2hcd	19.891	153	167	28.0	2.3e-8	2.7e-11	2	32819.1	HUMAN	Tropomyosin alpha-3 chain
[46]		P06753	TPM3_HUMAN	TPM3	3	14.8	5.82	3.7e-10	576.6353	3	-0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-11_FTMSms2hcd	37.708	92	105	35.8	2.2e-7	3.2e-10	4	32819.1	HUMAN	Tropomyosin alpha-3 chain
[46-1]	0	P67936	TPM4_HUMAN	TPM4	3	16.9	5.82	3.7e-10	492.8980	3	-1.2	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-11_FTMSms2hcd	13.312	77	89	45.5	3.7e-10	4.3e-13	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[46-1]	0	P67936	TPM4_HUMAN	TPM4	3	16.9	5.82	3.7e-10	454.7294	4	-1.4	HIAEEADRKYEEVAR	HIAEEADRKYEEVAR		15	V20130429-11_FTMSms2hcd	19.891	117	131	28.0	2.3e-8	2.7e-11	2	28522.0	HUMAN	Tropomyosin alpha-4 chain
[46-1]	0	P67936	TPM4_HUMAN	TPM4	3	16.9	5.82	3.7e-10	576.6353	3	-0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-11_FTMSms2hcd	37.708	56	69	35.8	2.2e-7	3.2e-10	4	28522.0	HUMAN	Tropomyosin alpha-4 chain
[46-2]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	5.82	3.7e-10	492.8980	3	-1.2	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-11_FTMSms2hcd	13.312	113	125	45.5	3.7e-10	4.3e-13	4	32851.0	HUMAN	Tropomyosin beta chain
[46-2]	0	P07951	TPM2_HUMAN	TPM2	2	9.5	5.82	3.7e-10	576.6353	3	-0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-11_FTMSms2hcd	37.708	92	105	35.8	2.2e-7	3.2e-10	4	32851.0	HUMAN	Tropomyosin beta chain
[46-3]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	5.82	3.7e-10	492.8980	3	-1.2	LEEAEKAADESER	LEEAEKAADESER		13	V20130429-11_FTMSms2hcd	13.312	113	125	45.5	3.7e-10	4.3e-13	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[46-3]	0	P09493	TPM1_HUMAN	TPM1	2	9.5	5.82	3.7e-10	576.6353	3	-0.52	IQLVEEELDRAQER	IQLVEEELDRAQER		14	V20130429-11_FTMSms2hcd	37.708	92	105	35.8	2.2e-7	3.2e-10	4	32708.8	HUMAN	Tropomyosin alpha-1 chain
[47]		Q00839	HNRPU_HUMAN	HNRNPU	3	6.1	5.64	5.0e-10	857.9602	2	0.50	SSGPTSLFAVTVAPPGAR	SSGPTSLFAVTVAPPGAR		18	V20130429-11_FTMSms2hcd	50.646	187	204	32.6	5.0e-10	8.4e-13	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[47]		Q00839	HNRPU_HUMAN	HNRNPU	3	6.1	5.64	5.0e-10	908.8002	3	11	EKPYFPIPEEYTFIQNVPLEDR	EKPYFPIPEEYTFIQNVPLEDR		22	V20130429-11_FTMSms2hcd	61.610	463	484	36.5	2.6e-9	3.5e-12	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[47]		Q00839	HNRPU_HUMAN	HNRNPU	3	6.1	5.64	5.0e-10	601.8536	2	0.70	VSELKEELKK	VSELKEELKK		10	V20130429-11_FTMSms2hcd	15.593	13	22	39.0	1.7e-6	5.6e-9	1	90585.2	HUMAN	Heterogeneous nuclear ribonucleoprotein U
[48]		P29692	EF1D_HUMAN	EEF1D	3	12.1	4.83	2.4e-8	536.7734	2	-2.5	MATNFLAHEK	M(Met-loss+Acetyl)ATNFLAHEK	Met-loss+Acetyl@1	10	V20130429-11_FTMSms2hcd	32.251	1	10	36.8	2.4e-8	3.7e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[48]		P29692	EF1D_HUMAN	EEF1D	3	12.1	4.83	2.4e-8	679.8685	2	1.7	IASLEVENQSLR	IASLEVENQSLR		12	V20130429-11_FTMSms2hcd	32.885	84	95	44.6	2.7e-8	5.1e-11	1	31122.1	HUMAN	Elongation factor 1-delta
[48]		P29692	EF1D_HUMAN	EEF1D	3	12.1	4.83	2.4e-8	650.3669	2	-0.13	GVVQELQQAISK	GVVQELQQAISK		12	V20130429-11_FTMSms2hcd	50.169	96	107	47.9	5.6e-8	1.3e-10	1	31122.1	HUMAN	Elongation factor 1-delta
[49]		P04083	ANXA1_HUMAN	ANXA1	3	13.3	7.01	2.3e-12	515.3022	3	15	GVDEATIIDILTKR	GVDEATIIDILTKR		14	V20130429-11_FTMSms2hcd	58.372	59	72	49.5	2.3e-12	1.0e-14	1	38714.6	HUMAN	Annexin A1
[49]		P04083	ANXA1_HUMAN	ANXA1	3	13.3	7.01	2.3e-12	786.0620	3	6.2	GGPGSAVSPYPTFNPSSDVAALHK	GGPGSAVSPYPTFNPSSDVAALHK		24	V20130429-11_FTMSms2hcd	44.123	30	53	30.1	1.0e-8	1.1e-11	1	38714.6	HUMAN	Annexin A1
[49]		P04083	ANXA1_HUMAN	ANXA1	3	13.3	7.01	2.3e-12	415.2613	2	1.4	NALLSLAK	NALLSLAK		8	V20130429-11_FTMSms2hcd	34.852	178	185	27.6	0.0037	7.9e-6	1	38714.6	HUMAN	Annexin A1
[50]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.72	1.1e-13	744.8826	2	-0.086	IFVGGLSPDTPEEK	IFVGGLSPDTPEEK		14	V20130429-11_FTMSms2hcd	37.734	184	197	43.7	1.1e-13	1.5e-16	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[50]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.72	1.1e-13	457.7609	2	1.2	GFGFVLFK	GFGFVLFK		8	V20130429-11_FTMSms2hcd	57.311	139	146	25.9	6.6e-6	1.7e-8	2	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[50]		Q14103	HNRPD_HUMAN	HNRNPD	3	9.9	7.72	1.1e-13	514.9144	3	-0.58	HSEAATAQREEWK	HSEAATAQREEWK		13	V20130429-11_FTMSms2hcd	12.306	86	98	12.9	3.5e-4	4.3e-7	1	38434.5	HUMAN	Heterogeneous nuclear ribonucleoprotein D0
[50-1]	0	O14979	HNRDL_HUMAN	HNRPDL	1	1.9	2.11	6.6e-6	457.7609	2	1.2	GFGFVLFK	GFGFVLFK		8	V20130429-11_FTMSms2hcd	57.311	190	197	25.9	6.6e-6	1.7e-8	2	46437.9	HUMAN	Heterogeneous nuclear ribonucleoprotein D-like
[51]		P63313	TYB10_HUMAN	TMSB10	3	70.5	5.93	2.2e-10	791.3595	2	1.0	MADKPDMGEIASFDK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-11_FTMSms2hcd	30.871	1	15	42.7	2.2e-10	2.9e-13	1	5025.7	HUMAN	Thymosin beta-10
[51]		P63313	TYB10_HUMAN	TMSB10	3	70.5	5.93	2.2e-10	562.9726	3	0.69	NTLPTKETIEQEKR	NTLPTKETIEQEKR		14	V20130429-11_FTMSms2hcd	19.553	27	40	36.1	5.0e-9	9.0e-12	1	5025.7	HUMAN	Thymosin beta-10
[51]		P63313	TYB10_HUMAN	TMSB10	3	70.5	5.93	2.2e-10	594.2860	3	0.71	MADKPDMGEIASFDKAK	M(Met-loss+Acetyl)ADKPDM(Oxidation)GEIASFDKAK	Met-loss+Acetyl@1;Oxidation@7	17	V20130429-11_FTMSms2hcd	28.476	1	17	20.2	3.4e-4	3.7e-7	1	5025.7	HUMAN	Thymosin beta-10
[52]		P21333	FLNA_HUMAN	FLNA	3	1.2	6.25	3.7e-11	715.3643	2	2.1	AFGPGLQGGSAGSPAR	AFGPGLQGGSAGSPAR		16	V20130429-11_FTMSms2hcd	26.467	1072	1087	39.0	3.7e-11	5.4e-14	1	280741.3	HUMAN	Filamin-A
[52]		P21333	FLNA_HUMAN	FLNA	3	1.2	6.25	3.7e-11	543.3168	2	2.0	LYSVSYLLK	LYSVSYLLK		9	V20130429-11_FTMSms2hcd	47.333	2613	2621	29.4	2.4e-8	5.3e-11	1	280741.3	HUMAN	Filamin-A
[52]		P21333	FLNA_HUMAN	FLNA	3	1.2	6.25	3.7e-11	486.2882	2	1.9	LLGWIQNK	LLGWIQNK		8	V20130429-11_FTMSms2hcd	39.612	172	179	23.2	2.1e-4	4.6e-7	3	280741.3	HUMAN	Filamin-A
[52-1]	1	O75369	FLNB_HUMAN	FLNB	2	0.8	4.92	1.3e-8	461.6337	3	9.8	LIALLEVLSQKR	LIALLEVLSQKR		12	V20130429-11_FTMSms2hcd	59.245	50	61	39.4	1.3e-8	3.8e-10	2	278166.3	HUMAN	Filamin-B
[52-1]	1	O75369	FLNB_HUMAN	FLNB	2	0.8	4.92	1.3e-8	486.2882	2	1.9	LLGWIQNK	LLGWIQNK		8	V20130429-11_FTMSms2hcd	39.612	145	152	23.2	2.1e-4	4.6e-7	3	278166.3	HUMAN	Filamin-B
[52-2]	1	Q14315	FLNC_HUMAN	FLNC	2	0.7	4.92	1.3e-8	461.6337	3	9.8	LIALLEVLSQKR	LIALLEVLSQKR		12	V20130429-11_FTMSms2hcd	59.245	70	81	39.4	1.3e-8	3.8e-10	2	291024.6	HUMAN	Filamin-C
[52-2]	1	Q14315	FLNC_HUMAN	FLNC	2	0.7	4.92	1.3e-8	486.2882	2	1.9	LLGWIQNK	LLGWIQNK		8	V20130429-11_FTMSms2hcd	39.612	165	172	23.2	2.1e-4	4.6e-7	3	291024.6	HUMAN	Filamin-C
[53]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14091.6	HUMAN	Histone H2A type 1
[53]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	14091.6	HUMAN	Histone H2A type 1
[53]		P0C0S8	H2A1_HUMAN	HIST1H2AG	3	35.4	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14091.6	HUMAN	Histone H2A type 1
[53-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14107.6	HUMAN	Histone H2A type 1-D
[53-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	14107.6	HUMAN	Histone H2A type 1-D
[53-1]	0	P20671	H2A1D_HUMAN	HIST1H2AD	3	35.4	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14107.6	HUMAN	Histone H2A type 1-D
[53-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	13988.5	HUMAN	Histone H2A type 2-C
[53-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	13988.5	HUMAN	Histone H2A type 2-C
[53-2]	0	Q16777	H2A2C_HUMAN	HIST2H2AC	3	35.7	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	13988.5	HUMAN	Histone H2A type 2-C
[53-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14095.6	HUMAN	Histone H2A type 2-A
[53-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	14095.6	HUMAN	Histone H2A type 2-A
[53-3]	0	Q6FI13	H2A2A_HUMAN	HIST2H2AA3	3	35.4	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14095.6	HUMAN	Histone H2A type 2-A
[53-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	13906.4	HUMAN	Histone H2A type 1-H
[53-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	13906.4	HUMAN	Histone H2A type 1-H
[53-4]	0	Q96KK5	H2A1H_HUMAN	HIST1H2AH	3	35.9	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	13906.4	HUMAN	Histone H2A type 1-H
[53-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	13936.4	HUMAN	Histone H2A type 1-J
[53-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	13936.4	HUMAN	Histone H2A type 1-J
[53-5]	0	Q99878	H2A1J_HUMAN	HIST1H2AJ	3	35.9	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	13936.4	HUMAN	Histone H2A type 1-J
[53-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14019.5	HUMAN	Histone H2A.J
[53-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	7.42	8.8e-14	702.0700	3	3.9	HLQLAIRNDEELNKLLGK	HLQLAIRNDEELNKLLGK		18	V20130429-11_FTMSms2hcd	45.474	83	100	33.2	1.7e-6	1.1e-8	7	14019.5	HUMAN	Histone H2A.J
[53-6]	0	Q9BTM1	H2AJ_HUMAN	H2AFJ	3	35.7	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14019.5	HUMAN	Histone H2A.J
[53-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14135.6	HUMAN	Histone H2A type 1-B/E
[53-7]	0	P04908	H2A1B_HUMAN	HIST1H2AB	2	21.5	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14135.6	HUMAN	Histone H2A type 1-B/E
[53-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14121.6	HUMAN	Histone H2A type 3
[53-8]	0	Q7L7L0	H2A3_HUMAN	HIST3H2A	2	21.5	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14121.6	HUMAN	Histone H2A type 3
[53-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	7.42	8.8e-14	644.4015	3	11	VTIAQGGVLPNIQAVLLPK	VTIAQGGVLPNIQAVLLPK		19	V20130429-11_FTMSms2hcd	65.268	101	119	36.5	8.8e-14	3.4e-15	10	14105.6	HUMAN	Histone H2A type 1-C
[53-9]	0	Q93077	H2A1C_HUMAN	HIST1H2AC	2	21.5	7.42	8.8e-14	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14105.6	HUMAN	Histone H2A type 1-C
[53-10]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.12	1.0e-9	1038.6042	3	13	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-11_FTMSms2hcd	75.383	90	119	35.5	1.0e-9	2.5e-11	3	13995.4	HUMAN	Histone H2A type 2-B
[53-10]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.12	1.0e-9	418.7589	2	0.51	HLQLAVR	HLQLAVR		7	V20130429-11_FTMSms2hcd	21.173	83	89	15.5	1.7e-4	1.6e-6	1	13995.4	HUMAN	Histone H2A type 2-B
[53-10]	2	Q8IUE6	H2A2B_HUMAN	HIST2H2AB	3	35.4	5.12	1.0e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	13995.4	HUMAN	Histone H2A type 2-B
[53-11]	1	P16104	H2AX_HUMAN	H2AFX	2	27.3	5.12	1.0e-9	1038.6042	3	13	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-11_FTMSms2hcd	75.383	90	119	35.5	1.0e-9	2.5e-11	3	15144.7	HUMAN	Histone H2A.x
[53-11]	1	P16104	H2AX_HUMAN	H2AFX	2	27.3	5.12	1.0e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	15144.7	HUMAN	Histone H2A.x
[53-12]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	29.8	5.12	1.0e-9	1038.6042	3	13	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK	NDEELNKLLGGVTIAQGGVLPNIQAVLLPK		30	V20130429-11_FTMSms2hcd	75.383	90	119	35.5	1.0e-9	2.5e-11	3	14233.6	HUMAN	Histone H2A type 1-A
[53-12]	1	Q96QV6	H2A1A_HUMAN	HIST1H2AA	2	29.8	5.12	1.0e-9	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	22	30	26.2	0.0010	1.7e-6	15	14233.6	HUMAN	Histone H2A type 1-A
[53-13]	0	P0C0S5	H2AZ_HUMAN	H2AFZ	1	7.0	0.95	0.0010	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	24	32	26.2	0.0010	1.7e-6	15	13552.8	HUMAN	Histone H2A.Z
[53-14]	0	Q71UI9	H2AV_HUMAN	H2AFV	1	7.0	0.95	0.0010	472.7700	2	1.6	AGLQFPVGR	AGLQFPVGR		9	V20130429-11_FTMSms2hcd	36.326	24	32	26.2	0.0010	1.7e-6	15	13508.8	HUMAN	Histone H2A.V
[54]		P35232	PHB_HUMAN	PHB	2	18.8	8.04	2.8e-14	791.0897	3	1.2	FGLALAVAGGVVNSALYNVDAGHR	FGLALAVAGGVVNSALYNVDAGHR		24	V20130429-11_FTMSms2hcd	66.543	12	35	52.1	2.8e-14	5.8e-17	1	29804.3	HUMAN	Prohibitin
[54]		P35232	PHB_HUMAN	PHB	2	18.8	8.04	2.8e-14	767.4092	4	-2.7	GVQDIVVGEGTHFLIPWVQKPIIFDCR	GVQDIVVGEGTHFLIPWVQKPIIFDCR		27	V20130429-11_FTMSms2hcd	72.498	44	70	26.5	2.7e-8	6.3e-11	1	29804.3	HUMAN	Prohibitin
[55]		P43487	RANG_HUMAN	RANBP1	2	16.9	7.27	2.9e-13	671.3386	4	7.2	AWVWNTHADFADECPKPELLAIR	AWVWNTHADFADECPKPELLAIR		23	V20130429-11_FTMSms2hcd	59.659	119	141	30.6	2.9e-13	3.5e-16	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[55]		P43487	RANG_HUMAN	RANBP1	2	16.9	7.27	2.9e-13	691.3246	2	3.6	TLEEDEEELFK	TLEEDEEELFK		11	V20130429-11_FTMSms2hcd	44.097	40	50	37.8	1.2e-8	1.7e-11	1	23310.3	HUMAN	Ran-specific GTPase-activating protein
[56]		Q15365	PCBP1_HUMAN	PCBP1	2	9.6	6.61	1.2e-11	726.4031	3	1.1	QVTITGSAASISLAQYLINAR	QVTITGSAASISLAQYLINAR		21	V20130429-11_FTMSms2hcd	63.783	326	346	41.1	1.2e-11	4.0e-14	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[56]		Q15365	PCBP1_HUMAN	PCBP1	2	9.6	6.61	1.2e-11	694.9133	2	3.3	IITLTGPTNAIFK	IITLTGPTNAIFK		13	V20130429-11_FTMSms2hcd	51.555	58	70	32.4	4.3e-9	2.3e-11	1	37498.2	HUMAN	Poly(rC)-binding protein 1
[57]		O43175	SERA_HUMAN	PHGDH	2	8.1	9.20	2.0e-16	889.2354	4	10	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLMR	SLTGVVNAQALTSAFSPHTKPWIGLAEALGTLM(Oxidation)R	Oxidation@343	34	V20130429-11_FTMSms2hcd	74.632	311	344	51.2	2.0e-16	1.1e-18	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[57]		O43175	SERA_HUMAN	PHGDH	2	8.1	9.20	2.0e-16	450.2883	2	2.3	TLGILGLGR	TLGILGLGR		9	V20130429-11_FTMSms2hcd	45.838	147	155	25.7	2.8e-4	1.2e-6	1	56651.0	HUMAN	D-3-phosphoglycerate dehydrogenase
[58]		P11586	C1TC_HUMAN	MTHFD1	3	5.0	5.20	5.1e-9	752.8592	2	-0.95	TDPTTLTDEEINR	TDPTTLTDEEINR		13	V20130429-11_FTMSms2hcd	29.890	505	517	46.4	5.1e-9	6.4e-12	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[58]		P11586	C1TC_HUMAN	MTHFD1	3	5.0	5.20	5.1e-9	854.8008	3	15	STTTIGLVQALGAHLYQNVFACVR	STTTIGLVQALGAHLYQNVFACVR		24	V20130429-11_FTMSms2hcd	77.290	387	410	19.2	4.9e-7	1.6e-9	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[58]		P11586	C1TC_HUMAN	MTHFD1	3	5.0	5.20	5.1e-9	456.7602	2	-2.0	MAPAEILNGK	M(Met-loss)APAEILNGK	Met-loss@1	10	V20130429-11_FTMSms2hcd	43.547	1	10	12.3	0.020	8.6e-5	1	101560.1	HUMAN	C-1-tetrahydrofolate synthase, cytoplasmic
[59]		P25398	RS12_HUMAN	RPS12	2	25.0	6.56	1.5e-11	1137.0717	2	1.4	MAEEGIAAGGVMDVNTALQEVLK	M(Met-loss+Acetyl)AEEGIAAGGVM(Oxidation)DVNTALQEVLK	Met-loss+Acetyl@1;Oxidation@12	23	V20130429-11_FTMSms2hcd	71.786	1	23	49.5	1.5e-11	1.8e-14	1	14515.1	HUMAN	40S ribosomal protein S12
[59]		P25398	RS12_HUMAN	RPS12	2	25.0	6.56	1.5e-11	533.8032	2	-1.2	TALIHDGLAR	TALIHDGLAR		10	V20130429-11_FTMSms2hcd	23.890	24	33	32.9	4.4e-7	1.3e-9	1	14515.1	HUMAN	40S ribosomal protein S12
[60]		P20700	LMNB1_HUMAN	LMNB1	1	5.1	10.44	1.0e-18	1137.8644	3	2.2	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR	TTIPEEEEEEEEAAGVVVEEELFHQQGTPR		30	V20130429-11_FTMSms2hcd	61.095	548	577	55.9	1.0e-18	9.9e-22	1	66408.9	HUMAN	Lamin-B1
[61]		P15311	EZRI_HUMAN	EZR	3	4.8	4.11	2.5e-7	708.8405	2	1.7	AQEEAERLEADR	AQEEAERLEADR		12	V20130429-11_FTMSms2hcd	16.372	382	393	38.2	2.5e-7	3.4e-10	1	69413.4	HUMAN	Ezrin
[61]		P15311	EZRI_HUMAN	EZR	3	4.8	4.11	2.5e-7	552.7985	2	5.5	IGFPWSEIR	IGFPWSEIR		9	V20130429-11_FTMSms2hcd	53.202	238	246	34.5	2.3e-6	3.4e-9	3	69413.4	HUMAN	Ezrin
[61]		P15311	EZRI_HUMAN	EZR	3	4.8	4.11	2.5e-7	447.7759	2	-0.25	LFFLQVK	LFFLQVK		7	V20130429-11_FTMSms2hcd	51.097	101	107	22.7	8.8e-5	5.8e-7	3	69413.4	HUMAN	Ezrin
[61-1]	0	P26038	MOES_HUMAN	MSN	2	2.8	3.21	2.3e-6	552.7985	2	5.5	IGFPWSEIR	IGFPWSEIR		9	V20130429-11_FTMSms2hcd	53.202	238	246	34.5	2.3e-6	3.4e-9	3	67820.6	HUMAN	Moesin
[61-1]	0	P26038	MOES_HUMAN	MSN	2	2.8	3.21	2.3e-6	447.7759	2	-0.25	LFFLQVK	LFFLQVK		7	V20130429-11_FTMSms2hcd	51.097	101	107	22.7	8.8e-5	5.8e-7	3	67820.6	HUMAN	Moesin
[61-2]	0	P35241	RADI_HUMAN	RDX	2	2.7	3.21	2.3e-6	552.7985	2	5.5	IGFPWSEIR	IGFPWSEIR		9	V20130429-11_FTMSms2hcd	53.202	238	246	34.5	2.3e-6	3.4e-9	3	68564.5	HUMAN	Radixin
[61-2]	0	P35241	RADI_HUMAN	RDX	2	2.7	3.21	2.3e-6	447.7759	2	-0.25	LFFLQVK	LFFLQVK		7	V20130429-11_FTMSms2hcd	51.097	101	107	22.7	8.8e-5	5.8e-7	3	68564.5	HUMAN	Radixin
[62]		P02768	ALBU_HUMAN	ALB	3	4.8	5.62	8.4e-10	547.3219	3	8.2	KVPQVSTPTLVEVSR	KVPQVSTPTLVEVSR		15	V20130429-11_FTMSms2hcd	36.438	438	452	43.8	8.4e-10	5.5e-12	1	69367.4	HUMAN	Serum albumin
[62]		P02768	ALBU_HUMAN	ALB	3	4.8	5.62	8.4e-10	395.2390	2	-1.2	LVTDLTK	LVTDLTK		7	V20130429-11_FTMSms2hcd	21.790	258	264	30.7	0.0011	3.3e-6	1	69367.4	HUMAN	Serum albumin
[62]		P02768	ALBU_HUMAN	ALB	3	4.8	5.62	8.4e-10	464.2505	2	0.30	YLYEIAR	YLYEIAR		7	V20130429-11_FTMSms2hcd	30.985	162	168	30.4	0.0014	3.2e-6	1	69367.4	HUMAN	Serum albumin
[63]		P62899	RL31_HUMAN	RPL31	2	25.6	6.82	5.1e-12	891.7847	3	3.8	NEDEDSPNKLYTLVTYVPVTTFK	NEDEDSPNKLYTLVTYVPVTTFK		23	V20130429-11_FTMSms2hcd	61.254	93	115	43.6	5.1e-12	6.4e-15	1	14463.0	HUMAN	60S ribosomal protein L31
[63]		P62899	RL31_HUMAN	RPL31	2	25.6	6.82	5.1e-12	494.7751	2	0.75	SAINEVVTR	SAINEVVTR		9	V20130429-11_FTMSms2hcd	23.040	15	23	26.0	1.3e-5	2.0e-8	1	14463.0	HUMAN	60S ribosomal protein L31
[64]		P30101	PDIA3_HUMAN	PDIA3	1	4.8	9.63	3.2e-17	859.1151	3	10	TFSHELSDFGLESTAGEIPVVAIR	TFSHELSDFGLESTAGEIPVVAIR		24	V20130429-11_FTMSms2hcd	60.179	306	329	42.7	3.2e-17	4.9e-20	1	56782.9	HUMAN	Protein disulfide-isomerase A3
[65]		Q16658	FSCN1_HUMAN	FSCN1	1	4.9	9.52	5.1e-17	873.4480	3	2.0	VGKDELFALEQSCAQVVLQAANER	VGKDELFALEQSCAQVVLQAANER		24	V20130429-11_FTMSms2hcd	73.228	248	271	48.1	5.1e-17	7.2e-20	1	54530.4	HUMAN	Fascin
[66]		P31949	S10AB_HUMAN	S100A11	2	23.8	5.87	2.9e-10	933.4620	2	9.5	TEFLSFMNTELAAFTK	TEFLSFM(Oxidation)NTELAAFTK	Oxidation@43	16	V20130429-11_FTMSms2hcd	60.218	37	52	42.8	2.9e-10	3.1e-13	1	11740.6	HUMAN	Protein S100-A11
[66]		P31949	S10AB_HUMAN	S100A11	2	23.8	5.87	2.9e-10	510.2539	2	0.14	ISSPTETER	ISSPTETER		9	V20130429-11_FTMSms2hcd	12.100	4	12	33.8	8.4e-6	1.4e-8	1	11740.6	HUMAN	Protein S100-A11
[67]		P62701	RS4X_HUMAN	RPS4X	3	11.8	4.13	3.5e-7	608.8601	2	0.57	ECLPLIIFLR	ECLPLIIFLR		10	V20130429-11_FTMSms2hcd	72.924	40	49	39.2	3.5e-7	1.2e-9	1	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[67]		P62701	RS4X_HUMAN	RPS4X	3	11.8	4.13	3.5e-7	526.7403	2	-2.1	DANGNSFATR	DANGNSFATR		10	V20130429-11_FTMSms2hcd	11.105	212	221	23.0	3.3e-6	6.9e-9	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[67]		P62701	RS4X_HUMAN	RPS4X	3	11.8	4.13	3.5e-7	405.8921	3	2.0	GIPHLVTHDAR	GIPHLVTHDAR		11	V20130429-11_FTMSms2hcd	16.269	135	145	12.2	0.024	3.9e-5	3	29598.0	HUMAN	40S ribosomal protein S4, X isoform
[67-1]	0	P22090	RS4Y1_HUMAN	RPS4Y1	1	3.8	1.98	3.3e-6	526.7403	2	-2.1	DANGNSFATR	DANGNSFATR		10	V20130429-11_FTMSms2hcd	11.105	212	221	23.0	3.3e-6	6.9e-9	3	29455.9	HUMAN	40S ribosomal protein S4, Y isoform 1
[67-2]	0	Q8TD47	RS4Y2_HUMAN	RPS4Y2	1	3.8	1.98	3.3e-6	526.7403	2	-2.1	DANGNSFATR	DANGNSFATR		10	V20130429-11_FTMSms2hcd	11.105	212	221	23.0	3.3e-6	6.9e-9	3	29295.7	HUMAN	40S ribosomal protein S4, Y isoform 2
[68]		Q15843	NEDD8_HUMAN	NEDD8	1	17.3	9.23	1.7e-16	487.6486	3	0.070	ILGGSVLHLVLALR	ILGGSVLHLVLALR		14	V20130429-11_FTMSms2hcd	67.011	61	74	53.1	1.7e-16	1.6e-17	1	9071.6	HUMAN	NEDD8
[69]		P60866	RS20_HUMAN	RPS20	2	26.1	4.54	8.4e-8	450.9258	3	0.077	LIDLHSPSEIVK	LIDLHSPSEIVK		12	V20130429-11_FTMSms2hcd	37.841	88	99	38.6	8.4e-8	2.5e-10	1	13372.8	HUMAN	40S ribosomal protein S20
[69]		P60866	RS20_HUMAN	RPS20	2	26.1	4.54	8.4e-8	510.0257	4	2.3	MAFKDTGKTPVEPEVAIHR	M(Met-loss+Acetyl)AFKDTGKTPVEPEVAIHR	Met-loss+Acetyl@1	19	V20130429-11_FTMSms2hcd	33.702	1	19	40.1	8.6e-8	1.6e-10	1	13372.8	HUMAN	40S ribosomal protein S20
[70]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.76	1.2e-6	445.9021	3	1.1	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-11_FTMSms2hcd	30.756	74	84	32.5	1.2e-6	1.7e-9	4	15404.2	HUMAN	Histone H3.1
[70]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.76	1.2e-6	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-11_FTMSms2hcd	20.168	42	50	38.4	1.9e-6	5.0e-9	5	15404.2	HUMAN	Histone H3.1
[70]		P68431	H31_HUMAN	HIST1H3A	3	19.1	3.76	1.2e-6	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-11_FTMSms2hcd	23.066	65	70	20.2	0.013	3.9e-5	5	15404.2	HUMAN	Histone H3.1
[70-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.76	1.2e-6	445.9021	3	1.1	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-11_FTMSms2hcd	30.756	74	84	32.5	1.2e-6	1.7e-9	4	15328.0	HUMAN	Histone H3.3
[70-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.76	1.2e-6	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-11_FTMSms2hcd	20.168	42	50	38.4	1.9e-6	5.0e-9	5	15328.0	HUMAN	Histone H3.3
[70-1]	0	P84243	H33_HUMAN	H3F3A	3	19.1	3.76	1.2e-6	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-11_FTMSms2hcd	23.066	65	70	20.2	0.013	3.9e-5	5	15328.0	HUMAN	Histone H3.3
[70-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.76	1.2e-6	445.9021	3	1.1	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-11_FTMSms2hcd	30.756	74	84	32.5	1.2e-6	1.7e-9	4	15508.4	HUMAN	Histone H3.1t
[70-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.76	1.2e-6	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-11_FTMSms2hcd	20.168	42	50	38.4	1.9e-6	5.0e-9	5	15508.4	HUMAN	Histone H3.1t
[70-2]	0	Q16695	H31T_HUMAN	HIST3H3	3	19.1	3.76	1.2e-6	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-11_FTMSms2hcd	23.066	65	70	20.2	0.013	3.9e-5	5	15508.4	HUMAN	Histone H3.1t
[70-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.76	1.2e-6	445.9021	3	1.1	EIAQDFKTDLR	EIAQDFKTDLR		11	V20130429-11_FTMSms2hcd	30.756	74	84	32.5	1.2e-6	1.7e-9	4	15388.2	HUMAN	Histone H3.2
[70-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.76	1.2e-6	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-11_FTMSms2hcd	20.168	42	50	38.4	1.9e-6	5.0e-9	5	15388.2	HUMAN	Histone H3.2
[70-3]	0	Q71DI3	H32_HUMAN	HIST2H3A	3	19.1	3.76	1.2e-6	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-11_FTMSms2hcd	23.066	65	70	20.2	0.013	3.9e-5	5	15388.2	HUMAN	Histone H3.2
[70-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	3.65	1.9e-6	516.8005	2	-1.1	YRPGTVALR	YRPGTVALR		9	V20130429-11_FTMSms2hcd	20.168	41	49	38.4	1.9e-6	5.0e-9	5	15213.9	HUMAN	Histone H3.3C
[70-4]	0	Q6NXT2	H3C_HUMAN	H3F3C	2	11.1	3.65	1.9e-6	394.7429	2	1.0	KLPFQR	KLPFQR		6	V20130429-11_FTMSms2hcd	23.066	64	69	20.2	0.013	3.9e-5	5	15213.9	HUMAN	Histone H3.3C
[71]		P19338	NUCL_HUMAN	NCL	1	3.1	8.44	5.0e-15	834.4273	3	0.64	TLVLSNLSYSATEETLQEVFEK	TLVLSNLSYSATEETLQEVFEK		22	V20130429-11_FTMSms2hcd	70.815	487	508	50.7	5.0e-15	6.7e-18	1	76615.0	HUMAN	Nucleolin
[72]		P62826	RAN_HUMAN	RAN	2	12.0	5.11	4.5e-10	595.6431	3	1.6	SNYNFEKPFLWLAR	SNYNFEKPFLWLAR		14	V20130429-11_FTMSms2hcd	57.792	153	166	33.4	4.5e-10	6.2e-13	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[72]		P62826	RAN_HUMAN	RAN	2	12.0	5.11	4.5e-10	622.8173	2	0.28	MAAQGEPQVQFK	M(Met-loss+Acetyl)AAQGEPQVQFK	Met-loss+Acetyl@1	12	V20130429-11_FTMSms2hcd	31.478	1	12	27.8	1.7e-6	2.3e-9	1	24423.3	HUMAN	GTP-binding nuclear protein Ran
[73]		P42025	ACTY_HUMAN	ACTR1B	1	5.1	8.21	1.4e-14	700.7175	3	0.18	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-11_FTMSms2hcd	70.230	337	355	42.4	1.4e-14	3.3e-17	2	42293.8	HUMAN	Beta-centractin
[73-1]	0	P61163	ACTZ_HUMAN	ACTR1A	1	5.1	8.21	1.4e-14	700.7175	3	0.18	LYSTWIGGSILASLDTFKK	LYSTWIGGSILASLDTFKK		19	V20130429-11_FTMSms2hcd	70.230	337	355	42.4	1.4e-14	3.3e-17	2	42614.1	HUMAN	Alpha-centractin
[74]		P55072	TERA_HUMAN	VCP	2	3.6	5.28	6.7e-10	845.9299	2	1.9	MASGADSKGDDLSTAILK	M(Met-loss+Acetyl)ASGADSKGDDLSTAILK	Met-loss+Acetyl@1	18	V20130429-11_FTMSms2hcd	38.001	1	18	28.4	6.7e-10	8.3e-13	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[74]		P55072	TERA_HUMAN	VCP	2	3.6	5.28	6.7e-10	602.3201	2	0.11	LAGESESNLRK	LAGESESNLRK		11	V20130429-11_FTMSms2hcd	12.212	278	288	36.1	2.2e-5	3.5e-8	1	89322.6	HUMAN	Transitional endoplasmic reticulum ATPase
[75]		P62241	RS8_HUMAN	RPS8	2	11.5	5.08	8.9e-10	753.8959	2	3.1	ISSLLEEQFQQGK	ISSLLEEQFQQGK		13	V20130429-11_FTMSms2hcd	39.468	158	170	34.7	8.9e-10	1.3e-12	1	24205.4	HUMAN	40S ribosomal protein S8
[75]		P62241	RS8_HUMAN	RPS8	2	11.5	5.08	8.9e-10	657.8420	2	-1.5	LTPEEEEILNK	LTPEEEEILNK		11	V20130429-11_FTMSms2hcd	32.393	129	139	24.5	6.0e-6	9.4e-9	1	24205.4	HUMAN	40S ribosomal protein S8
[76]		O75531	BAF_HUMAN	BANF1	2	14.6	4.41	1.2e-8	493.3145	3	10	AYVVLGQFLVLKK	AYVVLGQFLVLKK		13	V20130429-11_FTMSms2hcd	55.718	42	54	32.9	1.2e-8	8.3e-10	1	10058.7	HUMAN	Barrier-to-autointegration factor
[76]		O75531	BAF_HUMAN	BANF1	2	14.6	4.41	1.2e-8	675.4138	2	0.88	AYVVLGQFLVLK	AYVVLGQFLVLK		12	V20130429-11_FTMSms2hcd	63.996	42	53	34.1	6.6e-7	1.2e-8	1	10058.7	HUMAN	Barrier-to-autointegration factor
[77]		Q14116	IL18_HUMAN	IL18	3	13.5	3.26	3.9e-8	461.2600	2	5.8	GMAVTISVK	GM(Oxidation)AVTISVK	Oxidation@96	9	V20130429-11_FTMSms2hcd	23.566	95	103	14.1	3.9e-8	1.0e-10	1	22326.4	HUMAN	Interleukin-18
[77]		Q14116	IL18_HUMAN	IL18	3	13.5	3.26	3.9e-8	566.3100	2	0.78	TIFIISMYK	TIFIISM(Oxidation)YK	Oxidation@87	9	V20130429-11_FTMSms2hcd	44.464	81	89	25.4	5.1e-7	8.0e-10	1	22326.4	HUMAN	Interleukin-18
[77]		Q14116	IL18_HUMAN	IL18	3	13.5	3.26	3.9e-8	513.2745	2	0.26	SDIIFFQR	SDIIFFQR		8	V20130429-11_FTMSms2hcd	44.684	133	140	22.9	1.5e-5	3.0e-8	1	22326.4	HUMAN	Interleukin-18
[78]		P52272	HNRPM_HUMAN	HNRNPM	1	4.5	7.73	1.0e-13	924.7194	4	-0.066	GIGTVTFEQSIEAVQAISMFNGQLLFDRPMHVK	GIGTVTFEQSIEAVQAISM(Oxidation)FNGQLLFDRPM(Oxidation)HVK	Oxidation@263;Oxidation@274	33	V20130429-11_FTMSms2hcd	75.931	245	277	44.2	1.0e-13	1.6e-16	1	77516.4	HUMAN	Heterogeneous nuclear ribonucleoprotein M
[79]		P05783	K1C18_HUMAN	KRT18	1	5.3	7.73	1.1e-13	896.1365	3	3.0	YALQMEQLNGILLHLESELAQTR	YALQM(Oxidation)EQLNGILLHLESELAQTR	Oxidation@335	23	V20130429-11_FTMSms2hcd	72.778	331	353	48.5	1.1e-13	1.9e-16	1	48058.2	HUMAN	Keratin, type I cytoskeletal 18
[80]		P14174	MIF_HUMAN	MIF	2	18.3	5.41	3.2e-10	652.3447	2	-0.46	MPMFIVNTNVPR	M(Met-loss)PM(Oxidation)FIVNTNVPR	Met-loss@1;Oxidation@3	12	V20130429-11_FTMSms2hcd	36.678	1	12	35.6	3.2e-10	4.3e-13	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[80]		P14174	MIF_HUMAN	MIF	2	18.3	5.41	3.2e-10	494.2868	2	0.77	LLCGLLAER	LLCGLLAER		9	V20130429-11_FTMSms2hcd	46.616	79	87	33.5	1.8e-4	3.2e-7	1	12476.4	HUMAN	Macrophage migration inhibitory factor
[81]		P62306	RUXF_HUMAN	SNRPF	1	25.6	7.20	2.3e-13	770.1094	3	1.7	MSLPLNPKPFLNGLTGKPVMVK	M(Met-loss+Acetyl)SLPLNPKPFLNGLTGKPVM(Oxidation)VK	Met-loss+Acetyl@1;Oxidation@20	22	V20130429-11_FTMSms2hcd	58.916	1	22	36.5	2.3e-13	1.8e-15	1	9725.3	HUMAN	Small nuclear ribonucleoprotein F
[82]		Q00610	CLH1_HUMAN	CLTC	1	0.7	7.15	1.7e-13	667.8206	2	0.30	IYIDSNNNPER	IYIDSNNNPER		11	V20130429-11_FTMSms2hcd	21.147	882	892	35.4	1.7e-13	2.2e-16	1	191616.3	HUMAN	Clathrin heavy chain 1
[83]		P13804	ETFA_HUMAN	ETFA	1	7.8	7.12	1.4e-12	675.1277	4	9.1	IVAPELYIAVGISGAIQHLAGMKDSK	IVAPELYIAVGISGAIQHLAGM(Oxidation)KDSK	Oxidation@290	26	V20130429-11_FTMSms2hcd	74.588	269	294	42.5	1.4e-12	6.2e-15	1	35079.9	HUMAN	Electron transfer flavoprotein subunit alpha, mitochondrial
[84]		Q9Y262	EIF3L_HUMAN	EIF3L	1	3.9	6.94	3.1e-12	640.1060	4	0.94	IWNVHSVLNVLHSLVDKSNINR	IWNVHSVLNVLHSLVDKSNINR		22	V20130429-11_FTMSms2hcd	69.050	221	242	53.4	3.1e-12	1.3e-14	1	66727.6	HUMAN	Eukaryotic translation initiation factor 3 subunit L
[85]		Q14008	CKAP5_HUMAN	CKAP5	1	1.1	6.67	7.6e-13	807.8075	3	7.5	ILVQQTLNILQQLAVAMGPNIK	ILVQQTLNILQQLAVAM(Oxidation)GPNIK	Oxidation@931	22	V20130429-11_FTMSms2hcd	73.724	915	936	34.1	7.6e-13	1.3e-14	1	225496.6	HUMAN	Cytoskeleton-associated protein 5
[86]		P40926	MDHM_HUMAN	MDH2	1	5.6	6.60	1.3e-11	897.0572	2	9.8	VAVLGASGGIGQPLSLLLK	VAVLGASGGIGQPLSLLLK		19	V20130429-11_FTMSms2hcd	67.385	27	45	40.0	1.3e-11	6.6e-13	1	35503.6	HUMAN	Malate dehydrogenase, mitochondrial
[87]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.54	1.0e-6	611.3154	2	1.1	GHLENNPALEK	GHLENNPALEK		11	V20130429-11_FTMSms2hcd	14.849	67	77	34.4	1.0e-6	1.5e-9	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[87]		P05388	RLA0_HUMAN	RPLP0	2	6.6	3.54	1.0e-6	609.3437	2	2.1	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-11_FTMSms2hcd	45.798	17	26	35.9	1.4e-5	2.9e-8	2	34273.8	HUMAN	60S acidic ribosomal protein P0
[87-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.54	1.0e-6	611.3154	2	1.1	GHLENNPALEK	GHLENNPALEK		11	V20130429-11_FTMSms2hcd	14.849	67	77	34.4	1.0e-6	1.5e-9	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[87-1]	0	Q8NHW5	RLA0L_HUMAN	RPLP0P6	2	6.6	3.54	1.0e-6	609.3437	2	2.1	IIQLLDDYPK	IIQLLDDYPK		10	V20130429-11_FTMSms2hcd	45.798	17	26	35.9	1.4e-5	2.9e-8	2	34364.8	HUMAN	60S acidic ribosomal protein P0-like
[88]		P84090	ERH_HUMAN	ERH	2	16.3	5.12	3.4e-10	469.2715	4	1.9	MSHTILLVQPTKRPEGR	M(Met-loss+Acetyl)SHTILLVQPTKRPEGR	Met-loss+Acetyl@1	17	V20130429-11_FTMSms2hcd	30.050	1	17	32.9	3.4e-10	1.7e-12	1	12259.1	HUMAN	Enhancer of rudimentary homolog
[88]		P84090	ERH_HUMAN	ERH	2	16.3	5.12	3.4e-10	724.3752	2	3.6	MSHTILLVQPTK	MSHTILLVQPT(Phospho)K	Phospho@11=53	12	V20130429-11_FTMSms2hcd	48.059	1	12	10.6	0.0048	6.5e-6	1	12259.1	HUMAN	Enhancer of rudimentary homolog
[89]		P50454	SERPH_HUMAN	SERPINH1	1	3.1	6.15	7.9e-12	546.6356	3	5.1	LFYADHPFIFLVR	LFYADHPFIFLVR		13	V20130429-11_FTMSms2hcd	61.267	381	393	34.4	7.9e-12	2.0e-14	1	46440.9	HUMAN	Serpin H1
[90]		P62913	RL11_HUMAN	RPL11	1	7.9	6.10	1.1e-10	773.9261	2	-1.7	VLEQLTGQTPVFSK	VLEQLTGQTPVFSK		14	V20130429-11_FTMSms2hcd	42.254	39	52	46.9	1.1e-10	2.3e-13	1	20252.6	HUMAN	60S ribosomal protein L11
[91]		Q92688	AN32B_HUMAN	ANP32B	1	9.6	6.07	1.2e-10	653.6040	4	1.1	IFGGLDMLAEKLPNLTHLNLSGNK	IFGGLDM(Oxidation)LAEKLPNLTHLNLSGNK	Oxidation@82	24	V20130429-11_FTMSms2hcd	66.086	76	99	46.1	1.2e-10	3.1e-13	1	28787.9	HUMAN	Acidic leucine-rich nuclear phosphoprotein 32 family member B
[92]		P52565	GDIR1_HUMAN	ARHGDIA	2	15.7	3.96	6.1e-9	876.4359	2	15	AEEYEFLTPVEEAPK	AEEYEFLTPVEEAPK		15	V20130429-11_FTMSms2hcd	46.497	153	167	24.4	6.1e-9	7.2e-12	1	23207.3	HUMAN	Rho GDP-dissociation inhibitor 1
[92]		P52565	GDIR1_HUMAN	ARHGDIA	2	15.7	3.96	6.1e-9	682.6834	3	0.34	SIQEIQELDKDDESLRK	SIQEIQELDKDDESLRK		17	V20130429-11_FTMSms2hcd	33.237	34	50	28.0	1.7e-5	2.1e-8	1	23207.3	HUMAN	Rho GDP-dissociation inhibitor 1
[93]		P62851	RS25_HUMAN	RPS25	2	15.2	3.00	7.7e-6	486.7902	2	0.72	AALQELLSK	AALQELLSK		9	V20130429-11_FTMSms2hcd	39.094	86	94	35.2	7.7e-6	1.6e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[93]		P62851	RS25_HUMAN	RPS25	2	15.2	3.00	7.7e-6	542.8217	2	0.035	LITPAVVSER	LITPAVVSER		10	V20130429-11_FTMSms2hcd	32.529	67	76	32.5	8.2e-6	3.0e-8	1	13742.2	HUMAN	40S ribosomal protein S25
[94]		P06744	G6PI_HUMAN	GPI	1	2.7	5.91	2.3e-11	860.4881	2	13	ILLANFLAQTEALMR	ILLANFLAQTEALM(Oxidation)R	Oxidation@437	15	V20130429-11_FTMSms2hcd	65.578	424	438	34.5	2.3e-11	7.8e-14	1	63147.7	HUMAN	Glucose-6-phosphate isomerase
[95]		P10412	H14_HUMAN	HIST1H1E	1	6.8	5.90	2.6e-10	789.8978	2	0.80	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-11_FTMSms2hcd	21.108	65	79	68.5	2.6e-10	3.3e-13	5	21865.4	HUMAN	Histone H1.4
[95-1]	0	P16402	H13_HUMAN	HIST1H1D	1	6.8	5.90	2.6e-10	789.8978	2	0.80	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-11_FTMSms2hcd	21.108	66	80	68.5	2.6e-10	3.3e-13	5	22350.1	HUMAN	Histone H1.3
[95-2]	0	P16403	H12_HUMAN	HIST1H1C	1	7.0	5.90	2.6e-10	789.8978	2	0.80	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-11_FTMSms2hcd	21.108	65	79	68.5	2.6e-10	3.3e-13	5	21364.9	HUMAN	Histone H1.2
[95-3]	0	P22492	H1T_HUMAN	HIST1H1T	1	7.2	5.90	2.6e-10	789.8978	2	0.80	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-11_FTMSms2hcd	21.108	69	83	68.5	2.6e-10	3.3e-13	5	22019.2	HUMAN	Histone H1t
[95-4]	0	Q02539	H11_HUMAN	HIST1H1A	1	7.0	5.90	2.6e-10	789.8978	2	0.80	ALAAAGYDVEKNNSR	ALAAAGYDVEKNNSR		15	V20130429-11_FTMSms2hcd	21.108	68	82	68.5	2.6e-10	3.3e-13	5	21842.3	HUMAN	Histone H1.1
[96]		O75506	HSBP1_HUMAN	HSBP1	1	39.5	5.87	2.9e-10	871.6876	4	-4.9	TVQDLTSVVQTLLQQMQDKFQTMSDQIIGR	TVQDLTSVVQTLLQQM(Oxidation)QDKFQTM(Oxidation)SDQIIGR	Oxidation@23;Oxidation@30	30	V20130429-11_FTMSms2hcd	71.571	8	37	42.2	2.9e-10	3.7e-13	1	8543.7	HUMAN	Heat shock factor-binding protein 1
[97]		P07305	H10_HUMAN	H1F0	2	12.4	3.53	7.0e-7	530.7676	2	0.94	VGENADSQIK	VGENADSQIK		10	V20130429-11_FTMSms2hcd	11.335	60	69	34.9	7.0e-7	9.9e-10	1	20863.1	HUMAN	Histone H1.0
[97]		P07305	H10_HUMAN	H1F0	2	12.4	3.53	7.0e-7	745.8613	2	-0.14	MTENSTSAPAAKPK	M(Acetyl+Oxidation)TENSTSAPAAKPK		14	V20130429-11_FTMSms2hcd	10.661	1	14	16.1	1.9e-4	2.3e-7	1	20863.1	HUMAN	Histone H1.0
[98]		Q15056	IF4H_HUMAN	EIF4H	1	9.3	5.75	4.9e-10	784.4233	3	-1.1	TVATPLNQVANPNSAIFGGARPR	TVATPLNQVANPNSAIFGGARPR		23	V20130429-11_FTMSms2hcd	45.956	217	239	47.4	4.9e-10	1.2e-12	1	27385.3	HUMAN	Eukaryotic translation initiation factor 4H
[99]		P31948	STIP1_HUMAN	STIP1	1	1.8	5.71	6.7e-12	558.8263	2	0.70	LMDVGLIAIR	LM(Oxidation)DVGLIAIR	Oxidation@535	10	V20130429-11_FTMSms2hcd	44.330	534	543	29.6	6.7e-12	1.7e-14	1	62639.8	HUMAN	Stress-induced-phosphoprotein 1
[100]		P15259	PGAM2_HUMAN	PGAM2	1	5.5	5.69	8.9e-11	842.4711	2	15	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-11_FTMSms2hcd	61.851	163	176	35.4	8.9e-11	2.2e-13	3	28766.4	HUMAN	Phosphoglycerate mutase 2
[100-1]	0	P18669	PGAM1_HUMAN	PGAM1	1	5.5	5.69	8.9e-11	842.4711	2	15	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-11_FTMSms2hcd	61.851	163	176	35.4	8.9e-11	2.2e-13	3	28804.2	HUMAN	Phosphoglycerate mutase 1
[100-2]	0	Q8N0Y7	PGAM4_HUMAN	PGAM4	1	5.5	5.69	8.9e-11	842.4711	2	15	ALPFWNEEIVPQIK	ALPFWNEEIVPQIK		14	V20130429-11_FTMSms2hcd	61.851	163	176	35.4	8.9e-11	2.2e-13	3	28777.1	HUMAN	Probable phosphoglycerate mutase 4
[101]		P34932	HSP74_HUMAN	HSPA4	2	5.1	4.59	6.4e-10	1041.8810	3	1.1	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK	AFSDPFVEAEKSNLAYDIVQLPTGLTGIK		29	V20130429-11_FTMSms2hcd	72.334	74	102	29.1	6.4e-10	1.3e-12	1	94331.8	HUMAN	Heat shock 70 kDa protein 4
[101]		P34932	HSP74_HUMAN	HSPA4	2	5.1	4.59	6.4e-10	748.3557	2	1.2	AGGIETIANEYSDR	AGGIETIANEYSDR		14	V20130429-11_FTMSms2hcd	35.700	20	33	15.2	0.0024	2.9e-6	1	94331.8	HUMAN	Heat shock 70 kDa protein 4
[102]		Q14974	IMB1_HUMAN	KPNB1	1	1.7	5.60	5.9e-10	803.4567	2	13	LAATNALLNSLEFTK	LAATNALLNSLEFTK		15	V20130429-11_FTMSms2hcd	57.724	192	206	39.0	5.9e-10	2.1e-12	1	97171.1	HUMAN	Importin subunit beta-1
[103]		Q07020	RL18_HUMAN	RPL18	1	6.9	5.60	9.3e-10	730.9052	2	2.5	ILTFDQLALDSPK	ILTFDQLALDSPK		13	V20130429-11_FTMSms2hcd	52.725	120	132	48.6	9.3e-10	1.9e-12	1	21634.7	HUMAN	60S ribosomal protein L18
[104]		P62269	RS18_HUMAN	RPS18	2	14.5	4.01	3.7e-8	541.3253	3	12	MSLVIPEKFQHILR	M(Met-loss+Acetyl)SLVIPEKFQHILR	Met-loss+Acetyl@1	14	V20130429-11_FTMSms2hcd	54.775	1	14	32.8	3.7e-8	4.9e-10	1	17718.8	HUMAN	40S ribosomal protein S18
[104]		P62269	RS18_HUMAN	RPS18	2	14.5	4.01	3.7e-8	530.7831	2	1.4	IPDWFLNR	IPDWFLNR		8	V20130429-11_FTMSms2hcd	49.551	79	86	20.6	0.0018	2.4e-6	1	17718.8	HUMAN	40S ribosomal protein S18
[105]		P46776	RL27A_HUMAN	RPL27A	1	7.4	5.35	2.7e-9	556.3276	2	0.84	TGAAPIIDVVR	TGAAPIIDVVR		11	V20130429-11_FTMSms2hcd	38.807	95	105	44.3	2.7e-9	1.3e-11	1	16561.5	HUMAN	60S ribosomal protein L27a
[106]		P26599	PTBP1_HUMAN	PTBP1	1	3.4	5.34	1.2e-10	680.3694	3	-1.2	VTPQSLFILFGVYGDVQR	VTPQSLFILFGVYGDVQR		18	V20130429-11_FTMSms2hcd	74.771	349	366	32.6	1.2e-10	2.6e-13	1	57221.8	HUMAN	Polypyrimidine tract-binding protein 1
[107]		P62328	TYB4_HUMAN	TMSB4X	1	34.1	5.28	3.6e-9	570.9351	3	0.97	MSDKPDMAEIEKFDK	M(Met-loss+Acetyl)SDKPDM(Oxidation)AEIEKFDK	Met-loss+Acetyl@1;Oxidation@7	15	V20130429-11_FTMSms2hcd	28.135	1	15	42.7	3.6e-9	4.0e-12	1	5052.7	HUMAN	Thymosin beta-4
[108]		Q15084	PDIA6_HUMAN	PDIA6	1	3.4	5.20	1.9e-9	764.4324	2	5.6	LAAVDATVNQVLASR	LAAVDATVNQVLASR		15	V20130429-11_FTMSms2hcd	47.359	217	231	37.7	1.9e-9	5.0e-12	1	48121.7	HUMAN	Protein disulfide-isomerase A6
[109]		P55854	SUMO3_HUMAN	SUMO3	1	11.7	5.11	7.1e-9	617.8256	2	1.0	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-11_FTMSms2hcd	27.049	21	32	39.9	7.1e-9	1.1e-11	3	11637.1	HUMAN	Small ubiquitin-related modifier 3
[109-1]	0	P61956	SUMO2_HUMAN	SUMO2	1	12.6	5.11	7.1e-9	617.8256	2	1.0	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-11_FTMSms2hcd	27.049	22	33	39.9	7.1e-9	1.1e-11	3	10871.3	HUMAN	Small ubiquitin-related modifier 2
[109-2]	0	Q6EEV6	SUMO4_HUMAN	SUMO4	1	12.6	5.11	7.1e-9	617.8256	2	1.0	VAGQDGSVVQFK	VAGQDGSVVQFK		12	V20130429-11_FTMSms2hcd	27.049	22	33	39.9	7.1e-9	1.1e-11	3	10685.2	HUMAN	Small ubiquitin-related modifier 4
[110]		P23284	PPIB_HUMAN	PPIB	1	6.0	5.01	1.1e-8	682.8572	2	1.1	TVDNFVALATGEK	TVDNFVALATGEK		13	V20130429-11_FTMSms2hcd	45.268	72	84	40.2	1.1e-8	1.5e-11	1	23742.7	HUMAN	Peptidyl-prolyl cis-trans isomerase B
[111]		Q96AG4	LRC59_HUMAN	LRRC59	1	3.9	4.97	1.7e-9	658.4111	2	13	LVTLPVSFAQLK	LVTLPVSFAQLK		12	V20130429-11_FTMSms2hcd	56.869	97	108	35.2	1.7e-9	2.8e-11	1	34930.8	HUMAN	Leucine-rich repeat-containing protein 59
[112]		P10768	ESTD_HUMAN	ESD	1	7.4	4.97	2.8e-10	648.0707	4	7.8	LQEGYDHSYYFIATFITDHIR	LQEGYDHSYYFIATFITDHIR		21	V20130429-11_FTMSms2hcd	67.720	254	274	30.9	2.8e-10	3.0e-13	1	31463.1	HUMAN	S-formylglutathione hydrolase
[113]		P08708	RS17_HUMAN	RPS17	1	19.3	4.93	2.3e-10	1002.8333	3	12	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-11_FTMSms2hcd	59.284	82	107	30.1	2.3e-10	2.8e-13	2	15550.3	HUMAN	40S ribosomal protein S17
[113-1]	0	P0CW22	RS17L_HUMAN	RPS17L	1	19.3	4.93	2.3e-10	1002.8333	3	12	DNYVPEVSALDQEIIEVDPDTKEMLK	DNYVPEVSALDQEIIEVDPDTKEM(Oxidation)LK	Oxidation@105	26	V20130429-11_FTMSms2hcd	59.284	82	107	30.1	2.3e-10	2.8e-13	2	15550.3	HUMAN	40S ribosomal protein S17-like
[114]		P61313	RL15_HUMAN	RPL15	2	12.3	2.80	7.3e-7	853.4602	2	-0.082	GATYGKPVHHGVNQLK	GATYGKPVHHGVNQLK		16	V20130429-11_FTMSms2hcd	13.262	78	93	18.1	7.3e-7	1.5e-9	1	24146.3	HUMAN	60S ribosomal protein L15
[114]		P61313	RL15_HUMAN	RPL15	2	12.3	2.80	7.3e-7	509.7607	2	-2.2	SLQSVAEER	SLQSVAEER		9	V20130429-11_FTMSms2hcd	20.192	97	105	27.6	4.3e-5	7.3e-8	1	24146.3	HUMAN	60S ribosomal protein L15
[115]		P09429	HMGB1_HUMAN	HMGB1	1	7.0	4.59	3.6e-8	760.9258	2	0.79	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-11_FTMSms2hcd	27.222	113	127	38.5	3.6e-8	8.6e-11	2	24894.0	HUMAN	High mobility group protein B1
[115-1]	0	B2RPK0	HGB1A_HUMAN	HMGB1P1	1	7.1	4.59	3.6e-8	760.9258	2	0.79	IKGEHPGLSIGDVAK	IKGEHPGLSIGDVAK		15	V20130429-11_FTMSms2hcd	27.222	113	127	38.5	3.6e-8	8.6e-11	2	24238.2	HUMAN	Putative high mobility group protein B1-like 1
[116]		P05386	RLA1_HUMAN	RPLP1	1	14.0	4.57	3.7e-9	851.9547	2	4.1	AAGVNVEPFWPGLFAK	AAGVNVEPFWPGLFAK		16	V20130429-11_FTMSms2hcd	64.349	34	49	33.0	3.7e-9	6.0e-12	1	11514.0	HUMAN	60S acidic ribosomal protein P1
[117]		Q6UXB4	CLC4G_HUMAN	CLEC4G	1	3.8	4.53	4.6e-9	597.3419	2	11	AALLDGHDLLR	AALLDGHDLLR		11	V20130429-11_FTMSms2hcd	36.989	61	71	33.1	4.6e-9	1.6e-11	1	32562.0	HUMAN	C-type lectin domain family 4 member G
[118]		P62847	RS24_HUMAN	RPS24	1	9.0	4.48	2.5e-9	699.8743	2	-0.21	TTPDVIFVFGFR	TTPDVIFVFGFR		12	V20130429-11_FTMSms2hcd	65.470	50	61	31.1	2.5e-9	4.5e-12	1	15423.3	HUMAN	40S ribosomal protein S24
[119]		P16949	STMN1_HUMAN	STMN1	1	6.7	4.47	3.5e-9	583.2769	2	-1.6	AIEENNNFSK	AIEENNNFSK		10	V20130429-11_FTMSms2hcd	15.910	86	95	31.9	3.5e-9	5.9e-12	2	17302.7	HUMAN	Stathmin
[119-1]	0	Q93045	STMN2_HUMAN	STMN2	1	5.6	4.47	3.5e-9	583.2769	2	-1.6	ALEENNNFSK	ALEENNNFSK		10	V20130429-11_FTMSms2hcd	15.910	120	129	31.9	3.5e-9	5.9e-12	2	20828.2	HUMAN	Stathmin-2
[120]		P30050	RL12_HUMAN	RPL12	1	5.5	4.44	2.2e-8	441.2770	2	1.4	IGPLGLSPK	IGPLGLSPK		9	V20130429-11_FTMSms2hcd	33.769	32	40	35.9	2.2e-8	2.7e-10	1	17818.7	HUMAN	60S ribosomal protein L12
[121]		Q9NR30	DDX21_HUMAN	DDX21	1	1.4	4.25	2.7e-8	633.3678	2	11	TFSFAIPLIEK	TFSFAIPLIEK		11	V20130429-11_FTMSms2hcd	61.998	237	247	34.5	2.7e-8	1.2e-10	1	87345.1	HUMAN	Nucleolar RNA helicase 2
[122]		P22234	PUR6_HUMAN	PAICS	1	2.8	4.23	3.2e-7	593.3457	2	0.30	MATAEVLNIGKK	M(Met-loss+Acetyl)ATAEVLNIGKK	Met-loss+Acetyl@1	12	V20130429-11_FTMSms2hcd	36.863	1	12	43.0	3.2e-7	6.5e-10	1	47079.7	HUMAN	Multifunctional protein ADE2
[123]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	2.31	3.2e-7	585.9869	3	6.4	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-11_FTMSms2hcd	59.646	281	296	16.8	3.2e-7	6.8e-10	3	32852.5	HUMAN	ADP/ATP translocase 2
[123]		P05141	ADT2_HUMAN	SLC25A5	2	6.0	2.31	3.2e-7	674.0208	3	0.93	GMGGAFVLVLYDEIKKYT	GM(Oxidation)GGAFVLVLYDEIKKYT	Oxidation@282	18	V20130429-11_FTMSms2hcd	74.990	281	298	20.8	1.8e-6	2.4e-9	1	32852.5	HUMAN	ADP/ATP translocase 2
[123-1]	0	P12235	ADT1_HUMAN	SLC25A4	1	5.4	1.91	3.2e-7	585.9869	3	6.4	GMGGAFVLVLYDEIKK	GM(Oxidation)GGAFVLVLYDEIKK	Oxidation@282	16	V20130429-11_FTMSms2hcd	59.646	281	296	16.8	3.2e-7	6.8e-10	3	33064.8	HUMAN	ADP/ATP translocase 1
[123-2]	0	P12236	ADT3_HUMAN	SLC25A6	1	5.4	1.91	3.2e-7	585.9869	3	6.4	GMGGAFVLVLYDELKK	GM(Oxidation)GGAFVLVLYDELKK	Oxidation@282	16	V20130429-11_FTMSms2hcd	59.646	281	296	16.8	3.2e-7	6.8e-10	3	32866.6	HUMAN	ADP/ATP translocase 3
[124]		P47914	RL29_HUMAN	RPL29	1	9.4	4.17	2.7e-9	689.3774	2	-0.70	AQAAAPASVPAQAPK	AQAAAPASVPAQAPK		15	V20130429-11_FTMSms2hcd	20.590	135	149	28.2	2.7e-9	5.1e-12	1	17752.2	HUMAN	60S ribosomal protein L29
[125]		Q13740	CD166_HUMAN	ALCAM	1	2.6	4.08	6.4e-9	416.5154	4	5.6	VLHPLEGAVVIIFKK	VLHPLEGAVVIIFKK		15	V20130429-11_FTMSms2hcd	51.714	176	190	29.4	6.4e-9	3.8e-10	1	65102.9	HUMAN	CD166 antigen
[126]		O00299	CLIC1_HUMAN	CLIC1	1	3.3	4.08	1.5e-8	533.3115	2	-0.76	LFMVLWLK	LFM(Oxidation)VLWLK	Oxidation@32	8	V20130429-11_FTMSms2hcd	60.032	30	37	31.4	1.5e-8	5.9e-11	1	26923.0	HUMAN	Chloride intracellular channel protein 1
[127]		P49006	MRP_HUMAN	MARCKSL1	1	4.1	3.98	5.9e-8	494.2544	2	-0.79	LSGLSFKR	LSGLS(Phospho)FKR	Phospho@104=15	8	V20130429-11_FTMSms2hcd	29.838	100	107	33.5	5.9e-8	1.2e-10	1	19528.9	HUMAN	MARCKS-related protein
[128]		P67809	YBOX1_HUMAN	YBX1	1	7.4	3.87	1.2e-9	928.7406	3	0.75	EDGNEEDKENQGDETQGQQPPQRR	EDGNEEDKENQGDETQGQQPPQRR		24	V20130429-11_FTMSms2hcd	9.471	257	280	23.3	1.2e-9	1.2e-12	1	35924.5	HUMAN	Nuclease-sensitive element-binding protein 1
[129]		P38646	GRP75_HUMAN	HSPA9	3	4.6	2.04	4.0e-5	479.7513	2	0.092	VLENAEGAR	VLENAEGAR		9	V20130429-11_FTMSms2hcd	10.883	77	85	29.4	4.0e-5	8.5e-8	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[129]		P38646	GRP75_HUMAN	HSPA9	3	4.6	2.04	4.0e-5	814.4094	3	19	KDSETGENIRQAASSLQQASLK	KDSETGENIRQAASS(Phospho)LQQASLK	Phospho@639=11	22	V20130429-11_FTMSms2hcd	46.204	625	646	15.2	0.0021	2.4e-6	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[129]		P38646	GRP75_HUMAN	HSPA9	3	4.6	2.04	4.0e-5	1221.1110	2	20	KDSETGENIRQAASSLQQASLK	KDSETGENIRQAAS(Phospho)SLQQASLK	Phospho@638|639	22	V20130429-11_FTMSms2hcd	46.136	625	646	12.1	0.046	5.4e-5	1	73681.1	HUMAN	Stress-70 protein, mitochondrial
[130]		P23246	SFPQ_HUMAN	SFPQ	1	2.4	3.35	7.7e-8	655.3408	3	-2.3	LFVGNLPADITEDEFKR	LFVGNLPADITEDEFKR		17	V20130429-11_FTMSms2hcd	52.492	299	315	27.9	7.7e-8	1.0e-10	1	76150.0	HUMAN	Splicing factor, proline- and glutamine-rich
[131]		P11413	G6PD_HUMAN	G6PD	1	1.9	3.35	4.1e-8	574.8009	2	-0.079	VQPNEAVYTK	VQPNEAVYTK		10	V20130429-11_FTMSms2hcd	17.340	394	403	26.4	4.1e-8	6.3e-11	1	59257.3	HUMAN	Glucose-6-phosphate 1-dehydrogenase
[132]		Q8N187	AL2S8_HUMAN	ALS2CR8	1	1.0	3.07	2.6e-9	464.2022	2	4.3	VETNQTR	VETNQT(Phospho)R	Phospho@536=42	7	V20130429-11_FTMSms2hcd	13.755	531	537	17.2	2.6e-9	6.4e-12	1	80698.6	HUMAN	Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein
[133]		Q9UQ80	PA2G4_HUMAN	PA2G4	1	4.6	2.96	4.0e-8	919.3839	2	1.9	TAENATSGETLEENEAGD	TAENATSGETLEENEAGD		18	V20130429-11_FTMSms2hcd	23.079	377	394	22.4	4.0e-8	5.6e-11	1	43787.3	HUMAN	Proliferation-associated protein 2G4
[134]		P13010	XRCC5_HUMAN	XRCC5	1	1.2	2.91	3.6e-6	516.3099	2	-1.0	TLFPLIEAK	TLFPLIEAK		9	V20130429-11_FTMSms2hcd	50.711	535	543	32.5	3.6e-6	1.6e-8	1	82705.3	HUMAN	X-ray repair cross-complementing protein 5
[135]		P62750	RL23A_HUMAN	RPL23A	1	8.3	2.90	1.4e-7	702.8600	2	8.7	LAPDYDALDVANK	LAPDYDALDVANK		13	V20130429-11_FTMSms2hcd	37.221	140	152	24.8	1.4e-7	2.0e-10	1	17695.2	HUMAN	60S ribosomal protein L23a
[136]		P46783	RS10_HUMAN	RPS10	1	5.5	2.79	1.7e-6	555.3396	2	10	IAIYELLFK	IAIYELLFK		9	V20130429-11_FTMSms2hcd	64.814	9	17	29.6	1.7e-6	1.4e-8	1	18897.9	HUMAN	40S ribosomal protein S10
[137]		P31689	DNJA1_HUMAN	DNAJA1	1	3.8	2.76	1.3e-7	467.9446	4	-0.91	HYNGEAYEDDEHHPR	HYNGEAYEDDEHHPR		15	V20130429-11_FTMSms2hcd	10.191	375	389	23.2	1.3e-7	2.0e-10	1	44868.6	HUMAN	DnaJ homolog subfamily A member 1
[138]		P63173	RL38_HUMAN	RPL38	1	18.6	2.65	7.2e-8	525.9756	3	1.1	KIEEIKDFLLTAR	KIEEIKDFLLTAR		13	V20130429-11_FTMSms2hcd	45.824	4	16	20.7	7.2e-8	4.6e-10	1	8218.0	HUMAN	60S ribosomal protein L38
[139]		P40227	TCPZ_HUMAN	CCT6A	1	3.2	2.42	1.1e-6	884.5282	2	7.0	AQLGVQAFADALLIIPK	AQLGVQAFADALLIIPK		17	V20130429-11_FTMSms2hcd	75.604	433	449	24.9	1.1e-6	1.8e-8	1	58024.7	HUMAN	T-complex protein 1 subunit zeta
[140]		P26641	EF1G_HUMAN	EEF1G	1	3.2	2.39	7.7e-7	786.9154	2	0.47	KLDPGSEETQTLVR	KLDPGSEETQTLVR		14	V20130429-11_FTMSms2hcd	26.480	401	414	23.7	7.7e-7	1.2e-9	1	50119.2	HUMAN	Elongation factor 1-gamma
[141]		P17844	DDX5_HUMAN	DDX5	1	1.6	2.38	7.3e-6	626.8181	2	0.71	TAQEVETYRR	TAQEVETYRR		10	V20130429-11_FTMSms2hcd	11.632	69	78	28.9	7.3e-6	1.0e-8	1	69148.7	HUMAN	Probable ATP-dependent RNA helicase DDX5
[142]		P36578	RL4_HUMAN	RPL4	1	2.6	2.01	1.0e-6	478.7811	2	2.7	AAAAAAALQAK	AAAAAAALQAK		11	V20130429-11_FTMSms2hcd	16.652	354	364	20.6	1.0e-6	3.5e-9	1	47697.7	HUMAN	60S ribosomal protein L4
[143]		P62316	SMD2_HUMAN	SNRPD2	1	16.9	2.00	2.1e-6	554.3315	4	11	MFLRGDSVIVVLRNPLIAGK	M(Oxidation)FLRGDSVIVVLRNPLIAGK	Oxidation@99	20	V20130429-11_FTMSms2hcd	56.538	99	118	22.1	2.1e-6	4.5e-8	1	13527.0	HUMAN	Small nuclear ribonucleoprotein Sm D2
[144]		Q01469	FABP5_HUMAN	FABP5	1	7.4	1.99	6.2e-5	522.2784	2	1.5	MATVQQLEGR	M(Met-loss+Acetyl)ATVQQLEGR	Met-loss+Acetyl@1	10	V20130429-11_FTMSms2hcd	30.781	1	10	30.0	6.2e-5	1.3e-7	1	15164.6	HUMAN	Fatty acid-binding protein, epidermal
[145]		P08865	RSSA_HUMAN	RPSA	1	5.8	1.98	1.1e-6	870.9780	2	-0.18	AIVAIENPADVSVISSR	AIVAIENPADVSVISSR		17	V20130429-11_FTMSms2hcd	47.346	64	80	20.4	1.1e-6	2.6e-9	1	32854.4	HUMAN	40S ribosomal protein SA
[146]		P62333	PRS10_HUMAN	PSMC6	1	2.8	1.85	2.4e-6	582.7761	2	-17	LSDGFNGADLR	LSDGFNGADLR		11	V20130429-11_FTMSms2hcd	31.261	334	344	20.9	2.4e-6	3.9e-9	1	44173.4	HUMAN	26S protease regulatory subunit 10B
[147]		Q8NC51	PAIRB_HUMAN	SERBP1	1	3.4	1.84	9.8e-6	784.4196	2	1.3	VGRRPDQQLQGEGK	VGRRPDQQLQGEGK		14	V20130429-11_FTMSms2hcd	11.619	109	122	24.1	9.8e-6	1.5e-8	1	44965.7	HUMAN	Plasminogen activator inhibitor 1 RNA-binding protein
[148]		Q6ZQQ6	WDR87_HUMAN	WDR87	1	0.3	1.78	6.0e-6	610.8138	2	0.99	EEKALNLEMK	EEKALNLEM(Oxidation)K	Oxidation@1967	10	V20130429-11_FTMSms2hcd	37.361	1959	1968	22.4	6.0e-6	8.8e-9	1	333188.0	HUMAN	WD repeat-containing protein 87
[149]		P26373	RL13_HUMAN	RPL13	2	6.6	1.54	5.2e-5	475.7498	2	-1.9	GFSLEELR	GFSLEELR		8	V20130429-11_FTMSms2hcd	41.728	75	82	25.1	5.2e-5	9.9e-8	1	24261.7	HUMAN	60S ribosomal protein L13
[149]		P26373	RL13_HUMAN	RPL13	2	6.6	1.54	5.2e-5	379.7491	2	-1.8	LILFPR	LILFPR		6	V20130429-11_FTMSms2hcd	42.294	124	129	19.1	0.016	4.7e-5	1	24261.7	HUMAN	60S ribosomal protein L13
[150]		Q96AE4	FUBP1_HUMAN	FUBP1	1	1.4	1.70	5.7e-6	466.2909	2	2.3	FAVGIVIGR	FAVGIVIGR		9	V20130429-11_FTMSms2hcd	44.110	285	293	21.5	5.7e-6	3.2e-8	2	67560.9	HUMAN	Far upstream element-binding protein 1
[150-1]	0	Q96I24	FUBP3_HUMAN	FUBP3	1	1.6	1.70	5.7e-6	466.2909	2	2.3	FAVGIVIGR	FAVGIVIGR		9	V20130429-11_FTMSms2hcd	44.110	263	271	21.5	5.7e-6	3.2e-8	2	61640.9	HUMAN	Far upstream element-binding protein 3
[151]		Q7Z2K8	GRIN1_HUMAN	GPRIN1	1	1.6	1.69	9.3e-5	807.4628	2	4.6	VGSLPLEKGSPVTTTK	VGSLPLEKGSPVTTTK		16	V20130429-11_FTMSms2hcd	74.315	606	621	27.9	9.3e-5	3.2e-7	1	102400.1	HUMAN	G protein-regulated inducer of neurite outgrowth 1
[152]		Q5VVM6	CCD30_HUMAN	CCDC30	1	1.5	1.68	3.1e-5	695.3221	2	1.2	EGQKEEGSQQNR	EGQKEEGSQQNR		12	V20130429-11_FTMSms2hcd	23.676	166	177	25.2	3.1e-5	4.2e-8	1	91334.1	HUMAN	Coiled-coil domain-containing protein 30
[153]		Q9BZ72	PITM2_HUMAN	PITPNM2	1	0.5	1.64	0.0012	435.2587	2	1.2	LEPLLER	LEPLLER		7	V20130429-11_FTMSms2hcd	30.521	769	775	33.5	0.0012	5.5e-6	1	148934.5	HUMAN	Membrane-associated phosphatidylinositol transfer protein 2
[154]		P17096	HMGA1_HUMAN	HMGA1	1	17.8	1.62	2.2e-6	799.6484	3	1.7	KLEKEEEEGISQESSEEEQ	KLEKEEEEGISQES(Phospho)S(Phospho)EEEQ	Phospho@102=11;Phospho@103=11	19	V20130429-11_FTMSms2hcd	21.039	89	107	18.4	2.2e-6	4.1e-9	1	11676.1	HUMAN	High mobility group protein HMG-I/HMG-Y
[155]		Q56VL3	OCAD2_HUMAN	OCIAD2	1	9.1	1.48	2.3e-7	700.3259	2	-0.21	HGLSEKGDSQPSAS	HGLSEKGDSQPSAS		14	V20130429-11_FTMSms2hcd	9.458	141	154	11.7	2.3e-7	3.1e-10	1	16953.7	HUMAN	OCIA domain-containing protein 2
[156]		O60333	KIF1B_HUMAN	KIF1B	1	0.6	1.47	1.5e-7	727.2896	2	-9.1	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@852;Oxidation@855;Phospho@856	10	V20130429-11_FTMSms2hcd	29.070	849	858	10.6	1.5e-7	3.8e-10	2	204478.0	HUMAN	Kinesin-like protein KIF1B
[156-1]	0	Q12756	KIF1A_HUMAN	KIF1A	1	0.6	1.47	1.5e-7	727.2896	2	-9.1	LDLMREMYDR	LDLM(Oxidation)REM(Oxidation)Y(Phospho)DR	Oxidation@812;Oxidation@815;Phospho@816	10	V20130429-11_FTMSms2hcd	29.070	809	818	10.6	1.5e-7	3.8e-10	2	191065.8	HUMAN	Kinesin-like protein KIF1A
[157]		A6NHP6	YR011_HUMAN		1	3.1	1.47	1.5e-7	727.2896	2	-7.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-11_FTMSms2hcd	29.070	173	182	10.6	1.5e-7	3.8e-10	2	37918.4	HUMAN	NPIP-like protein LOC729602
[157-1]	0	A8MZ50	NPIL4_HUMAN		1	3.0	1.47	1.5e-7	727.2896	2	-7.9	LDMKEIHTYK	LDM(Oxidation)KEIHT(Phospho)Y(Phospho)K	Oxidation@175;Phospho@180;Phospho@181	10	V20130429-11_FTMSms2hcd	29.070	173	182	10.6	1.5e-7	3.8e-10	2	38380.9	HUMAN	Putative NPIP-like protein ENSP00000381263
[158]		P46778	RL21_HUMAN	RPL21	1	9.4	1.39	8.5e-6	547.6431	3	1.8	VYNVTQHAVGIVVNK	VYNVTQHAVGIVVNK		15	V20130429-11_FTMSms2hcd	34.586	64	78	19.3	8.5e-6	2.4e-8	1	18565.0	HUMAN	60S ribosomal protein L21
[159]		P39019	RS19_HUMAN	RPS19	1	6.9	1.33	2.6e-4	563.8507	2	-0.13	RVLQALEGLK	RVLQALEGLK		10	V20130429-11_FTMSms2hcd	34.279	102	111	26.8	2.6e-4	1.8e-6	1	16060.6	HUMAN	40S ribosomal protein S19
[160]		Q12882	DPYD_HUMAN	DPYD	1	1.5	1.14	0.0016	920.4250	2	12	SLSVNEMTLSTLKEK	SLSVNEMT(Phospho)LS(Phospho)TLKEK	Phospho@267&269|267&270|269&270	15	V20130429-11_FTMSms2hcd	28.254	260	274	29.1	0.0016	1.8e-6	1	111402.5	HUMAN	Dihydropyrimidine dehydrogenase [NADP(+)]
[161]		Q96S38	KS6C1_HUMAN	RPS6KC1	1	0.8	1.12	1.3e-6	643.7554	2	8.5	KSSEYSRNR	KS(Phospho)S(Phospho)EYSRNR	Phospho@369=47;Phospho@370|372|373	9	V20130429-11_FTMSms2hcd	23.663	368	376	12.3	1.3e-6	3.3e-9	1	118683.4	HUMAN	Ribosomal protein S6 kinase delta-1
[162]		Q9UHC7	MKRN1_HUMAN	MKRN1	1	2.3	0.92	3.2e-5	760.7839	2	-13	VGTSSRYRAQR	VGT(Phospho)SS(Phospho)RY(Phospho)RAQR	Phospho@407=19;Phospho@409=29;Phospho@411=48	11	V20130429-11_FTMSms2hcd	12.401	405	415	17.7	3.2e-5	1.1e-7	1	53350.0	HUMAN	E3 ubiquitin-protein ligase makorin-1
[163]		Q6ZS72	CS035_HUMAN	C19orf35	1	1.9	0.88	1.3e-4	541.3642	2	-9.7	VRRGLLVLR	VRRGLLVLR		9	V20130429-11_FTMSms2hcd	59.473	426	434	20.6	1.3e-4	7.9e-6	1	50509.8	HUMAN	Putative uncharacterized protein C19orf35
[164]		Q9C0D5	TANC1_HUMAN	TANC1	1	0.9	0.84	9.6e-5	704.9985	3	-5.2	FPREGFGEDMRPFNELR	FPREGFGEDM(Oxidation)RPFNELR	Oxidation@1328	17	V20130429-11_FTMSms2hcd	55.613	1319	1335	19.5	9.6e-5	9.5e-8	1	202221.0	HUMAN	Protein TANC1
[165]		Q0D2J5	ZN763_HUMAN	ZNF763	1	2.8	0.84	8.4e-5	668.3305	2	14	ALSYKFSNTPK	ALSYKFS(Phospho)NTPK	Phospho@382|384	11	V20130429-11_FTMSms2hcd	29.608	376	386	19.2	8.4e-5	1.2e-7	1	46099.6	HUMAN	Zinc finger protein 763
[166]		O14744	ANM5_HUMAN	PRMT5	1	3.3	0.77	1.2e-4	775.7755	3	5.9	AAILPTSIFLTNKKGFPVLSK	AAILPTSIFLT(Phospho)NKKGFPVLSK	Phospho@238|247	21	V20130429-11_FTMSms2hcd	59.713	228	248	19.4	1.2e-4	8.1e-7	1	72684.5	HUMAN	Protein arginine N-methyltransferase 5
[167]		Q9NXG0	CNTLN_HUMAN	CNTLN	1	0.7	0.73	0.0021	376.5479	3	1.0	RQVAEANALR	RQVAEANALR		10	V20130429-11_FTMSms2hcd	15.863	776	785	25.6	0.0021	6.4e-6	1	161604.6	HUMAN	Centlein
[168]		Q15233	NONO_HUMAN	NONO	1	3.2	0.66	4.2e-5	801.8270	2	-1.5	MGQMAMGGAMGINNR	M(Oxidation)GQM(Oxidation)AM(Oxidation)GGAM(Oxidation)GINNR	Oxidation@384;Oxidation@387;Oxidation@389;Oxidation@393	15	V20130429-11_FTMSms2hcd	9.877	384	398	15.8	4.2e-5	9.0e-8	1	54232.0	HUMAN	Non-POU domain-containing octamer-binding protein
[169]		Q9NR33	DPOE4_HUMAN	POLE4	1	9.4	0.66	4.9e-5	636.3226	2	7.6	AAELFVETIAK	AAELFVET(Phospho)IAK	Phospho@77	11	V20130429-11_FTMSms2hcd	35.155	70	80	16.1	4.9e-5	7.2e-8	1	12208.9	HUMAN	DNA polymerase epsilon subunit 4
[170]		O43390	HNRPR_HUMAN	HNRNPR	1	2.1	0.63	4.3e-5	805.4162	2	16	DLYEDELVPLFEK	DLYEDELVPLFEK		13	V20130429-11_FTMSms2hcd	61.400	175	187	15.5	4.3e-5	5.5e-8	1	70943.6	HUMAN	Heterogeneous nuclear ribonucleoprotein R
[171]		Q6ZVZ8	ASB18_HUMAN	ASB18	1	4.9	0.62	2.8e-4	1106.0583	2	13	GAHVDARNGRGETALSAACGAAR	GAHVDARNGRGETALSAACGAAR		23	V20130429-11_FTMSms2hcd	45.372	242	264	19.8	2.8e-4	3.2e-7	1	50803.8	HUMAN	Ankyrin repeat and SOCS box protein 18
[172]		O95466	FMNL_HUMAN	FMNL1	1	0.9	0.51	0.0021	569.2686	2	-0.049	RDSELGPGVK	RDS(Phospho)ELGPGVK	Phospho@624	10	V20130429-11_FTMSms2hcd	16.704	622	631	23.4	0.0021	3.7e-6	1	121854.6	HUMAN	Formin-like protein 1
[173]		Q96MH6	TMM68_HUMAN	TMEM68	1	3.7	0.50	0.046	665.3608	2	-3.9	IPGNIMSALLER	IPGNIM(Oxidation)SALLER	Oxidation@316	12	V20130429-11_FTMSms2hcd	19.597	311	322	30.6	0.046	8.0e-5	1	37425.1	HUMAN	Transmembrane protein 68
[174]		Q86UQ4	ABCAD_HUMAN	ABCA13	1	0.1	0.50	0.0038	426.2717	2	1.4	HILDIIK	HILDIIK		7	V20130429-11_FTMSms2hcd	36.100	994	1000	24.7	0.0038	5.3e-5	1	576164.4	HUMAN	ATP-binding cassette sub-family A member 13
[175]		P08069	IGF1R_HUMAN	IGF1R	1	0.5	0.47	4.3e-5	523.7285	2	4.0	YRPPDYR	YRPPDY(Phospho)R	Phospho@517=53	7	V20130429-11_FTMSms2hcd	15.636	512	518	13.9	4.3e-5	9.1e-8	1	154794.5	HUMAN	Insulin-like growth factor 1 receptor
[176]		Q9Y6I7	WSB1_HUMAN	WSB1	1	2.6	0.47	7.6e-5	646.3331	2	9.7	MASFPPRVNEK	M(Oxidation)ASFPPRVNEK	Oxidation@1	11	V20130429-11_FTMSms2hcd	54.756	1	11	15.2	7.6e-5	1.1e-7	1	47432.6	HUMAN	WD repeat and SOCS box-containing protein 1
[177]		Q8NG11	TSN14_HUMAN	TSPAN14	1	3.0	0.45	0.0037	416.7426	2	0.56	GVLSDLTK	GVLSDLTK		8	V20130429-11_FTMSms2hcd	44.636	45	52	24.2	0.0037	7.3e-6	1	30691.1	HUMAN	Tetraspanin-14
[178]		Q9Y520	PRC2C_HUMAN	PRRC2C	1	0.3	0.45	2.6e-4	371.2089	3	11	LPDLSPVENK	LPDLSPVENK		10	V20130429-11_FTMSms2hcd	19.956	2101	2110	17.9	2.6e-4	7.2e-7	1	316913.6	HUMAN	Protein PRRC2C
[179]		Q9Y5S1	TRPV2_HUMAN	TRPV2	1	1.4	0.36	0.014	643.8450	2	4.2	LCPTVQLEDIR	LCPTVQLEDIR		11	V20130429-11_FTMSms2hcd	15.286	280	290	26.4	0.014	2.2e-5	1	85981.9	HUMAN	Transient receptor potential cation channel subfamily V member 2
[180]		Q8NDV7	TNR6A_HUMAN	TNRC6A	1	1.0	0.32	3.2e-5	1136.9728	2	12	MEIDDGTSAWGDPSKYNYK	M(Oxidation)EIDDGTSAWGDPSKY(Phospho)NYK	Oxidation@999;Phospho@1014|1016	19	V20130429-11_FTMSms2hcd	43.420	999	1017	11.7	3.2e-5	4.2e-8	1	210298.9	HUMAN	Trinucleotide repeat-containing gene 6A protein
[181]		Q4G0M1	F132B_HUMAN	FAM132B	1	4.0	0.29	3.0e-4	750.3665	2	17	AGPAARPPEPTAER	AGPAARPPEPT(Phospho)AER	Phospho@69	14	V20130429-11_FTMSms2hcd	24.576	59	72	16.6	3.0e-4	3.7e-7	1	37279.2	HUMAN	Protein FAM132B
[182]		P13667	PDIA4_HUMAN	PDIA4	1	2.0	0.29	3.8e-4	751.8785	2	18	FEGGDRDLEHLSK	FEGGDRDLEHLSK		13	V20130429-11_FTMSms2hcd	37.133	617	629	17.2	3.8e-4	5.2e-7	1	72933.1	HUMAN	Protein disulfide-isomerase A4
[183]		Q02224	CENPE_HUMAN	CENPE	1	0.3	0.27	0.090	457.2833	2	1.7	LLRENLR	LLRENLR		7	V20130429-11_FTMSms2hcd	19.468	2498	2504	29.9	0.090	3.3e-4	1	316417.9	HUMAN	Centromere-associated protein E
[184]		Q9H2D6	TARA_HUMAN	TRIOBP	1	0.3	0.20	0.0012	488.2711	2	-0.80	LSEEIEKK	LSEEIEKK		8	V20130429-11_FTMSms2hcd	28.371	2022	2029	19.0	0.0012	2.1e-6	1	261377.7	HUMAN	TRIO and F-actin-binding protein
[185]		A1L390	PKHG3_HUMAN	PLEKHG3	1	1.1	0.16	3.3e-5	719.3250	2	7.8	IWEGMESSGGSPGK	IWEGM(Oxidation)ESSGGSPGK	Oxidation@821	14	V20130429-11_FTMSms2hcd	55.012	817	830	10.2	3.3e-5	4.5e-8	1	134413.3	HUMAN	Pleckstrin homology domain-containing family G member 3
[186]		O95747	OXSR1_HUMAN	OXSR1	1	1.7	0.12	3.2e-4	536.2743	2	-1.5	IVEEPQSNR	IVEEPQSNR		9	V20130429-11_FTMSms2hcd	14.215	489	497	15.1	3.2e-4	5.6e-7	1	58022.7	HUMAN	Serine/threonine-protein kinase OSR1
[187]		Q86UP3	ZFHX4_HUMAN	ZFHX4	1	0.3	0.12	3.2e-4	723.3602	2	5.7	LQIHSQYHAIR	LQIHSQY(Phospho)HAIR	Phospho@1373=10	11	V20130429-11_FTMSms2hcd	42.706	1367	1377	15.1	3.2e-4	4.1e-7	1	393733.1	HUMAN	Zinc finger homeobox protein 4
[188]		Q14320	FA50A_HUMAN	FAM50A	1	4.7	0.10	1.5e-4	890.4023	2	-11	LLSDATVEKDESHAGK	LLSDAT(Phospho)VEKDESHAGK	Phospho@295=19	16	V20130429-11_FTMSms2hcd	43.833	290	305	13.2	1.5e-4	1.8e-7	1	40241.9	HUMAN	Protein FAM50A
[189]		Q08257	QOR_HUMAN	CRYZ	1	3.3	0.06	0.0042	407.8879	3	-1.8	VFEFGGPEVLK	VFEFGGPEVLK		11	V20130429-11_FTMSms2hcd	18.431	13	23	20.6	0.0042	7.4e-6	1	35206.9	HUMAN	Quinone oxidoreductase
[190]		P60842	IF4A1_HUMAN	EIF4A1	1	3.4	0.02	2.1e-4	803.4200	2	3.9	KGVAINMVTEEDKR	KGVAINM(Oxidation)VTEEDKR	Oxidation@375	14	V20130429-11_FTMSms2hcd	18.817	369	382	13.2	2.1e-4	2.9e-7	1	46154.4	HUMAN	Eukaryotic initiation factor 4A-I
[191]		Q01995	TAGL_HUMAN	TAGLN	1	6.0	0.02	6.5e-5	613.2858	2	1.1	MANKGPSYGMSR	M(Met-loss+Acetyl)ANKGPSYGM(Oxidation)SR	Met-loss+Acetyl@1;Oxidation@10	12	V20130429-11_FTMSms2hcd	11.040	1	12	10.4	6.5e-5	1.0e-7	1	22611.1	HUMAN	Transgelin
[192]		P20020	AT2B1_HUMAN	ATP2B1	1	0.9	0.01	0.014	658.3521	2	0.36	GLQSRIEQEQK	GLQSRIEQEQK		11	V20130429-11_FTMSms2hcd	13.977	183	193	22.9	0.014	2.0e-5	3	138756.4	HUMAN	Plasma membrane calcium-transporting ATPase 1
[192-1]	0	Q01814	AT2B2_HUMAN	ATP2B2	1	0.9	0.01	0.014	658.3521	2	0.36	GLQSRIEQEQK	GLQSRIEQEQK		11	V20130429-11_FTMSms2hcd	13.977	181	191	22.9	0.014	2.0e-5	3	136877.5	HUMAN	Plasma membrane calcium-transporting ATPase 2
[192-2]	0	Q16720	AT2B3_HUMAN	ATP2B3	1	0.9	0.01	0.014	658.3521	2	0.36	GLQSRIEQEQK	GLQSRIEQEQK		11	V20130429-11_FTMSms2hcd	13.977	184	194	22.9	0.014	2.0e-5	3	134198.3	HUMAN	Plasma membrane calcium-transporting ATPase 3
